{
 "cells": [
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "# Pre-match pipeline with tagged trials set\n",
    "\n",
    "using the deepseek-r1:14b to tagged the patient and the trials"
   ],
   "id": "10aa3c0e70318ce1"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "### load data",
   "id": "14eccde4da8d0452"
  },
  {
   "cell_type": "code",
   "id": "initial_id",
   "metadata": {
    "collapsed": true,
    "ExecuteTime": {
     "end_time": "2025-07-15T04:09:42.607669Z",
     "start_time": "2025-07-15T04:09:42.578604Z"
    }
   },
   "source": [
    "import pandas as pd\n",
    "from fsspec.asyn import private\n",
    "from sqlalchemy import false\n",
    "\n",
    "# patient_df = pd.read_csv('./data/input/Prematch OncoPATH_20250303-07.csv')\n",
    "patient_file = 'OncoPATH Prematch 20250630-0704'\n",
    "trial_file = '06 NCCS_CT dd 10May2025'\n",
    "\n",
    "patient_df = pd.read_excel(f'./data/input/patient/{patient_file}.xlsx')\n",
    "trials_df = pd.read_csv(f'./data/input/trials/{trial_file}.csv')\n",
    "\n",
    "trials_df.columns, patient_df.columns"
   ],
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(Index(['Trial Name', 'Site', 'Stage of cancer', 'Title of Study', 'Trial ID',\n",
       "        'Unnamed: 5', 'Study Description', 'Inclusion Criteria',\n",
       "        'Exclusion Criteria', 'Study Status', 'No. of patients accrued',\n",
       "        'Target number', 'Phase', 'Targeting mutation'],\n",
       "       dtype='object'),\n",
       " Index(['Patient_No', 'Primary', 'Stage', 'Clinical Note'], dtype='object'))"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 20
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "#### clean trials name",
   "id": "5b489c5a706822e9"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:09:43.276075Z",
     "start_time": "2025-07-15T04:09:43.269058Z"
    }
   },
   "cell_type": "code",
   "source": [
    "clear_name = []\n",
    "for i, name in enumerate(trials_df['Trial Name']):\n",
    "    # print(i,name)\n",
    "    name = name.replace('\\n', ' ').replace('\\t', ' ')\n",
    "    print(i,name)\n",
    "    clear_name.append(name)\n",
    "trials_df['Trial Name'] = clear_name\n",
    "trials_df.to_csv(f'./data/input/trials/{trial_file}.csv', index=False)"
   ],
   "id": "9a73e15a1e0abed5",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0 TAPISTRY\n",
      "1 BAYER 21820\n",
      "2 EBC-129-01\n",
      "3 NVL-520-01\n",
      "4 PRT3789-01 \n",
      "5 NVL-655-01\n",
      "6 PAUF-I\n",
      "7 CAAA603D12101\n",
      "8 PMV-586-101\n",
      "9 ZWI-ZW191-01\n",
      "10 ALE.P02.01\n",
      "11 SGNDV-001\n",
      "12 BT8009-230\n",
      "13 LaPemERLA\n",
      "14 ELEVATE\n",
      "15 INAVO122\n",
      "16 TROPION-Breast04\n",
      "17 CO44657\n",
      "18 J2J-MC-JZLH / EMBER-4\n",
      "19 MK-2870-012\n",
      "20 ASPEN-06\n",
      "21 D9800C00001 / CLARITY-PanTumour01\n",
      "22 CA209-7R9\n",
      "23 AHCC09\n",
      "24 AHCC12\n",
      "25 BO42777 (HORIZON01)\n",
      "26 BI 1479-0008 (BEAMION LUNG-02)\n",
      "27 HMBD-001-103\n",
      "28 D5087C00001 SAFFRON\n",
      "29 20230016 DeLLphi-306\n",
      "30 BO45217 Krascendo 1\n",
      "31 TAS6417-301 \n",
      "32 LUNAR-2 EF-44 \n",
      "33 20230153\n",
      "34 V940-009\n",
      "35 IOV-LUN-202\n",
      "36 M25-274\n",
      "37 GSK 213823\n",
      "38 MK2140-006\n",
      "39 POLAR\n",
      "40 R1979-HM-2299  OLYMPIA-4\n",
      "41 CA073-1020 GOLSEEK-1\n",
      "42 M22-128\n",
      "43 SG-AAA-II-01 / CAAA601A0SG01T\n",
      "44 LDOXIRI-PDAC-01\n",
      "45 CAAA617D12302\n",
      "46 MK-5684-003\n",
      "47 MK5684-004\n",
      "48 CAAA817A12201\n",
      "49 AMG 20230005\n",
      "50 XL092-304\n",
      "51 APL10101 SPARTA\n",
      "52 TPX-0005-01 TRIDENT-1\n",
      "53 NCCS-2018-Phase2-PRL3\n",
      "54 STCC-01\n",
      "55 MK6482-015\n",
      "56 TORL123-002\n"
     ]
    }
   ],
   "execution_count": 21
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "### summarize the patient profile",
   "id": "f947547d524fa029"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "the summarize model",
   "id": "54e3c360094b54dd"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:09:44.931325Z",
     "start_time": "2025-07-15T04:09:44.929021Z"
    }
   },
   "cell_type": "code",
   "source": [
    "from ollama import chat\n",
    "from ollama import ChatResponse\n",
    "\n",
    "\n",
    "def Ask_LLM(model, role, query):\n",
    "    response: ChatResponse = chat(model=model,\n",
    "                                  messages=[\n",
    "                                      {'role': 'system', 'content': role},\n",
    "                                      {'role': 'user', 'content': query},\n",
    "                                  ],\n",
    "                                  options={\n",
    "                                      'temperature': 0  # very conservative (good for coding and correct syntax)\n",
    "                                  })\n",
    "\n",
    "    return response.message.content"
   ],
   "id": "50b40ce1ae64c66f",
   "outputs": [],
   "execution_count": 22
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "summarize profile",
   "id": "9c66acb92422e0b0"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "de-identify process",
   "id": "f3d1f3777358810"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:09:50.717086Z",
     "start_time": "2025-07-15T04:09:48.666149Z"
    }
   },
   "cell_type": "code",
   "source": [
    "from transformers import pipeline\n",
    "\n",
    "pipe = pipeline(\"token-classification\", model=\"StanfordAIMI/stanford-deidentifier-base\", device=\"cuda\")"
   ],
   "id": "645ae43b4029c935",
   "outputs": [],
   "execution_count": 23
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:09:50.724910Z",
     "start_time": "2025-07-15T04:09:50.721653Z"
    }
   },
   "cell_type": "code",
   "source": [
    "\n",
    "def aggregate_masks(deindentify_marks):\n",
    "    if len(deindentify_marks) == 0:\n",
    "        return deindentify_marks\n",
    "    new_deindentify_marks = []\n",
    "    # print(deindentify_marks)\n",
    "    new_deindentify_marks.append(deindentify_marks[0])\n",
    "    for mark in deindentify_marks[1:]:\n",
    "        if (mark['index'] - new_deindentify_marks[-1]['index'] == 1) and (\n",
    "                mark['entity'] == new_deindentify_marks[-1]['entity']):\n",
    "            new_deindentify_marks[-1]['end'] = mark['end']\n",
    "            new_deindentify_marks[-1]['index'] = mark['index']\n",
    "        else:\n",
    "            new_deindentify_marks.append(mark)\n",
    "    # print(new_deindentify_marks)\n",
    "    return new_deindentify_marks\n",
    "\n",
    "\n",
    "def deidentify(sentence, deindentify_marks):\n",
    "    sentence = list(sentence)\n",
    "    last_end = 0\n",
    "    marked_sentence = ''\n",
    "    aggregate_deindentify_marks = aggregate_masks(deindentify_marks)\n",
    "    for mark in aggregate_deindentify_marks:\n",
    "        marked_sentence += ''.join(sentence[last_end:mark['start']]) + '<' + mark['entity'] + '>'\n",
    "        last_end = mark['end']\n",
    "    if last_end < len(sentence):\n",
    "        marked_sentence += ''.join(sentence[last_end:])\n",
    "    return ''.join(marked_sentence)"
   ],
   "id": "c52f8d8e2781cc81",
   "outputs": [],
   "execution_count": 24
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "test de-id",
   "id": "9b9fbbe6fb41202d"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:09:50.771086Z",
     "start_time": "2025-07-15T04:09:50.768426Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# summarized_patients = []\n",
    "# de_identify_patients = []\n",
    "# for patient, in zip(patient_df['Clinical Note']):\n",
    "#     de_indentify_result = pipe(patient)\n",
    "#     # print(de_indentify_result)\n",
    "#     de_identify_patients.append(deidentify(patient, de_indentify_result))\n",
    "#     print(de_identify_patients[-1])"
   ],
   "id": "c3bcb7033a10dcd8",
   "outputs": [],
   "execution_count": 25
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "summarize patient data",
   "id": "205201d708ab8742"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:09:50.819048Z",
     "start_time": "2025-07-15T04:09:50.816217Z"
    }
   },
   "cell_type": "code",
   "source": [
    "llm_query_role = 'you are an experienced oncology physician'\n",
    "patient_llm_query_prompt = 'I have a patient which profile is below: {patient_profile}, can you tell the cancer site, cancer stage from it with no more information as the following structure: {structure}, Do not add preceding text before the abstraction, and do not add notes or commentary afterwards. This will not be used for clinical care, so do not write any disclaimers or cautionary notes.'\n",
    "Ner_response_structure = {\n",
    "    \"diagnosis\": 'cancer site',\n",
    "    \"stage\": 'cancer stage'\n",
    "}"
   ],
   "id": "21bced131b861510",
   "outputs": [],
   "execution_count": 26
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:16:04.425966Z",
     "start_time": "2025-07-15T04:09:50.866415Z"
    }
   },
   "cell_type": "code",
   "source": [
    "summarized_patients = []\n",
    "de_identify_patients = []\n",
    "for patient in patient_df['Clinical Note']:\n",
    "    de_indentify_result = pipe(patient)\n",
    "    de_identify_patients.append(deidentify(patient, de_indentify_result))\n",
    "    # print(deidentify(patient, de_indentify_result))\n",
    "    summarized_patients.append(Ask_LLM(model='deepseek-r1:14b',\n",
    "                                       role=llm_query_role,\n",
    "                                       query=patient_llm_query_prompt.format(patient_profile=patient,\n",
    "                                                                             structure=Ner_response_structure)))\n",
    "\n",
    "patient_df['Clinical Note'] = de_identify_patients"
   ],
   "id": "600e8dcd1f005871",
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "You seem to be using the pipelines sequentially on GPU. In order to maximize efficiency please use a dataset\n"
     ]
    }
   ],
   "execution_count": 27
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "~~summarize trials data~~  now the site and stage are given in the file",
   "id": "e4407f368949e8d1"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:24.030015Z",
     "start_time": "2025-07-15T04:20:24.026883Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# llm_query_role = 'you are an experienced oncology physician'\n",
    "# trial_llm_query_prompt = '''I have a trials information below: {trial_info}, can you tell the cancer site, cancer stage the trial requiring with no more information as the following structure: {structure}, if there are more than one sub trials, you can show as following structure {more_structure}. Use only double quotes in response. Just answering once using the structure. Do not add preceding text before the abstraction, and do not add notes or commentary afterwards. This will not be used for clinical care, so do not write any disclaimers or cautionary notes.'''\n",
    "# Ner_response_structure = {\n",
    "#     \"diagnosis\": 'cancer site',\n",
    "#     \"stage\": 'cancer stage'\n",
    "# }\n",
    "# multi_structure = {\n",
    "#     \"1\": {\"diagnosis\": \"cancer site\", \"stage\": \"cancer stage\"},\n",
    "#     \"2\": {\"diagnosis\": \"cancer site\", \"stage\": \"cancer stage\"},\n",
    "#     \"3\": {\"diagnosis\": \"cancer site\", \"stage\": \"cancer stage\"},\n",
    "# }"
   ],
   "id": "e2387b54353609dd",
   "outputs": [],
   "execution_count": 28
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:24.325004Z",
     "start_time": "2025-07-15T04:20:24.322567Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# summarized_trials = []\n",
    "# for title, study, inclusion in zip(trials_df['Title of Study'], trials_df['Study Description'],\n",
    "#                                    trials_df['Inclusion Criteria']):\n",
    "#     summarized_trials.append(Ask_LLM(model='deepseek-r1:14b',\n",
    "#                                      role=llm_query_role,\n",
    "#                                      query=trial_llm_query_prompt.format(trial_info=title + study + inclusion,\n",
    "#                                                                          structure=Ner_response_structure,\n",
    "#                                                                          more_structure=multi_structure)))"
   ],
   "id": "9203375072b21042",
   "outputs": [],
   "execution_count": 29
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:24.652667Z",
     "start_time": "2025-07-15T04:20:24.649575Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# for s in summarized_trials:\n",
    "#     print(s)\n",
    "#\n",
    "# trials_df['site_stage_from_deepseek'] = summarized_trials\n",
    "\n",
    "# if not os.path.exists('./data/output/example/'):\n",
    "#     os.makedirs('./data/output/example/')\n",
    "# trials_df.to_csv('./data/output/example/06 NCCS_CT dd 10May2025_deepseek.csv')"
   ],
   "id": "441c36c9f0e33ee2",
   "outputs": [],
   "execution_count": 30
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "prepare patient data, get the NER result",
   "id": "9503583eb271a8cb"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:25.283766Z",
     "start_time": "2025-07-15T04:20:25.258273Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import json\n",
    "\n",
    "\n",
    "class Patient():\n",
    "    def __init__(self, cancer_site, cancer_stage, patient_number):\n",
    "        self.site = cancer_site\n",
    "        self.stage = cancer_stage\n",
    "        self.score = dict()\n",
    "        self.mapped_site = []\n",
    "        self.profile = ''\n",
    "        self.patient_number = patient_number\n",
    "\n",
    "    def add_profile(self, profile):\n",
    "        self.profile = profile\n",
    "\n",
    "    def mapping_site(self, mapped_site):\n",
    "        self.mapped_site = mapped_site\n",
    "\n",
    "\n",
    "summarized_patient_json = []\n",
    "patient_list = []\n",
    "\n",
    "for sp, profile, patient_number in zip(summarized_patients, patient_df['Clinical Note'], patient_df['Patient_No']):\n",
    "    # print(sp)\n",
    "    ind_left = sp.find('{')\n",
    "    ind_right = sp.find('}')\n",
    "    sp = sp[ind_left:ind_right + 1]\n",
    "    # print(sp, profile)\n",
    "    patient_json = json.loads(sp.replace(\"'\", '\"').replace(\"\\\\n\", \"\"))\n",
    "    summarized_patient_json.append(patient_json)\n",
    "    patient = Patient(cancer_site=[patient_json['diagnosis']], cancer_stage=[patient_json['stage']], patient_number=patient_number)\n",
    "    patient.add_profile(profile)\n",
    "    patient_list.append(patient)\n",
    "\n",
    "full_patient_profile_template = '''the patient is having {cancer_site}, which is {cancer_stage}, patient's known gene mutations are {gene}, known prior treatments are {treatments}. other related information are {related}'''\n",
    "patient_site_stage_template = '''the patient is having {cancer_site}, which is {cancer_stage}'''"
   ],
   "id": "46a9b2ef43a17aab",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'diagnosis': 'Small cell neuroendocrine carcinoma of left axillary lymph node', 'stage': 'Stage IV'} \n",
      "78 yr old indonesia male\n",
      "married with 5 children\n",
      "own business\n",
      "\n",
      "ex smoker\n",
      "\n",
      "NKDA\n",
      "\n",
      "ischaemic cardiomyopathy LVEF 30%\n",
      "AMI in 2010\n",
      "mild CKD\n",
      "fundoplication\n",
      "right inguinal hernia repair\n",
      "previous BPPV\n",
      "\n",
      "\n",
      "felt left axillary lymph node mass\n",
      "\n",
      "CT PET <DATE>\n",
      "left axillary lymph node mass\n",
      "\n",
      "several sub-cm lung nodules\n",
      "\n",
      "likely benign adrenal hyperplasia\n",
      "\n",
      "cardiomegaly\n",
      "\n",
      "prostatomegaly\n",
      "\n",
      "\n",
      "histology :\n",
      "left axillary lump biopsy done <DATE> : met small cell neuroendocrine carcinoma\n",
      "Ki67% 50-60%\n",
      "high grade undifferentiated\n",
      "\n",
      "started etoposide + carboplatin and atezolizumab under <HCW> at <HOSPITAL>\n",
      "\n",
      "oe :\n",
      "alert + lucid\n",
      "cx ln- and sc ln-\n",
      "hlungs clear\n",
      "left axillary LN+\n",
      "abdomen soft + non tender\n",
      "no masses felt\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "{'diagnosis': 'clear cell ovarian cancer', 'stage': 'Stage 4B'} 1) Stage 4B clear cell ovarian cancer \n",
      "- presented in 2017 with new-onset ascites; staging investigations (bone scan) then had shown solitary rib metastases. CA125 at diagnosis was 524 \n",
      "- s/p THBSO with pelvic LN dissection \n",
      "- s/p 6 cycles of adjuvant Pac/Carbo in 2017 (<HCW>) \n",
      "- <DATE> noted CA 125 rising from 13.3 > 29.3\n",
      "- CTTAP done on <DATE> showed interval development of two left lower lobe lung masses ? primary lung malignancy or metastases.  \n",
      "Initially declined lung biopsy which was eventually taken on <DATE> showed metastatic carcinoma of Mullerian origin \n",
      "<DATE>- <DATE> : pac/carbo 4 cycles ( declined  bevacizumab) -> progressed\n",
      "<DATE> : gemcitabine/carboplatin and bevacizumab \n",
      "\n",
      "PMH : \n",
      "1) <DATE> Small bowel intestinal obstruction 2' adhesions cx small bowel perforation with 4 quadrant faeculent peritonitis \n",
      "<DATE>.<DATE> s/p diagnostic laparotomy, adhesiolysis and small bowel resection <DATE> ( <HCW> , DSO)\n",
      "\n",
      "FH : No family history of Malignancy\n",
      "\n",
      "Social history:\n",
      "Stays with husband\n",
      "No children\n",
      "Retired beautician\n",
      "Non smoker, Non drinker\n",
      "\n",
      "Finances : <VENDOR>, <VENDOR> , No IP\n",
      "SOC 70%MAF75% MG; well   \n",
      "came alone  \n",
      "otherwise feels well   \n",
      "no chest pain   \n",
      "no SOB   \n",
      "\n",
      "has ulcers using oracort\n",
      " \n",
      "Vital Signs:  \n",
      "BP 147 / 76mmHg (<DATE> 10:42:00)   Ht: 153.8 cm (<DATE> 08:21:20)  Wt: 38.9 kg (<DATE> 08:21:20)  BSA: 1.29 m2   BMI: 16.4  \n",
      "  \n",
      "P/E   \n",
      "Not toxic.        \n",
      "Pallor - none       \n",
      "Jaundice - none       \n",
      "Lymph nodes - none    \n",
      "Cardiovascular: Heart sounds  S1 and S2, No murmurs       \n",
      "Respiratory: clear   \n",
      "Abdominal: Soft nontender, nondistended, no palpable liver or spleen or mass. no LL edema   \n",
      "   \n",
      "ca 125 169 ->132-> 45.9 -> 40.1\n",
      "plt 94\n",
      "Hb 7.3 g/dL \n",
      " \n",
      " \n",
      "Imp :recurrent clear cell ovarian cancer , now on 3nd line gem/carbo   + bevacizumab \n",
      " \n",
      " \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "{'diagnosis': 'cancer site', 'stage': 'cancer stage'} Oncological Diagnosis\n",
      "1. Metastatic cholangiocarcinoma\n",
      "- SOD: liver, non regional LN (supradiaphragmatic, para-aortic, gastrohepatic, periportal) \n",
      "\n",
      "Cx hypercalcemia on Denosumab \n",
      "\n",
      "Tx\n",
      "<DATE>-<DATE>: s/p palliative first-line Gem/Cis/Durva (Durva added from #2) (20.5.24-29.8.24) -> PD \n",
      "- Initially dx and tx in Onc<HOSPITAL> (<HCW>), received #1 Gem-Cis in private \n",
      "- Care transferred to <HOSPITAL> for financial concerns from #2 \n",
      "<DATE>: s/p palliative second-line #2 FOLFOX (3-17.10.24) -> PD after #2 \n",
      "- Omitted 5FU bolus and required dose reduction for fatigue \n",
      "<DATE>-<DATE>: s/p palliative third-line #8 Pemigatinib (19.11.24-15.4.25) -> PR after #4 -> PD after #8\n",
      "<DATE>-present: s/p palliative fourth-line #1 5FU-NalIRI (13.5.25-3.6.25)\n",
      "\n",
      "IMPACT\n",
      "PBRM1 stop_gained Exon17 c.2208T>A p.(Cys736*)23.4%\n",
      "Amplification2(number of copies)\n",
      "DDR2 (1), EIF1AX (5.23), ARAF (4.9), AR (5.2)\n",
      "Fusion\n",
      "FGFR2 (exon 17) :: BICC1 (exon 3) / Read counts: 825838\n",
      "Tumour Mutation Burden (TMB)3\n",
      "* The estimated mutation burden = 3.79 mutations per Mbp.\n",
      "\n",
      "PMHx DM, IHD, AF on Apixaban, R mid-pole thyroid nodules (TR-3, FNAC not feasible to bx due to location)\n",
      "\n",
      "Lives with wife, youngest son, helper \n",
      "$$ No Pte insurance. <VENDOR>. <HOSPITAL>. \n",
      "\n",
      "Pt son HP <ID>; \n",
      "-\n",
      "DMO EXP Clinic      \n",
      "Consultant: <HCW>    \n",
      "EXP Reg: <HCW>  \n",
      "Please contact EXP reg for any issues      \n",
      "-\n",
      "\n",
      "Reason for Visit: Due for #2 5FU-Nal-IRI \n",
      "\n",
      "Came with son\n",
      "\n",
      "On Review\n",
      "Came in wheelchair\n",
      "G1 RIF pain from hernia - improved\n",
      "G1 onycholysis \n",
      "G0 oral ulcers\n",
      "G2 lethargy\n",
      "G1 anorexia \n",
      "\n",
      "O/E\n",
      "Ht 170cm\n",
      "Wt 56.6kg (<DATE>) -> 55.6kg (<DATE>) -> 53.9 kg -> 54.3kg -> 53.2kg -> 53.9kg -> 51.25kg (today) \n",
      "\n",
      "Came in wheelchair \n",
      "Alert, oriented \n",
      "H: S1S2  \n",
      "L: clear, no obvious creps/rhonchi      \n",
      "Abdo: SNT, not distended, no organomegaly/palpable mass, BS +      \n",
      "- Right inguinal lump palpable on standing, reducible \n",
      "Ext: No pedal oedema. Calves supple.    \n",
      "           \n",
      "Investigations\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "03/06/25\tHb: 10.4(L), WBC: 6.78, Hct: 31.4(L), Plt: 158. \n",
      "03/06/25\tNa: 135(L), K+: 3.7, Cl: 102, HCO3: 26.8, Urea: 8.1(H), Cre: 65, Glu:13.2(H). \n",
      "03/06/25\tTP: 62(L), Alb: 36(L), Bil: 13, AST: 92(H), ALT: 33, ALP: 159(H). \n",
      "03/06/25\tCA 19-9: 223(H). \n",
      "03/06/25\tCalcium : 2.46, Phosphate : 0.74(L). \n",
      "  \n",
      "Tumour Markers:\n",
      "Ca 19-9 56 > 46.2 > 60 > 99 > 129 > 38.0 > 47.8 > 57.5 > 44.7 > 47.7 > 63.8 > 81.6 > 105 > 223\n",
      "\n",
      "Radiological:\n",
      "28.4.25 CT T/A/P showed PD in liver metastases, other sites of disease SD\n",
      "\n",
      "Assessment\n",
      "1. Fit for treatment \n",
      "2. G2 Cr elevation and G1 hyperphosphatemia likely from Pemigatinib \n",
      "3. Low volume progression of liver mets\n",
      "\n",
      "Communications\n",
      "Discussed if tolerating to proceed with #2 5FU-NalIRI with interval CT after #3 in view of rising tumour markers. Discussed that if CT shows further progression on chemotherapy will likely be for best supportive care; alternate option would be to continue Pemigatinib beyond progression although this comes with significant financial toxicity.\n",
      "Son understands and is agreeable with above plans. \n",
      "; \n",
      "-\n",
      "DMO EXP Clinic      \n",
      "Consultant: Dr Matthew Ng    \n",
      "EXP Reg: Dr Bok Ke Xin  \n",
      "Please contact EXP reg for any issues      \n",
      "-\n",
      "\n",
      "Reason for Visit: Due for #2 5FU-Nal-IRI \n",
      "\n",
      "Came with son\n",
      "\n",
      "On Review\n",
      "Came in wheelchair\n",
      "Seen at SKH ED recently for RIF pain\n",
      "- Seen GP, likely symptomatic inguinal hernia\n",
      "- No intestinal obstruction noted on AXR done at ED -> planned for CLR TCU\n",
      "\n",
      "No rash\n",
      "G1 onycholysis \n",
      "G0 oral ulcers\n",
      "\n",
      "O/E\n",
      "Ht 170cm\n",
      "Wt 56.6kg (May24) -> 55.6kg (Nov24) -> 53.9 kg -> 54.3kg -> 53.2kg -> 53.9kg -> 51.25kg (today) \n",
      "\n",
      "Came in wheelchair \n",
      "Alert, oriented \n",
      "H: S1S2  \n",
      "L: clear, no obvious creps/rhonchi      \n",
      "Abdo: SNT, not distended, no organomegaly/palpable mass, BS +      \n",
      "- Right inguinal lump palpable on standing, reducible \n",
      "Ext: No pedal oedema. Calves supple.    \n",
      "           \n",
      "Investigations\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "03/06/25\tHb: 10.4(L), WBC: 6.78, Hct: 31.4(L), Plt: 158. \n",
      "03/06/25\tNa: 135(L), K+: 3.7, Cl: 102, HCO3: 26.8, Urea: 8.1(H), Cre: 65, Glu:13.2(H). \n",
      "03/06/25\tTP: 62(L), Alb: 36(L), Bil: 13, AST: 92(H), ALT: 33, ALP: 159(H). \n",
      "03/06/25\tCA 19-9: 223(H). \n",
      "03/06/25\tCalcium : 2.46, Phosphate : 0.74(L). \n",
      "  \n",
      "Tumour Markers:\n",
      "Ca 19-9 56 > 46.2 > 60 > 99 > 129 > 38.0 > 47.8 > 57.5 > 44.7 > 47.7 > 63.8 > 81.6 > 105 > 223\n",
      "\n",
      "Radiological:\n",
      "28.4.25 CT T/A/P showed PD in liver metastases, other sites of disease SD\n",
      "\n",
      "Assessment\n",
      "1. Fit for treatment \n",
      "2. G2 Cr elevation and G1 hyperphosphatemia likely from Pemigatinib \n",
      "3. Low volume progression of liver mets\n",
      "\n",
      "Communications\n",
      "Discussed if tolerating to proceed with #2 5FU-NalIRI with interval CT after #4\n",
      "\n",
      "; Oncological Diagnosis\n",
      "1. Metastatic cholangiocarcinoma\n",
      "- SOD: liver, non regional LN (supradiaphragmatic, para-aortic, gastrohepatic, periportal) \n",
      "\n",
      "Cx hypercalcemia on Denosumab \n",
      "\n",
      "Tx\n",
      "May-Sep24: s/p palliative first-line Gem/Cis/Durva (Durva added from #2) (20.5.24-29.8.24) -> PD \n",
      "- Initially dx and tx in Oncocare (Dr Thomas Soh), received #1 Gem-Cis in private \n",
      "- Care transferred to NCCS for financial concerns from #2 \n",
      "Oct24: s/p palliative second-line #2 FOLFOX (3-17.10.24) -> PD after #2 \n",
      "- Omitted 5FU bolus and required dose reduction for fatigue \n",
      "Nov24-Apr25: s/p palliative third-line #8 Pemigatinib (19.11.24-15.4.25) -> PR after #4 -> PD after #8\n",
      "May 25-present: s/p palliative fourth-line #3 5FU-NalIRI (13.5.25-3.6.25)\n",
      "\n",
      "IMPACT\n",
      "PBRM1 stop_gained Exon17 c.2208T>A p.(Cys736*)23.4%\n",
      "Amplification2(number of copies)\n",
      "DDR2 (1), EIF1AX (5.23), ARAF (4.9), AR (5.2)\n",
      "Fusion\n",
      "FGFR2 (exon 17) :: BICC1 (exon 3) / Read counts: 825838\n",
      "Tumour Mutation Burden (TMB)3\n",
      "* The estimated mutation burden = 3.79 mutations per Mbp.\n",
      "\n",
      "PMHx DM, IHD, AF on Apixaban, R mid-pole thyroid nodules (TR-3, FNAC not feasible to bx due to location)\n",
      "\n",
      "Lives with wife, youngest son, helper \n",
      "$$ No Pte insurance. Medisave. Medishield. \n",
      "\n",
      "Pt son HP 91092048; \n",
      "-\n",
      "DMO EXP Clinic      \n",
      "Consultant: Dr Matthew Ng    \n",
      "EXP Reg: Dr Bok Ke Xin  \n",
      "Please contact EXP reg for any issues      \n",
      "-\n",
      "\n",
      "Reason for Visit: Due for #3 5FU-Nal-IRI \n",
      "\n",
      "Came with son\n",
      "\n",
      "On Review\n",
      "Came in wheelchair\n",
      "G1 RIF pain from hernia - improved\n",
      "G1 onycholysis \n",
      "G0 oral ulcers\n",
      "G2 lethargy\n",
      "G1 anorexia \n",
      "No diarrhea \n",
      "\n",
      "O/E\n",
      "Ht 170cm\n",
      "Wt 56.6kg (May24) -> 55.6kg (Nov24) -> 53.9 kg -> 54.3kg -> 53.2kg -> 53.9kg -> 51.25kg -> 51kg (today) \n",
      "\n",
      "Came in wheelchair \n",
      "Alert, oriented \n",
      "H: S1S2  \n",
      "L: clear, no obvious creps/rhonchi      \n",
      "Abdo: SNT, not distended, no organomegaly/palpable mass, BS +      \n",
      "- Right inguinal lump palpable on standing, reducible \n",
      "Ext: No pedal oedema. Calves supple.    \n",
      "           \n",
      "Investigations\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "17/06/25\tHb: 10.5(L), WBC: 8.99, Hct: 31.1(L), Plt: 137(L). \n",
      "17/06/25\tNa: 135(L), K+: 3.8, Cl: 102, HCO3: 27.2, Urea: 7.3(H), Cre: 72, Glu:9.3. \n",
      "17/06/25\tTP: 62(L), Alb: 37(L), Bil: 12, AST: 68(H), ALT: 28, ALP: 161(H). \n",
      "17/06/25\tCA 19-9: 302(H). \n",
      " \n",
      "Tumour Markers:\n",
      "Ca 19-9 56 > 46.2 > 60 > 99 > 129 > 38.0 > 47.8 > 57.5 > 44.7 > 47.7 > 63.8 > 81.6 > 105 > 223\n",
      "\n",
      "Radiological:\n",
      "28.4.25 CT T/A/P showed PD in liver metastases, other sites of disease SD\n",
      "\n",
      "Assessment\n",
      "1. Fit for treatment \n",
      "2. G2 Cr elevation and G1 hyperphosphatemia likely from Pemigatinib \n",
      "3. Low volume progression of liver mets\n",
      "\n",
      "Communications\n",
      "Discussed if tolerating to proceed with #2 5FU-NalIRI with interval CT after #3 in view of rising tumour markers. Discussed that if CT shows further progression on chemotherapy will likely be for best supportive care; alternate option would be to continue Pemigatinib beyond progression although this comes with significant financial toxicity.\n",
      "Son understands and is agreeable with above plans. \n",
      "\n",
      "{'diagnosis': 'renal cell carcinoma', 'stage': 'metastatic'} ===PHx===\n",
      "1. DM\n",
      "2. HLD\n",
      "3. CKD Stage 3\n",
      "\n",
      "===Oncological Hx===\n",
      "1. Metastatic Recurrent clear-cell RCC\n",
      "- s/p CT-guided cryoablation <DATE> \n",
      "- Cx by aggressive recurrence/residual tumour\n",
      "> size of current disease is equal/greater than original tumour\n",
      "- s/p Lap Right Radical Nephrectomy (<DATE>)\n",
      "- IM<HOSPITAL> intermediate-risk: Hb (DFI 2.5yrs)\n",
      "\n",
      "Treatment Hx:\n",
      "- 1L Ipi/Nivo started <DATE>; Metastatic ccRCC\n",
      "S/p mainteanance Nivo #4\n",
      "Did not attend #5\n",
      "Tolerated well\n",
      "\n",
      "Bloods:\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "<DATE>\tHb: 11.6(L), WBC: 4.11, Hct: 35.4(L), Plt: 241. \n",
      "<DATE>\tNeut: 49.5% , Neut Abs: 2.03, MCV: 95.4% , Lymph: 37.2% , Mono: 9.5% , Eos: 3.6% , Baso: 0.2% . \n",
      "\n",
      "O/E,\n",
      "Alert and comfortable\n",
      "H: s1s2\n",
      "L: clear\n",
      "A: soft, non-tender\n",
      "No pedal oedema\n",
      "Calves supple\n",
      "\n",
      "Imp,\n",
      "Mixed response\n",
      "{'diagnosis': 'Head and Neck Squamous Cell Carcinoma', 'stage': 'Stage IV'} squamous cell carcinoma unknown primary involving R level II/III, lower neck, SCM \n",
      "no clear HNN primary seen / no tonsillectomy performed \n",
      "p16 negative\n",
      "no PD-L1 testing performed (insuf tissue) \n",
      "\n",
      "s/p #5 chemo IO with good response -> RT 15# right neck completed <DATE> \n",
      "\n",
      "PMHx - hep B carrier, HLD on diet control (takes hypocol)\n",
      "\n",
      "CSC card holder\n",
      "\n",
      "one son working in <HOSPITAL> as dietician\n",
      "\n",
      "ADR grade 3 to paclitaxel; \n",
      "on maintenance pembrolizumab \n",
      "\n",
      "clinically well \n",
      "no neck nodes \n",
      "skin clear \n",
      "\n",
      "\n",
      "      \n",
      "IMP       \n",
      "- locally advanced HNSCC involving R neck with dermal mets/ skin involvement to chest wall       \n",
      "      \n",
      "- not resectable/ not amenable to radical RT       \n",
      "      \n",
      "- ADR grade 3 to paclitaxel       \n",
      "s/p pall RT \n",
      "now on maintenance pembrolizumab \n",
      "      \n",
      "Communications      \n",
      "- explained to continue pembrolizumab  \n",
      "\n",
      "\n",
      "{'diagnosis': 'Metastatic Lung Adenocarcinoma', 'stage': 'Stage IV'} 71/Chinese/Male \n",
      "Never smoker \n",
      " \n",
      "Oncological Hx: \n",
      "Metastatic lung adenocarcinoma \n",
      "SOD: Pleura, nodes, adrenal.  \n",
      "Pleural fluid cytology <DATE> - adenocarcinoma, PDL1 TPS 90% \n",
      "EGFR Exon 19 del, ALK negative \n",
      " \n",
      "CT TA <DATE> - massive R pleural effusion, multiple pleural nodules. mediastinal and R hilar LN, subcarinal LN.\n",
      "L adrenal 2.3 x 1.4cm nodule\n",
      "MRI Brain <DATE> - no brain met.\n",
      "Bone scan - normal\n",
      "\n",
      "Dacomitinib <DATE> - Current\n",
      "\n",
      "PMH:\n",
      "JAK2 ET - On hydroxyurea, known to Haematology; DMO CRC SR\n",
      "\n",
      "On Dacomitinib\n",
      "\n",
      "Subjective:  \n",
      "<DATE> hx of cough - slight yellowish sputum\n",
      "since <DATE> has gone to GP and noted to have ?left LZ creps - started on Augmentin\n",
      "cough not exacerbated by exercise, cold\n",
      "no fever/running nose/sore throat\n",
      "still playing basketball daily but effort tolerance reduced slightly these past 2 weeks\n",
      "\n",
      "O/E:\n",
      "Spo2 98% RA\n",
      "ECOG 0       \n",
      "Alert\n",
      "comfortable\n",
      "speaks full sentences\n",
      "H S1S2\n",
      "L Clear\n",
      "\n",
      "Assessment: \n",
      "Cough for evaluation possibly infective/post-viral\n",
      "TRO pneumonia and to add on HRCT on <DATE> CT TAP to exclude drug-induced pneumonitis; DMO CRC SR\n",
      "\n",
      "On Dacomitinib\n",
      "\n",
      "Subjective:  \n",
      "<DATE> hx of cough - slight yellowish sputum\n",
      "since <DATE> has gone to GP and noted to have ?left LZ creps - started on Augmentin\n",
      "cough not exacerbated by exercise, cold\n",
      "no fever/running nose/sore throat\n",
      "still playing basketball daily but effort tolerance reduced slightly these past 2 weeks\n",
      "\n",
      "O/E:\n",
      "Spo2 98% RA\n",
      "ECOG 0       \n",
      "Alert\n",
      "comfortable\n",
      "speaks full sentences\n",
      "H S1S2\n",
      "L Clear\n",
      "\n",
      "Assessment: \n",
      "Persistent Cough for evaluation possibly infective/post-viral with Right lower zone collapse/consolidation\n",
      "\n",
      "{'diagnosis': 'Gastroesophageal Junction (GEJ) Adenocarcinoma with focal squamous differentiation', 'stage': 'Localized'} Dx Localised Type 2 GEJ mixed adenosquamous carcinoma\n",
      "Molecular: not done.\n",
      "\n",
      "Rx\n",
      "28.5.25 <HOSPITAL>. black stools and Fe deficiency anaemia. OGD polyploidal tumour at 39-42cm. GEJ at 42cm. no sig luminal narrowing. \n",
      "CT TAP  ill defined mucosal hypoattenuation  at GEJ. worse IPF.  Resp opinion high risk of IPF exacerbation with GA, risk of needing intubation\n",
      "\n",
      "PMH\n",
      "1. Idiopathic pul fibrosis  (f/u RES Dr Low SY)\n",
      "<DATE> PFT: FEV1 2.20(89%), FVC 2.47(78%), FEV1/FVC 89%, TLC 4.39(71%), DLCO 4.38(62%\n",
      "- Declined anti-fibrotics, slow progression of IPF since 2017\n",
      "2. CKD G3bA2 presumptive DKD, hx of NSAID nephropathy\n",
      "3. DM \n",
      "4. HTN\n",
      "5. HLD\n",
      "6. Tophaceous gout\n",
      "7. BPH\n",
      "8. Colonic polyps\n",
      "- Colonoscopy 8.3.23- cecal and transverse colon polyps removed\n",
      "9. L renal calculi\n",
      "10. Normal tension glaucoma, cataracts\n",
      "11. Hyperkalemia likely related to ARB/MRA use, possible type 4 RTA; Dx Localised Type 2 GEJ mixed adenosquamous carcinoma\n",
      "Molecular: not done.\n",
      "\n",
      "Rx\n",
      "28.5.25 <HOSPITAL>. black stools and Fe deficiency anaemia. OGD polyploidal tumour at 39-42cm. GEJ at 42cm. no sig luminal narrowing. \n",
      "CT TAP  ill defined mucosal hypoattenuation  at GEJ. worse IPF.  Resp opinion high risk of IPF exacerbation with GA, risk of needing intubation\n",
      "\n",
      "PMH\n",
      "1. Idiopathic pul fibrosis  (f/u RES Dr Low SY)\n",
      "<DATE> PFT: FEV1 2.20(89%), FVC 2.47(78%), FEV1/FVC 89%, TLC 4.39(71%), DLCO 4.38(62%\n",
      "- Declined anti-fibrotics, slow progression of IPF since 2017\n",
      "2. CKD G3bA2 presumptive DKD, hx of NSAID nephropathy\n",
      "3. DM \n",
      "4. HTN\n",
      "5. HLD\n",
      "6. Tophaceous gout\n",
      "7. BPH\n",
      "8. Colonic polyps\n",
      "- Colonoscopy 8.3.23- cecal and transverse colon polyps removed\n",
      "9. L renal calculi\n",
      "10. Normal tension glaucoma, cataracts\n",
      "11. Hyperkalemia likely related to ARB/MRA use, possible type 4 RTA\n",
      "\n",
      "Research: ctNA; Reason for visit: Referred for further mx of GEJ Ca\n",
      "Came with:  daughters x 2 \n",
      "Speak: Chinese \n",
      "\n",
      "ADL independent, cooks and clean himself.\n",
      "Nutritional concerns: 0\n",
      "Psychological concerns: 0\n",
      "FH: Father liver cancer @ 50yrs +, ? eso ca, younger bro (no2) CRC @ 60yrs,  younger bro (no4)breast ca @ 60yrs. \n",
      "\n",
      "SH: Married with children, lives alone in rental flat, wife currently in Malaysia taking care of grandkids. 2x daughters live nearby. \n",
      "Non-smoker, non-drinker \n",
      "$: retired chef in coffee shop. medishield. CHAS blue. SOC 70%, MAF 75%, Merdeka \n",
      "\n",
      "Presenting hx\n",
      "was doing PT at Woodlands health. Found to be dyspnoea.\n",
      "May 2025 noted black stool\n",
      "went ED, found  iron deficincy anemia Hb 9.0  with LOW 5kg over 1/12 and ?black stools \n",
      "\n",
      "28.5.25 OGD (Woodlands Health)\n",
      "Scoped to D2\n",
      "Oesophagus - GEJ 42cm. A 3cm semipedunculated malignant looking, friable polypoidal oesophageal mass arising \n",
      "from the GEJ seen, extending up to 39cm from incisors. The base of polyp (at the GEJ) is ulcerated with raised irregular \n",
      "edges. Standard OGD able to pass GEJ comfortably with no significant luminal narrowing currently\n",
      "Stomach - mild antral gastritis - biopsies taken. Mild mid body gastritis (greater curve) - biopsies taken\n",
      "D1/D2 - normal, ampulla not seen\n",
      "\n",
      "28.5.25 Histopathology (NEHR)\n",
      "Oesophagus (mass) - biopsy:\n",
      "- Adenocarcinoma (with focal features suggestive of squamous differentiation, raising possibility of adenosquamous carcinoma).\n",
      "\n",
      "Stomach: body and antrum - biopsies:\n",
      "- Body: normal mucosa.\n",
      "- Antrum: mild reactive changes.\n",
      "\n",
      "28.5.25 CT T/A/P\n",
      "1/ An area of ill defined mucosal hypoattenuation is seen at the gastroesophageal junction; it is hard to accurately characterize as the stomach is not gas distended - to correlate with endoscope findings. Small nodes (0.7 cm along the anterior gastric \n",
      "im 601/84; 0.6 cm anterior diaphragmatic Se 601/84 and 0.7 cm left gastric nodes Se 601/89) noted; these nodes were not present in 2022 .  \n",
      "2/ Significant progression of interstitial pulmonary fibrosis in keeping with usual interstitial pneumonia pattern of disease.\n",
      "3/ Possible 0.6 cm left lung nodule (im 58), difficult to characterize due to adjacent multiple cysts distorting the lung parenchymal architecture.\n",
      "The rest of the incidental finding are as described above. \n",
      "\n",
      "29.5.25 s/p 1g IV Ferinject during admission \n",
      "\n",
      "10.6.25 S/B RES and deemed to be at risk of IPF acute exacerbation with GA should he decide to undergo surgery which could result in respiratory failure requiring mechanical ventilation which would entail significant morbidity and mortality.\n",
      "\n",
      "\n",
      "Sx\n",
      "G1 breathlessness on exertion, can walk 1000 steps and climb 1 flight for stairs. but when flares up cannot complete a flight of stairs\n",
      "No dysphagia \n",
      "Appt normal \n",
      "\n",
      "BO: intermittent dark stools.\n",
      "PU: ok \n",
      "\n",
      "\n",
      "O/E\n",
      "walked in \n",
      "talks comfortably \n",
      "well\n",
      "no rash\n",
      "mouth clear\n",
      "CVS nad\n",
      "Resp pan inspiratory fine creps, mid zone down. \n",
      "GIT nad\n",
      "no ankle swelling \n",
      "\n",
      "Imp\n",
      "unlikely surgical candidate due to IPF\n",
      "need to complete staging with PET/CT. \n",
      "review imaging at UGI tb, if localised and polypoid ? dCRT or ESD possible.\n",
      "immunotherapy contraindicated, \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "; Reason for visit: Referred for further mx of GEJ Ca\n",
      "Came with:  daughters x 2 \n",
      "Speak: Chinese \n",
      "\n",
      "ADL independent, cooks and clean himself.\n",
      "Nutritional concerns: 0\n",
      "Psychological concerns: 0\n",
      "FH: Father liver cancer @ 50yrs +, ? eso ca, younger bro (no2) CRC @ 60yrs,  younger bro (no4)breast ca @ 60yrs. \n",
      "\n",
      "SH: Married with children, lives alone in rental flat, wife currently in Malaysia taking care of grandkids. 2x daughters live nearby. \n",
      "Non-smoker, non-drinker \n",
      "$: retired chef in coffee shop. medishield. CHAS blue. SOC 70%, MAF 75%, Merdeka \n",
      "\n",
      "Presenting hx\n",
      "was doing PT at Woodlands health. Found to be dyspnoea.\n",
      "May 2025 noted black stool\n",
      "went ED, found  iron deficincy anemia Hb 9.0  with LOW 5kg over 1/12 and ?black stools \n",
      "\n",
      "28.5.25 OGD (Woodlands Health)\n",
      "Scoped to D2\n",
      "Oesophagus - GEJ 42cm. A 3cm semipedunculated malignant looking, friable polypoidal oesophageal mass arising \n",
      "from the GEJ seen, extending up to 39cm from incisors. The base of polyp (at the GEJ) is ulcerated with raised irregular \n",
      "edges. Standard OGD able to pass GEJ comfortably with no significant luminal narrowing currently\n",
      "Stomach - mild antral gastritis - biopsies taken. Mild mid body gastritis (greater curve) - biopsies taken\n",
      "D1/D2 - normal, ampulla not seen\n",
      "\n",
      "28.5.25 Histopathology (NEHR)\n",
      "Oesophagus (mass) - biopsy:\n",
      "- Adenocarcinoma (with focal features suggestive of squamous differentiation, raising possibility of adenosquamous carcinoma).\n",
      "\n",
      "Stomach: body and antrum - biopsies:\n",
      "- Body: normal mucosa.\n",
      "- Antrum: mild reactive changes.\n",
      "\n",
      "28.5.25 CT T/A/P\n",
      "1/ An area of ill defined mucosal hypoattenuation is seen at the gastroesophageal junction; it is hard to accurately characterize as the stomach is not gas distended - to correlate with endoscope findings. Small nodes (0.7 cm along the anterior gastric \n",
      "im 601/84; 0.6 cm anterior diaphragmatic Se 601/84 and 0.7 cm left gastric nodes Se 601/89) noted; these nodes were not present in 2022 .  \n",
      "2/ Significant progression of interstitial pulmonary fibrosis in keeping with usual interstitial pneumonia pattern of disease.\n",
      "3/ Possible 0.6 cm left lung nodule (im 58), difficult to characterize due to adjacent multiple cysts distorting the lung parenchymal architecture.\n",
      "The rest of the incidental finding are as described above. \n",
      "\n",
      "29.5.25 s/p 1g IV Ferinject during admission \n",
      "\n",
      "10.6.25 S/B RES and deemed to be at risk of IPF acute exacerbation with GA should he decide to undergo surgery which could result in respiratory failure requiring mechanical ventilation which would entail significant morbidity and mortality.\n",
      "\n",
      "told by woodlands GS, he is not fit for op\n",
      "\n",
      "Sx\n",
      "G1 breathlessness on exertion, can walk 1000 steps and climb 1 flight for stairs. but when flares up cannot complete a flight of stairs\n",
      "No dysphagia \n",
      "Appt normal \n",
      "\n",
      "BO: intermittent dark stools.\n",
      "PU: ok \n",
      "\n",
      "\n",
      "O/E\n",
      "walked in \n",
      "talks comfortably \n",
      "well\n",
      "no rash\n",
      "mouth clear\n",
      "CVS nad\n",
      "Resp pan inspiratory fine creps, mid zone down. \n",
      "GIT nad\n",
      "no ankle swelling \n",
      "\n",
      "Imp\n",
      "unlikely surgical candidate due to IPF\n",
      "need to complete staging with PET/CT. \n",
      "review imaging at UGI tb, if localised and polypoid ? dCRT or ESD possible.\n",
      "immunotherapy contraindicated, \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "; pre-clerking pt not yet seen\n",
      "\n",
      "Reason for visit: Referred for further mx of GEJ Ca\n",
      "Came with: \n",
      "Speak: \n",
      "\n",
      "ADL independent\n",
      "Nutritional concerns: \n",
      "Psychological concerns: \n",
      "FH:\n",
      "\n",
      "SH: Married with children, lives alone in rental flat, wife currently in Malaysia taking care of grandkids\n",
      "Non-smoker, non-drinker \n",
      "\n",
      "ETOH 0 \n",
      "$: _\n",
      "\n",
      "Oncological Diagnosis\n",
      "1. T_ N_Mx Siewert I-II GEJ adenoca with focal ft of sq differentiation\n",
      "\n",
      "P/w iron deficincy anemia with LOW 5kg over 1/12 and ?black stools \n",
      "\n",
      "28.5.25 OGD (Woodlands Health)\n",
      "Scoped to D2\n",
      "Oesophagus - GEJ 42cm. A 3cm semipedunculated malignant looking, friable polypoidal oesophageal mass arising \n",
      "from the GEJ seen, extending up to 39cm from incisors. The base of polyp (at the GEJ) is ulcerated with raised irregular \n",
      "edges. Standard OGD able to pass GEJ comfortably with no significant luminal narrowing currently\n",
      "Stomach - mild antral gastritis - biopsies taken. Mild mid body gastritis (greater curve) - biopsies taken\n",
      "D1/D2 - normal, ampulla not seen\n",
      "\n",
      "28.5.25 Histopathology (NEHR)\n",
      "Oesophagus (mass) - biopsy:\n",
      "- Adenocarcinoma (with focal features suggestive of squamous differentiation, raising possibility of adenosquamous carcinoma).\n",
      "\n",
      "Stomach: body and antrum - biopsies:\n",
      "- Body: normal mucosa.\n",
      "- Antrum: mild reactive changes.\n",
      "\n",
      "28.5.25 CT T/A/P\n",
      "1/ An area of ill defined mucosal hypoattenuation is seen at the gastroesophageal junction; it is hard to accurately characterize as the stomach is not gas distended - to correlate with endoscope findings. Small nodes (0.7 cm along the anterior gastric \n",
      "im 601/84; 0.6 cm anterior diaphragmatic Se 601/84 and 0.7 cm left gastric nodes Se 601/89) noted; these nodes were not present in 2022 .  \n",
      "2/ Significant progression of interstitial pulmonary fibrosis in keeping with usual interstitial pneumonia pattern of disease.\n",
      "3/ Possible 0.6 cm left lung nodule (im 58), difficult to characterize due to adjacent multiple cysts distorting the lung parenchymal architecture.\n",
      "The rest of the incidental finding are as described above. \n",
      "\n",
      "29.5.25 s/p 1g IV Ferinject during admission \n",
      "\n",
      "10.6.25 S/B RES and deemed to be at risk of IPF acute exacerbation with GA should he decide to undergo surgery which could result in respiratory failure requiring mechanical ventilation which would entail significant morbidity and mortality.\n",
      "\n",
      "\n",
      "On Review\n",
      "\n",
      "\n",
      "O/E\n",
      "\n",
      "\n",
      "Imp\n",
      "unlikely surgical candidate due to IPF\n",
      "need to complete staging with PET/CT\n",
      "review imaging at UGI tb, if localised and polypoid ? dCRT or ESD possible.\n",
      "immunotherapy contraindicated, \n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "{'diagnosis': 'Endometrial', 'stage': 'Stage IVB'} Stage IVB Endometrial cancer serous, pMMR, HER2 neg 1+ <10%\n",
      "- SOD: left pleural effusion, omental/peritoneal, ascites\n",
      "- Cx pulmonary embolism on apixaban\n",
      "- b/g elderly, scoliosis\n",
      "Shining Tower FM1 CDx: MSS, TMB 6Muts/mb, MCL1 amplification, TP53 E286K\n",
      "<DATE>: Pac/Carbo\n",
      "<DATE>: Pac/Carbo/Bev from C2 in view of ascites and persistent pleural effusion. Clinical response after C3 and C6\n",
      "<DATE>: MDT discussion limited role for interval debulking\n",
      "<DATE>: Maintenance Bev\n",
      "<DATE>: PR\n",
      "<DATE>: Rising CA 125\n",
      "<DATE>: PD in peritoneum after #9 maintenance Bev\n",
      "<DATE>: ongoing PD in the peritoneum\n",
      "<DATE>-<DATE>: PLD #2\n",
      "<DATE>: PD in peritoneum post #2 (but marker response, coud still consider rechallenge)\n",
      "<DATE>: Pac/carbo rechallenge\n",
      "<DATE>: PR post #4 \n",
      "<DATE>: Rising CA 125 post #6, asymptomatic\n",
      "<DATE>: PD in peritoneum, indeterminate R lung subpleural nodule. Expectant Mx\n",
      "<DATE>: Gemcitabine -> Ca 125 stable after #2\n",
      "<DATE>: Gemcitabine + Bev -> PD after #6\n",
      "<DATE>25: palliative third-line Pembro+Lenvatinib\n",
      "\n",
      "1. <HOSPITAL> anaemia- B12 deficiency and possible thalassaemia  \n",
      "-pt reports FH of thalassaemia (SR and children have thalassaemia)  \n",
      "- anaemia workup: B12 deficient, no iron def  \n",
      "- given 3/7 IM vit B12 and started on oral B12 replacement  \n",
      "2. Transaminitis likely related to TCM use  \n",
      "3. Retrocardiac opacity possibly hiatus hernia  \n",
      "4. HTN; Reason for visit: Due #3 Pembro + Lenvatinib    \n",
      "Came with: Husband  \n",
      "Speaks: Chinese / Hokkien                       \n",
      "$: Insurance - not sure about coverage                       \n",
      "                           \n",
      "Subjective:        \n",
      "G1 fatigue        \n",
      "Nil constipation        \n",
      "NIl alopecia                          \n",
      "no SOB         \n",
      "no abdo pain           \n",
      "appetite fair           \n",
      "nil abdo bloating           \n",
      " \n",
      "Home SBP stable around 100-110, not on regular BP meds \n",
      "                               \n",
      "O/e:                          \n",
      "Vital Signs:              \n",
      "BP 146 / 77mmHg (<DATE> 14:05:00)   Ht: 146.4 cm (<DATE> 14:06:59)  Wt: 50.2 kg (<DATE> 14:06:59)  BSA: 1.43 m2   BMI: 23.4     \n",
      "BP 127 / 76mmHg (<DATE> 16:09:00)   Ht: 145.1 cm (10-Jun-2025 09:30:00)  Wt: 47.4 kg (10-Jun-2025 09:30:00)  BSA: 1.38 m2   BMI: 22.5 \n",
      "        \n",
      "       \n",
      "well                        \n",
      "non toxic                        \n",
      "L clear                         \n",
      "no ascites                         \n",
      "                       \n",
      "CT TAP 17/2/25: PD but only started chemo in Dec and had Ca 125 response     \n",
      "Since CT study of 18 October 2024:     \n",
      "     \n",
      "1. Interval increase in size of right cardiophrenic node, suspicious for metastasis.     \n",
      "     \n",
      "2. Interval decrease in size of previously new right lung lower lobe subpleural nodule,      \n",
      "indeterminate.       \n",
      "     \n",
      "3. New and larger multiple peritoneal nodules, while some are stable, suspicious      \n",
      "for metastasis.     \n",
      "     \n",
      "4. Interval increase in amount of ascites.     \n",
      "     \n",
      "5. Stable minimal endometrial cavity distension, possibly post-treatment change of      \n",
      "known primary malignancy.     \n",
      "     \n",
      "6. No evidence of pulmonary thromboembolism or right heart strain.        \n",
      "                 \n",
      "TTE 12/12/23 - EF 63%        \n",
      "Did not go for repeat 2DE                 \n",
      "                         \n",
      "Ca 125 stable slight rise    \n",
      "            \n",
      "Comms     \n",
      "Advised on AE management and treatment schedule. \n",
      "Dietary and fever advice reiterated. Patient was advised to avoid unnecessary supplements/traditional medicines while on therapy. \n",
      "Patient's and family's questions were answered. \n",
      "Patient advised regarding need to seek medical attention earlier if any problems - patient understood. \n",
      "       \n",
      "Previously Explained scan findings of PD in peritoneum, new indeterminate R lung nodule          \n",
      "           \n",
      "Explained options                  \n",
      "1. Pembro/lenvatinib                 \n",
      "2. Chemo switch           \n",
      "Options include          \n",
      "- Rechallenge Caelyx, vinorelbine, topotecan        \n",
      "- informed that Trastuzumab and Enhertu are FDA approved only for HER2 positive solid tumours    \n",
      "3. BSC alone                 \n",
      "                 \n",
      "Preferred option is pembro/lenvatinib.   \n",
      "Informed that the goal of treatment was palliative. Benefits of treatment, if successful, were to prolong life, prevent/postpone cancer-related complications/symptoms, and preserve QOL;  However I could not guarantee that the treatment would help patient definitely.         \n",
      "The alternative to therapy might be best supportive care.         \n",
      "Patient's care would be by team of healthcare providers.         \n",
      "Informed that chemotherapy medications could have short-term and long-term side effects. Side effects include: allergic/hypersensitivity reactions, fatigue, nausea/vomiting, hair loss, low red blood cell count/anaemia, low white cell count/risk of infection, low platelet count/risk of bleeding, constipation, diarrhoea, sores/ulcers of mouth and throat, skin/nail effects, muscle/bone effects, nerve effects, kidney/liver effects, heart and blood vessel effects, lung effects.         \n",
      "Patient and family were informed that severe complications from chemotherapy could be life-threatening and cause death (risk <1%). Each patient could respond differently to chemotherapy, and could have side effects that had not been reported by others. Patient was informed that patient might stop this treatment at any\n",
      "{'diagnosis': 'gastric adenocarcinoma', 'stage': 'IV'} Metastatic unresectable gastric adenocarcinoma (cT4N1-2M1 - SMV tumour thrombus)  \n",
      "HER2 neg, MSS, CPS 10 \n",
      "\n",
      "--\n",
      "\n",
      "PMHx:  \n",
      "Dyspepsia \n",
      "BPH \n",
      " \n",
      "Family history: \n",
      "Father and brother also has GI malignancy (patient unsure of etiology); Purpose of visit: 2L #3 Pac/Ramu \n",
      "PD post #12 FOLFOX Nivo        \n",
      "         \n",
      "Seen by <HCW> in <HOSPITAL> as a blue letter         \n",
      "         \n",
      "<PATIENT>         \n",
      "<ID>         \n",
      "69/Chi/Male         \n",
      "           \n",
      "History of presenting complaint:          \n",
      "p/w intermittent chest discomfort a/w SOBOE         \n",
      "a/w epigastric discomfort and abdominal bloating + reflux for 1 month         \n",
      "a/w early satiety and LOW over past 2 months         \n",
      "          \n",
      "Hb 6.1 OA          \n",
      "         \n",
      "CT TAP <DATE>           \n",
      "1. Largely exophytic heterogeneously dominant mass of the gastric antropyloric region          \n",
      "with associated adjacent fat stranding and adenopathy suspicious for primary gastric          \n",
      "malignancy with extra-serosal spread.         \n",
      "2. Likely extension from the main tumour or adenopathy into the gastroepiploic veins          \n",
      "with resultant extensive (likely tumour) thrombus of the superior mesenteric vein, some of its ileal and right colic tributaries as well as the main portal vein. The intrahepatic portal and hepatic veins, splenic vein as well as the far upstream tributaries of the superior mesenteric veins remain patent.         \n",
      "3. Small indeterminate segment II hepatic lesion, and metastasis is not excluded.         \n",
      "         \n",
      "MRI Liver <DATE>:          \n",
      "The observation of concern in hepatic segment II probably corresponds to a 0.6 cm          \n",
      "hypointense signal focus on the post-contrast sequences. This is not well assessed          \n",
      "on the rest of the sequences, but no definite focal raised DWI hyperintense signal          \n",
      "is identified in this region. This may have been present on prior CT of <DATE>.         \n",
      "Hepatic cysts. No definite hepatic metastases.          \n",
      "         \n",
      "OGD done on <DATE>         \n",
      "z line at 37cm         \n",
      "extensive tumour starting at 49cm from incisors, from  gastric body greater curve posterior wall extending to antrum and encroaching onto pylorus and duodenum bulb posterior wall         \n",
      "scope able to traverse pylorus         \n",
      "         \n",
      "Biopsies taken from          \n",
      "  (1) duodenum ? tumour extension         \n",
      "  (2) gastric body greater curve anterior wall         \n",
      "  (3) tumour at gastric body greater curve posterior wall         \n",
      "         \n",
      "Histology:         \n",
      "A. Duodenum thickening, biopsy: A tiny ulcerated fragment with atypical cells suspicious for tumour involvement (see microscopy).          \n",
      "B. Stomach, body, biopsy: Chronic gastritis with severe intestinal metaplasia and focal low grade dysplasia.         \n",
      "C. Stomach, antrum tumour, biopsy: Adenocarcinoma, poorly differentiated.             \n",
      "         \n",
      "-------------------------------------------------------------------------         \n",
      "         \n",
      "Subsequently case discussed at TB:          \n",
      "Unresectable from GS POV - thrombus of SMV extensive, suspicious for tumour thrombus          \n",
      "UGI Dr June Lee d/w HPB - lesion is extending into duodenum, no fat plane with pancreas and with PV thrombus, not resectable         \n",
      "Intent of treatment is palliative, for systemic chemotherapy          \n",
      "         \n",
      "DRO seen by Dr Connie Yip - offered RT for hemostasis          \n",
      "Completed 20Gy/5# on 6/9/24         \n",
      "         \n",
      "-------------------------------------------------------------------------         \n",
      "         \n",
      "s/p C1 FOLFOX Nivo 16/9        \n",
      "Adm thereafter for CINV         \n",
      "        \n",
      "- OGD on 24/9/24: Scoped till D2. Thickened indurated mucosa from the greater curve towards the antrum. Smooth scope and easy intubation into the duodenum. No obvious evidence of GOO. No food residue in the stomach.  Duodenum unremarkable, smooth scope into D2         \n",
      "(no evidence of GOO)        \n",
      "- CT TAP 24/9/24:         \n",
      "No gastric or bowel dilatation is seen to suggest obstruction.        \n",
      "Mural thickening of the cecum to hepatic flexure may represent colitis.        \n",
      "Slight interval decrease in size of necrotic mass at the distal stomach is in keeping with known primary gastric malignancy.\n",
      "{'diagnosis': 'Small Cell Lung Cancer', 'stage': 'Extensive Stage'} ONCOLOGICAL HISTORY\n",
      "1. ES-SCLC\n",
      "- p/w SOBOE for 1m, LOW, dry cough; smoker 50py\n",
      "- failed trial of frusemide in OPS\n",
      "- NT proBNP 255\n",
      "- CXR (<DATE>): There is opacification in the right mid and lower zones associated with a small right sided pleural effusion. There is a bulky right hilum (4.8 cm x 4.1 cm) (series 1001, image 1001) and suggestion of bulky right lower paratracheal stripe thickening. It is difficult to ascertain if this is partly related to the rotation and right pulmonary venous congestion but a right hilar /pulmonary mass remains a consideration. Either repeat PA and Lateral radiographs after treatment of the fluid overload or a CT scan may be considered for evaluation.\n",
      "- CT NTAP (<DATE>): Bulky right-sided central tumour with mediastinal invasion as noted above including obliteration of the SVC. This could represent a squamous cell carcinoma. Histological correlation recommended.\n",
      "It is contiguous with right hilar and mediastinal adenopathy\n",
      "Nodular consolidation in the right upper lobe indeterminate for postobstructive pneumonia versus lung metastases.\n",
      "Bilateral pleural effusions, larger on the right. There is anterior right lower lobe consolidation/atelectasis . there is ill-defined glass opacity with septal thickening in the anterior right upper lobe and middle lobe may be due to venous congestion.\n",
      "- s/b RES <DATE>: advised for IR Bx of malignancy, pleural tap done\n",
      "- MRI brain <DATE>: 1. No evidence of intracranial metastasis.\n",
      "- while inpatient, clinically well and saturating on room air\n",
      "- IR percutaneous bx of lung lesion done on <DATE>, histo sent as urgent\n",
      "\n",
      "PMH: \n",
      "1. HTN\n",
      "\n",
      "SHx: Ex-smoker 50 pack years, stopped 1m ago\n",
      "Lives at home with son\n",
      "Previously worked in <VENDOR>\n",
      "FHx: nil\n",
      "Allergies: NKDA; Reason for visit: ES-SCLC\n",
      "- 1L carbo/etop/atezo <DATE>\n",
      "\n",
      "CURRENT SYMPTOMS:\n",
      "Some ongoing breathlessness\n",
      "Slight cough\n",
      "Difficult sleeping\n",
      "Facial swelling in mornings\n",
      "\n",
      "Above all improving after starting systemic therapy\n",
      "\n",
      "Post C3\n",
      "Cough returning\n",
      "Dry cough\n",
      "Appetite slightly reduced\n",
      "No fevers\n",
      "\n",
      "O/E: Alert\n",
      "No nodes\n",
      "HSDNM\n",
      "Lungs clear\n",
      "Abdomen SNT\n",
      "No peripheral oedema\n",
      "\n",
      "Bloods\n",
      "FBC EUC LFT TFT ok\n",
      "\n",
      "IMP: ES-SCLC\n",
      "\n",
      "COMMS:\n",
      "Cont chemoimmunotherapy\n",
      "Seen by DRO, not for RT\n",
      "\n",
      "P:\n",
      "Admit for chemo Th<DATE>\n",
      "- Plan C4 carbo/etoposide/atezolizumab 6-8/6/25\n",
      "- Dose reduce by 25% due to toxicity\n",
      "- Repeat FBC on admission KIV transfusion\n",
      "- Ok for upper limb cannulation\n",
      "TCU 3/7/25 with bloods (FBC UEC LFT TFT) and CTBCAP prior\n",
      "Pre-book C5 atezolizumab 3/7/25\n",
      "Advised to return earlier if unwell\n",
      "\n",
      "{'diagnosis': 'renal cell carcinoma', 'stage': 'M1'} ===Onco Hx===\n",
      "1. Recurrent metastatic right clear-cell RCC\n",
      "- S/p lap right radical nephrectomy on <DATE> -> DFI ~2yrs\n",
      "- SOD: pancreatic tail lesion (since <DATE>), ?LN\n",
      "- IMDC intermediate risk: Hb, ANC\n",
      "\n",
      "===PHx===\n",
      "1. Previous CVA  \n",
      "2. Mild cognitive impairment\n",
      "3. HTN, HLD, DM\n",
      "4. IHD with recurrent NSTEMIs <DATE>, <DATE>\n",
      "- Follow-up CGH CVM (<HCW>)\n",
      "- DSE <DATE>  negative LVEF 60% No RWMA.  Baseline LVEF 60% No RWMA. \n",
      "- <DATE> NSTEMI cx HF on DAPT\n",
      "- <DATE> TTE LVEF 45% RWMA G2DD Mod dilated LA. Mild MR\n",
      "- <DATE> recurrent NSTEMI, cath held off due to issue of pancreatic mass (Issue 2)\n",
      "- <DATE> TTE LVEF 35-40% RWMA Mild MR\n",
      "- On DAPT since <DATE> - <DATE> (planned for 1 year); IMDC intermediate risk ccRCC on Ipi/Nivo\n",
      "S/p Ipi/Nivo #1 > G3 transaminitis and significant fatigue > de-escalated to Nivo alone\n",
      "\n",
      "On weaning dose of Prednisolone - just completed 20mg\n",
      "\n",
      "Bloods:\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "<DATE>\tHb: 11.6(L), WBC: 16.16(H), Hct: 35.1(L), Plt: 277. \n",
      "<DATE>\tNeut: 74.7% , Neut Abs: 12.06(H), MCV: 81.4% , Lymph: 19.4% , Mono: 4.8% , Eos: 0.9% , Baso: 0.2% . \n",
      "<DATE>\tNa: 130(L), K+: 5.0, Cl: 98(L), HCO3: 24.1, Urea: 9.2(H), Cre: 77(H), Glu:5.5. \n",
      "<DATE>\tTP: 69, Alb: 32(L), Bil: 14, AST: 43(H), ALT: 66, ALP: 332(H). \n",
      "<DATE>\tCalcium : 2.24. \n",
      "\n",
      "O/E,\n",
      "Alert and comfortable\n",
      "H: s1s2\n",
      "L: clear\n",
      "A: soft, non-tender\n",
      "No pedal oedema\n",
      "Calves supple; IMDC intermediate risk ccRCC on Ipi/Nivo\n",
      "S/p Ipi/Nivo #1 > G3 transaminitis and significant fatigue > de-escalated to Nivo alone\n",
      "\n",
      "On weaning dose of Prednisolone - just completed 20mg\n",
      "\n",
      "Some subjective SOB on day after infusion\n",
      "Resolved thereafter\n",
      "Currently no dyspnoea\n",
      "\n",
      "Bloods:\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "03/06/25\tHb: 11.6(L), WBC: 16.16(H), Hct: 35.1(L), Plt: 277. \n",
      "03/06/25\tNeut: 74.7% , Neut Abs: 12.06(H), MCV: 81.4% , Lymph: 19.4% , Mono: 4.8% , Eos: 0.9% , Baso: 0.2% . \n",
      "03/06/25\tNa: 130(L), K+: 5.0, Cl: 98(L), HCO3: 24.1, Urea: 9.2(H), Cre: 77(H), Glu:5.5. \n",
      "03/06/25\tTP: 69, Alb: 32(L), Bil: 14, AST: 43(H), ALT: 66, ALP: 332(H). \n",
      "03/06/25\tCalcium : 2.24. \n",
      "\n",
      "O/E,\n",
      "Alert and comfortable\n",
      "H: s1s2\n",
      "L: clear\n",
      "A: soft, non-tender\n",
      "No pedal oedema\n",
      "Calves supple\n",
      "{'diagnosis': 'Pancreatic ductal adenocarcinoma (PDAC)', 'stage': 'Stage IV'} 1) LA PDAC inseparable from SMA/SMV \n",
      "pMMR\n",
      "\n",
      "2) HepB core total Ab + (DNA viral load negative) -> on ETV \n",
      "\n",
      "3) Bilateral middle bronchiectasis on b/g of chronic smoking\n",
      "? NTM disease \n",
      "\n",
      "--\n",
      "\n",
      "Smoker 1 pack/day  \n",
      "Alcoholic 3 bottles of beer/day - stopped 2-3m; \n",
      "\n",
      "#11 FOLFIRINOX    \n",
      "     \n",
      "Referred from HPB <PATIENT>      \n",
      "     \n",
      "Initially referred from GP with obstructive jaundice and LOW 6kg and anorexia over 1 month     \n",
      "       \n",
      "Bil 259 on admission with deranged liver function  > last check <DATE> 122      \n",
      "     \n",
      "CT TAP <DATE>:     \n",
      "- Mass 2.5cm at pancreatic head causing atrophy of pancreas, pancreatic duct dilatation and biliary dilatation is suspicious for pancreatic adenocarcinoma. Ill-defined soft tissue inseparable from the superior mesenteric vessels, suspicious for nodal metastasis.     \n",
      "- Ascites in the abdomen and pelvis. Colitis in the rectum.     \n",
      "- No CT evidence of pulmonary metastasis. Post inflammatory sequelae in both lungs suggest sequelae of chronic atypical mycobacterial chest infection.     \n",
      "     \n",
      "s/p Linear EUS + FNB on <DATE>     \n",
      "> Celiac take off identified without enlarged LN. Diffusely dilated MPD. A peripanreatic LN at the neck measures 8.3 x 13.1 mm. Dilated CBD at 16.9 mm. A hypoechoic heterogenous mass with areas of calcification and cystic spaces was seen at the head measuring 37.5 x 31.9 mm. Three passes with 22G Acquire FNB needle performed with adequate cores on MOSE.     \n",
      "     \n",
      "s/p ERCP + Biliary sphincterotomy + FCSEMS insertion on <DATE>     \n",
      "     \n",
      "Histo: adenocarcinoma pMMR      \n",
      "Mycobacterial smear and c/s pending      \n",
      "     \n",
      "-------------------------------------------------------------------------     \n",
      "     \n",
      "Current symptoms     \n",
      "No abdominal pain  - resolved    \n",
      "No nausea/vomiting     \n",
      "Appetite ok - better     \n",
      "No diarrhoea     \n",
      "No fever     \n",
      "\n",
      "Went to <HOSPITAL> ED because he got into argument with roommate today\n",
      "Roommate used a plastic cup to hit his face\n",
      "Suffered a 1 cm laceration over left cheek\n",
      "Made police report\n",
      "Did not sustain other injuries \n",
      "\n",
      "Non compliant to diet \n",
      "\n",
      "O/E     \n",
      "H/L clear      \n",
      "A SNT BS +      \n",
      "calves supple, nil pedal edema      \n",
      "  \n",
      " Glu 15.3 \n",
      "HBsAg -ve, HBcAB positive, Hep C -ve     \n",
      "CA 19-9 3765 > 3338 > 2136 > 1267 > 940 > 639 > 978 > 602 > 457 > 406   \n",
      "CEA 56.2 > 36.5 > 20.1 > 18.7 >21.9 > 20.1  \n",
      "Bil 122 on last check (downtrending)  > 99 > 49 > 22      \n",
      "     \n",
      "MRI Liver 23/4/25:   \n",
      "1. No focal lesion is seen corresponding to previously noted hepatic segment VII hypodensities on the CT of 1 Apr 2025, possibly resolved abscesses. No evidence of liver metastasis.  \n",
      " \n",
      "2. Stable irregular pancreatic head mass allowing for modality differences, consistent with biopsied adenocarcinoma. Associated main pancreatic ductal dilation up to 1.1cm is unchanged. \n",
      " \n",
      "3. Stable size of mesenteric nodular soft tissue, suspicious for nodal disease vs contiguous disease extension of pancreatic mass.   \n",
      " \n",
      "CT TAP April 2025 (post #6 FOLFIRINOX): PR \n",
      "1. Stable irregular pancreatic head mass encasing gastroduodenal artery, abutting   \n",
      "the patent superior mesenteric vein and artery(slightly more than 180 degree contact),   \n",
      "consistent with biopsied adenocarcinoma. Stable associated distal main pancreatic   \n",
      "ductal dilation and distal pancreatic atrophy.  \n",
      "  \n",
      "2. Interval decrease in size of mesenteric nodular soft tissue, suspicious for nodal   \n",
      "metastasis vs contiguous disease extension of pancreatic mass.  \n",
      "  \n",
      "3. Interval improvement of peripancreatic fat stranding, resolution of peripancreatic   \n",
      "fluid, resolution of pancreatic pseudocysts, improvement of gastroduodenal oedema,   \n",
      "and decrease in volume of ascites presumably related to pancreatitis.   \n",
      "  \n",
      "4. New hepatic segment VII hypodensities, indeterminate. Attention on follow-up is   \n",
      "suggested.   \n",
      "  \n",
      "Imp: PR but new liver hypodensities - indeterminate  \n",
      "1) LA PDAC inseparable from SMA/SMV      \n",
      "pMMR     \n",
      "     \n",
      "2) HepB core total Ab     \n",
      "     \n",
      "3) Bilateral middle bronchiectasis on b/g of chronic smoking       \n",
      "     \n",
      "-------------------------------------------------------------------------     \n",
      "     \n",
      "Prev Comms  \n",
      "Explained latest MRI finding - no evidence of hepatic met, resolved abscess  \n",
      "Biochemically respo\n",
      "{'diagnosis': 'Distal Cholangiocarcinoma', 'stage': 'Stage IV'} Oncological History  \n",
      "\n",
      "1. Recurrent metastatic distal CBD adenoCA\n",
      "- SOD: lung\n",
      "\n",
      "On dx Stage IIIA (pT3N2M0)\n",
      " (pMMR, G2) \n",
      "- Presented with painless obstructive jaundice  \n",
      "- At diagnosis: Ca 19-9 530, CEA 3.8 \n",
      "- s/p ERCP and stenting on <DATE>: Cholangiogram showed 3cm distal CBD stricture with upstream biliary dilatation.  \n",
      "- Histo:  \n",
      "(A) biliary stricture biopsy: dysplasia. \n",
      "(B) biliary brushing cytology : atypical cells present suspicious for malignancy \n",
      "- Laparoscopic whipple's <DATE>, R0 resection \n",
      "> Histo: Moderately-differentiated (G2) adenocarcinoma; of extrapancreatic common bile duct origin; pMMR \n",
      "- Initiated adjuvant capecitabine <DATE>\n",
      "- #3 Capecitabine delayed due to dengue \n",
      "- Rising CA19-9 > CT <DATE> metastatic disease (lungs) \n",
      "- <DATE>: #1 Gemcitabine\n",
      "-  <DATE> CT PD\n",
      "- <DATE>: Escalated to Gem/Cis/Durva\n",
      "> Durva added from #2\n",
      "- <DATE>: CT after #3 - PD small vol in lungs\n",
      "- Inc gem to 1550mg abs, cisplatin 40mg abs, continued durva\n",
      "- Given GCSF on D2, D9, ANC tolerated.  \n",
      "- #4 increased gem from 1400 (790mg/m2) to 1550 (880mg/m2) , cis from 36mg (20mg/m2) to 40mg abs (23mg/m2) -- in view of PD\n",
      "- #5 -D1 initially planned on <DATE>, but poor venous cannulation had to await port insertion - delayed \n",
      "- Port inserted <DATE>, and C5D1 given <DATE>\n",
      "- C5D8 noted AKI - likely cisplatin induced - \n",
      "> CrCl 38 from 65, held off cisplatin for D8, continued with gemcitabine \n",
      "- 6.1.25 #6 Gem/Cis/Durva\n",
      "- 8.1.25 CT TAP: minimal progression in lungs\n",
      "- 27.1.25 #7 Gem/Cis/Durva\n",
      "- 17.2.25 #8 Gem/Cis/Durva\n",
      "- 19.2.25 - sent foundation one: HRD neg, CDKN2A loss, KRAS G12V, MTAP loss exons 2-8, CDKN2B loss, SMAD4 S138*, R97H, TP53 I232T | no reportable alterations for: FGFR2, IDH1 GFR2, IDH1\n",
      "- 3.3.25 CT further PD in lungs\n",
      "\n",
      "- 10.3.25 2L #1 XELOX\n",
      "- 3.4.25 #2 XELOX\n",
      "- 12.4.25 admitted for SOB 2' symptomatic L pleural effusion s/p L chest drain 12/4/25 + talc, cx air leak s/p blood patch 25.4.25, IR glue embolisation 1.5.25. Cyto positive for malignant cells.\n",
      "- 27.4.25 CT minimal PD in lungs, Persist with XELOX as only #2 given and #2  was truncated.\n",
      "- 14.5.25 #3 XELOX\n",
      "- 20.5.25 readmitted 2nd time for SOB 2' symptomatic L malignant pleural effusion s/p L chest drain. Deemed as PD on XELOX\n",
      "\n",
      "2.6.25 #1 Naliri-5FU\n",
      "8-11.6.25 admitted 3rd time for recurrence of L MPE s/p IPC 9.6.25\n",
      "\n",
      "Past Medical History  \n",
      "1. HTN  / HLD / DM  \n",
      "2. OA  \n",
      "3. Premature atrial complexes  \n",
      "4. Dengue infection (May 2024) \n",
      "\n",
      "Social History  \n",
      "Stays with wife \n",
      "3 children - eldest daughter based in USA, 2 other daughters in SG stay separately  \n",
      "Retired \n",
      "Non-smoker, Non-drinker  \n",
      "Brother in law works as a GP (sister's husband)  \n",
      " \n",
      "$: No private medical insurance; EXP Clinic     \n",
      "Consultant in charge: Dr Justina Lam \n",
      "SR in charge: Kee Wanyi\n",
      "Please contact SR in charge for issues     \n",
      "\n",
      "Came alone\n",
      "     \n",
      "Reason for review: #2 Naliri-5FU\n",
      "\n",
      "Interval progress: admitted 8-11.6.25 for recurrence of L MPE s/p IPC 9.6.25\n",
      "\n",
      "Subjective\n",
      "No sob \n",
      "Functionally fit \n",
      "G1 constipation from atropine\n",
      "Taking laxatives but not working very well\n",
      "\n",
      "Objective\n",
      "Wt 66.9kg >65.6kg> 65.8kg > 64.8 kg > 63.7 kg > 61.8 kg > 59.2 kg > 56.3kg\n",
      " \n",
      "ECOG 0      \n",
      "Walked in      \n",
      "Non-toxic   \n",
      "H S1S2     \n",
      "L clear R side, L side air entry better than last visit \n",
      "L IPC dressing clean\n",
      "A soft, non-tender     \n",
      "Laparoscopic scars well healed      \n",
      " \n",
      "Port clean\n",
      "\n",
      "Investigations\n",
      "16/06/25\tHb: 10.5(L), WBC: 6.82, Hct: 32.0(L), Plt: 191. \n",
      "16/06/25\tNeut: 63.4% , Neut Abs: 4.33, MCV: 94.1% , Lymph: 18.2% , Mono: 11.6% (H), Eos: 5.9% , Baso: 0.9% . \n",
      "16/06/25\tNa: 132(L), K+: 3.6, Cl: 97(L), HCO3: 25.6, Urea: 3.9, Cre: 69, Glu:6.7. \n",
      "16/06/25\tTP: 61(L), Alb: 35(L), Bil: 13, AST: 15, ALT: 10, ALP: 101(H). \n",
      "08/06/25\tPT: 11.5, APTT: 24.7. \n",
      "\n",
      "Ca 19-9: 939 > 1716 > 2222 > 2817 > 3056 >> >10k\n",
      "\n",
      "Assessment \n",
      "1. Tolerating Naliri 5 FU \n",
      "2. recurrent symptomatic left pleural effusion s/p IPC 9.6.25 \n",
      "3. G1 constipation from atropine\n",
      "\n",
      "Comms\n",
      "he is keen to omit atropine due to constipation\n",
      "counselled risk of diarrhea\n",
      "will standby loperamide\n",
      "wanted to drain IPC every fortnight instead of every week as recommended by RES\n",
      "explained we keep to RES recommendation first kiv cut frequency if not symptomatic subsequently\n",
      "  \n",
      "\n",
      "{'diagnosis': 'Urothelial carcinoma', 'stage': 'Stage IV'} Metastatic urothelial carcinoma\n",
      "<DATE>: 1L EV+Pembro; Metastatic urothelial carcinoma\n",
      "SOD: liver, right renal mass, retroperitoneal & peritoneal nodules, bilateral adnexae, likely vulva \n",
      "<DATE>: 1L EV+Pembro; === NEW CASE ===\n",
      "68 year old Chinese woman \n",
      "\n",
      "PMH:\n",
      "1. HLD\n",
      "\n",
      "DH:\n",
      "Simvastatin ON\n",
      "NKDA \n",
      "\n",
      "SH:\n",
      "ECOG 2 (previously 1)\n",
      "iADLs\n",
      "Mobilises independently previously; now on crutches\n",
      "Stays with husband and daugther\n",
      "\n",
      "Non-smoker \n",
      "Social drinker\n",
      "\n",
      "Insurance - rider\n",
      "\n",
      "FH:\n",
      "Breast cancer mum 90y.o. \n",
      "\n",
      "Oncological Hx:\n",
      "- First presented with melena <DATE> -> self resolved but \n",
      "- Last 2 weeks of lower back pain on right \n",
      "- Nausea\n",
      "- Fatigue\n",
      "- Intermittent haematuria \n",
      "\n",
      "- SOD: spinal cord, liver\n",
      "- CTAP done in <HOSPITAL> <DATE>:\n",
      "1. Large infiltrative mass occupying most of the R kidney is suspicious for malignancy, likely primary RCC\n",
      "2. Evidence of invasion of the R renal pelvis, R renal vein and proximal R ureter is noted\n",
      "3. Several R retroperitoneal nodules are suspicious for satallite deposits \n",
      "4. R adrenal gland lateral limb nodule is suspicious for mets\n",
      "5. Multiple enlarged and/or necrotic abdominal and thoracic LN are suspicious for nodal mets\n",
      "6. Peritoneal thickening and a small amount of pelvic fluid, in the given context, may represent disease involvement\n",
      "7. Multiple hypodense lesions in the liver are suspicious for bilobar hepatic mets\n",
      "8. Heterogenous soft tissue thickening in the b/l adnexae are indeterminate for b/l ovarian metastatic disease\n",
      "9. Irregular soft tissue thickening in the L vulva region is indeterminate, metastatic deposit cannot be excluded\n",
      "\n",
      "\n",
      "Histo 10 <DATE>\n",
      "DIAGNOSIS\n",
      "   (A&B) Right lobe liver biopsy & imprint:\n",
      "   Metastatic carcinoma, suggestive of urothelial origin.\n",
      "\n",
      "S/\n",
      "Came with \n",
      "English speaking\n",
      "Otherwise well, with no other symptoms\n",
      "\n",
      "O/E: \n",
      "ECOG \n",
      "Wt 63.45kg\n",
      "Ht 175.8cm\n",
      "No nodes felt \n",
      "H: S1S2\n",
      "L: clear\n",
      "A: soft NT\n",
      "\n",
      "CrCl 39ml/min\n",
      "\n",
      "Imp:\n",
      "\n",
      "Communication \n",
      "Explained that patient has stage 4 disease, disease is incurable. Natural history of disease explained. Complications of underlying disease explained. \n",
      "Explained the role of palliative treatment is first and foremost  for symptom control, then aiming to control primary disease and metastasis, and hopefully prolong life.\n",
      "\n",
      "As her CrCl is 39ml/min, she is cisplatin-ineligible\n",
      "Discussed option\n",
      "Best EV+pembro -> has insurance \n",
      "Discussed EV AEs with skin tox mainly, peripheral neuropathy, bone marrow suppression\n",
      "Explained common mild side effects of immunotherapy - fatigue, rash, diarrhea, hypothyroidism. More serious side effects would be immune related adverse events which occur due to the immune system attacking own body. Any organs can be potentially attacked and greatest danger is usually when vital organs such as the lungs, heart, kidney, liver, bowel are attacked. Can be potentially life threatening but only affects a small proportion of patients. Most patients can tolerate immunotherapy relatively well.\n",
      "\n",
      "Drug info handout given. \n",
      "Fever and food advice given.\n",
      "All questions answered. \n",
      "Patient consented\n",
      "\n",
      "Plan\n",
      "Second opinion CT scan\n",
      "Shining tower consent\n",
      "Analgesia \n",
      "Add PD-L1\n",
      "Proceed with EV+ pembro this sat\n",
      "Bloods today\n",
      "TCU 2 weeks with bloods OA; === NEW CASE ===\n",
      "68 year old Chinese woman \n",
      "\n",
      "PMH:\n",
      "1. HLD\n",
      "\n",
      "DH:\n",
      "Simvastatin ON\n",
      "NKDA \n",
      "\n",
      "SH:\n",
      "ECOG 2 (previously 1)\n",
      "iADLs\n",
      "Mobilises independently previously; now on crutches\n",
      "Stays with husband and daugther\n",
      "\n",
      "Non-smoker \n",
      "Social drinker\n",
      "\n",
      "Insurance - rider\n",
      "\n",
      "FH:\n",
      "Breast cancer mum 90y.o. \n",
      "\n",
      "Oncological Hx:\n",
      "- First presented with melena april 2025 -> self resolved but \n",
      "- Last 2 weeks of lower back pain on right \n",
      "- Nausea\n",
      "- Fatigue\n",
      "- Intermittent haematuria \n",
      "\n",
      "- SOD: spinal cord, liver\n",
      "- CTAP done in Thomson Medical 2/5/25:\n",
      "1. Large infiltrative mass occupying most of the R kidney is suspicious for malignancy, likely primary RCC\n",
      "2. Evidence of invasion of the R renal pelvis, R renal vein and proximal R ureter is noted\n",
      "3. Several R retroperitoneal nodules are suspicious for satallite deposits \n",
      "4. R adrenal gland lateral limb nodule is suspicious for mets\n",
      "5. Multiple enlarged and/or necrotic abdominal and thoracic LN are suspicious for nodal mets\n",
      "6. Peritoneal thickening and a small amount of pelvic fluid, in the given context, may represent disease involvement\n",
      "7. Multiple hypodense lesions in the liver are suspicious for bilobar hepatic mets\n",
      "8. Heterogenous soft tissue thickening in the b/l adnexae are indeterminate for b/l ovarian metastatic disease\n",
      "9. Irregular soft tissue thickening in the L vulva region is indeterminate, metastatic deposit cannot be excluded\n",
      "\n",
      "\n",
      "Histo 10 June 2025\n",
      "DIAGNOSIS\n",
      "   (A&B) Right lobe liver biopsy & imprint:\n",
      "   Metastatic carcinoma, suggestive of urothelial origin.\n",
      "\n",
      "S/\n",
      "Came with daughter, husband\n",
      "English speaking\n",
      "C/o nausea, LOA, fatigue\n",
      "Poor functional decline in 2 weeks\n",
      "Otherwise well, with no other symptoms\n",
      "\n",
      "O/E: \n",
      "ECOG 2 (previously ECOG 1 2 weeks ago)\n",
      "Wt 63.45kg\n",
      "Ht 175.8cm\n",
      "No nodes felt \n",
      "H: S1S2\n",
      "L: clear\n",
      "A: soft NT\n",
      "\n",
      "CrCl 39ml/min\n",
      "\n",
      "Imp:\n",
      "\n",
      "Communication \n",
      "Explained that patient has stage 4 disease, disease is incurable. Natural history of disease explained. Complications of underlying disease explained. \n",
      "Explained the role of palliative treatment is first and foremost  for symptom control, then aiming to control primary disease and metastasis, and hopefully prolong life.\n",
      "\n",
      "As her CrCl is 39ml/min, she is cisplatin-ineligible\n",
      "Discussed option\n",
      "Best EV+pembro -> has insurance \n",
      "Discussed EV AEs with skin tox mainly, peripheral neuropathy, bone marrow suppression\n",
      "Explained common mild side effects of immunotherapy - fatigue, rash, diarrhea, hypothyroidism. More serious side effects would be immune related adverse events which occur due to the immune system attacking own body. Any organs can be potentially attacked and greatest danger is usually when vital organs such as the lungs, heart, kidney, liver, bowel are attacked. Can be potentially life threatening but only affects a small proportion of patients. Most patients can tolerate immunotherapy relatively well.\n",
      "\n",
      "Drug info handout given. \n",
      "Fever and food advice given.\n",
      "All questions answered. \n",
      "Patient consented\n",
      "\n",
      "Plan\n",
      "Second opinion CT scan\n",
      "Shining tower consent\n",
      "Analgesia \n",
      "Add PD-L1\n",
      "Proceed with EV+ pembro this sat\n",
      "Bloods today\n",
      "TCU 2 weeks with bloods OA; Metastatic urothelial carcinoma\n",
      "SOD: liver, right renal mass, retroperitoneal & peritoneal nodules, bilateral adnexae, likely vulva \n",
      "June 2025: 1L EV+Pembro; ATU REG REVIEW\n",
      "\n",
      "CTSP: noted in ATU screening LFT worsening compared to 8 days ago\n",
      "\n",
      "18/06/25\tHb: 8.1(L), WBC: 9.18, Hct: 25.2(L), Plt: 232. \n",
      "18/06/25\tNeut: 91.0% (H), Neut Abs: 8.35(H), MCV: 88.7% , Lymph: 5.0% (L), Mono: 3.0% , Eos: 1.0% , Baso: 0.5% (10/06/25). \n",
      "18/06/25\tNa: 132(L), K+: 5.0, Cl: 97(L), HCO3: 19.6, Urea: 17.8(H), Cre: 113(H), Glu:5.6. \n",
      "18/06/25\tTP: 70, Alb: 35(L), Bil: 19, AST: 280(H), ALT: 83(H), ALP: 788(H). \n",
      "10/06/25\tPT: 11.3, APTT: 30.7. \n",
      "18/06/25\tCalcium : 2.58(H). \n",
      "\n",
      "\n",
      "Px denies any fever at home\n",
      "Mainly N/V on and off\n",
      "Occ back pain relieved by morphine\n",
      "Dg mentioned mild functional decline\n",
      "However noted subsequently that temp in ATU screening at 38.5\n",
      "\n",
      "\n",
      "Case discussed with Dr Sophia Wong (primary DMO)\n",
      "She noted will repeat bloods with septic work up - no need to wait for result\n",
      "Proceed with EV + pembro today as it is not myelosuppressive\n",
      "Overall symptoms all related to underlying cancer and the high liver burden and px may miss the boat\n",
      "If need to cover with abx, to cover empirically\n",
      "\n",
      "\n",
      "Dr Sophia Wong also spoke to px dg re: the above\n",
      "Px dg also keen to proceed with chemo\n",
      "Understand the above and all questions answered; Metastatic urothelial carcinoma\n",
      "SOD: liver, right renal mass, retroperitoneal & peritoneal nodules, bilateral adnexae, likely vulva \n",
      "June 2025: 1L EV+Pembro; ATU MO\n",
      "\n",
      "CTSP fever\n",
      "\n",
      "====subjective===\n",
      "noted fever T 38.6 while waiting for blood transfusion\n",
      "noted SpO2 90% RA\n",
      "vitals were ok in screening earlier\n",
      "pt noted feeling cold since ytd\n",
      "has intermittent long standing nausea\n",
      "daughter by bedside reports pt has been feeling nauseated although nil vomitting\n",
      "has been trying to take the abx given on Sat\n",
      "\n",
      "O/E:\n",
      "T 38.2 HR 115 RR 18 BP 104/54 SpO2 90% by bedside - does up to 97% on 2L NP\n",
      "lethargic looking in bed\n",
      "hydration still good\n",
      "nil resp distress\n",
      "H S1S2 nil murmur\n",
      "L clear\n",
      "abdo soft non tender BS present\n",
      "calves supple\n",
      "\n",
      "Imp: persistent fever with desat possible infection\n",
      "B/G mets urothelial CA last EV+pembro on 21/6/2025\n",
      "\n",
      "Plan:\n",
      "proceed with blood transfusion\n",
      "septic workup\n",
      "KIV admit; ATU MO\n",
      "\n",
      "CTSP fever\n",
      "\n",
      "====subjective===\n",
      "noted fever T 38.6 while waiting for blood transfusion\n",
      "noted SpO2 90% RA\n",
      "vitals were ok in screening earlier\n",
      "pt noted feeling cold since ytd\n",
      "has intermittent long standing nausea\n",
      "daughter by bedside reports pt has been feeling nauseated although nil vomitting\n",
      "has been trying to take the abx given on Sat\n",
      "\n",
      "O/E:\n",
      "T 38.2 HR 115 RR 18 BP 104/54 SpO2 90% by bedside - does up to 97% on 2L NP\n",
      "lethargic looking in bed\n",
      "hydration still good\n",
      "nil resp distress\n",
      "H S1S2 nil murmur\n",
      "L clear\n",
      "abdo soft non tender BS present\n",
      "calves supple\n",
      "\n",
      "Imp: persistent fever with desat possible infection\n",
      "B/G mets urothelial CA last EV+pembro on 21/6/2025\n",
      "\n",
      "Plan:\n",
      "proceed with blood transfusion\n",
      "septic workup\n",
      "KIV admit\n",
      "\n",
      "====addendum at 1625h===\n",
      "updated primary oncologist Dr Sophia Wong and agreeable to admit\n",
      "clarified with MO Dr Jeremiah that 1 dose 6mg pegfilgrastim to be given today\n",
      "pt reviewed by Dr Jonathan Soon (ATU reg)\n",
      "\n",
      "Plan:\n",
      "ECG \n",
      "add on trop\n",
      "KIV CTPA\n",
      "admit\n",
      "start abx\n",
      "6mg pegfilgrastim; ATU MO\n",
      "\n",
      "CTSP fever\n",
      "\n",
      "====subjective===\n",
      "noted fever T 38.6 while waiting for blood transfusion\n",
      "noted SpO2 90% RA\n",
      "vitals were ok in screening earlier\n",
      "pt noted feeling cold since ytd\n",
      "has intermittent long standing nausea\n",
      "daughter by bedside reports pt has been feeling nauseated although nil vomitting\n",
      "has been trying to take the abx given on Sat\n",
      "\n",
      "O/E:\n",
      "T 38.2 HR 115 RR 18 BP 104/54 SpO2 90% by bedside - does up to 97% on 2L NP\n",
      "lethargic looking in bed\n",
      "hydration still good\n",
      "nil resp distress\n",
      "H S1S2 nil murmur\n",
      "L clear\n",
      "abdo soft non tender BS present\n",
      "calves supple\n",
      "\n",
      "Imp: persistent fever with desat possible infection\n",
      "B/G mets urothelial CA last EV+pembro on 21/6/2025\n",
      "\n",
      "Plan:\n",
      "proceed with blood transfusion\n",
      "septic workup\n",
      "KIV admit\n",
      "\n",
      "====addendum at 1625h===\n",
      "updated primary oncologist Dr Sophia Wong and agreeable to admit\n",
      "clarified with MO Dr Jeremiah that 1 dose 6mg pegfilgrastim to be given today\n",
      "pt reviewed by Dr Jonathan Soon (ATU reg)\n",
      "\n",
      "Plan:\n",
      "ECG \n",
      "add on trop\n",
      "KIV CTPA\n",
      "admit\n",
      "start abx\n",
      "6mg pegfilgrastim\n",
      "\n",
      "=====addendum at 1705h===\n",
      "confirmed with Dr Sophia WOng - no need for pegfilgrastim and can watch inpatient\n",
      "\n",
      "Plan:\n",
      "no need pegfilgrastim\n",
      "{'diagnosis': 'Retroperitoneal liposarcoma', 'stage': 'Stage IIIA'} Intraabdominal dedifferentiated sarcoma\n",
      "<DATE> Right retroperitoneal liposarcoma tumor with right hemicolectomy, right kidney and right ureter:\n",
      "pT4 Dedifferentiated liposarcoma, size 280mm, grade 3\n",
      "No tumor invasion into the colon, kidney or ureter.\n",
      "Benign kidney cysts noted.\n",
      "Colonic diverticula present.\n",
      "Tumor is present at the exposed radial margin \n",
      "\n",
      "<DATE>: Relapsed\n",
      "(Bx proven and decided for expectant management)\n",
      "\n",
      "<DATE> C1 Caelyx\n",
      "<DATE> C2 Caelyx\n",
      "<DATE> C3 Caelyx\n",
      "CT: PD \n",
      "<DATE> C1 Gem/Tax\n",
      "<DATE> C2 Gem/Tax\n",
      "<DATE> C3 Gem/Tax\n",
      "CT: PR\n",
      "<DATE> C4 Gem/Tax\n",
      "<DATE> C5 Gem/Tax\n",
      "<DATE> C6  Gem/Tax\n",
      "CT: Primary mass PR but new lung changes, possible infective\n",
      "\n",
      "Past Medical History:\n",
      "1. BPH with ARU s/p TURP <DATE>\n",
      "2. Diverticular bleed <DATE>\n",
      "3. Asthma on symbicort\n",
      "4. LBGIT likely diverticular bleed <DATE> requires clips \n",
      "5. Small incidental  aneurysm noted at the bifurcation of celiac artery\n",
      "6. Solitary function left kidney\n",
      "\n",
      "Covid-19 status\n",
      "<DATE>.<DATE> Pfizer\n",
      "25.04.21 Pfizer\n",
      "23.10.<DATE> Pfizer\n",
      "<DATE> Covid-19 infection\n",
      "\n",
      "Contact\n",
      "Patient <ID><PHONE>\n",
      "<PATIENT> (Son) <ID>\n",
      "Abigail <ID>; 67M with intraabdominal dedifferentiated liposarcoma             \n",
      "s/p resection of Right retroperitoneal liposarcoma tumor with right hemicolectomy, right kidney and right ureter <DATE> Relapse with biopsy proven, further PD in <DATE>      \n",
      "PD post 3# Caelyx    \n",
      " post C6 Gemcitabine/Docetaxel completed <DATE>\n",
      "\n",
      "CTTAP <DATE>: \n",
      "- Status post resection of right retroperitoneal liposarcoma with right nephro-ureterectomy and right hemicolectomy (<DATE>).\n",
      "- Interval decrease in size of the right iliac fossa heterogeneously enhancing mass, consistent with biopsy proven recurrenet liposarcoma.\n",
      "- Interval increase in size of mesenteric node anterior to the left kidney, indeterminate.\n",
      "- Slightly larger subcarinal and new right perihilar nodes associated with right lower lobe mass like consolidation. This may be due to infection or metastasis. Please correlate clinically\n",
      "\n",
      "patient at the same time saw DSO to discuss palliative debulking, patient was not keen in view of the risks, and high risk of tumor recurring/progressing \n",
      "\n",
      "Patient was then referred to respi after MDT discussion for biopsy of the R LL mass like consolidation, respi saw 4/11/24 and decided to delay biopsy till after scan \n",
      "\n",
      "29/11/24: \n",
      "Interval decrease in subcarinal adenopathy. \n",
      "Stable mass right iliac fossa inseparable from right iliopsoas and abutting adjacent \n",
      "bowel loops, consistent with submitted diagnosis. \n",
      "Stable left mesenteric adenopathy.\n",
      "\n",
      "Dec 24: expectant management \n",
      "\n",
      "Jan 25: s/b DSO and patient not keen on palliative resection \n",
      "\n",
      "March 25: PD\n",
      "\n",
      "#1 eribulin 22/4/25 (70% dose) \n",
      "\n",
      "#2 eribulin 23/5/25 (postponed in view of fever) (80%) \n",
      "\n",
      "TO REVIEW FOR #3\n",
      "\n",
      "===\n",
      "    \n",
      "Subjective:    \n",
      "     \n",
      "HERE to review \n",
      "\n",
      "more tired\n",
      "\n",
      "nil fever\n",
      "\n",
      "has some LL edema \n",
      "\n",
      "\n",
      "Objective:    \n",
      "     \n",
      "Alert    \n",
      "Oral cavity clean  \n",
      "No palpable nodes    \n",
      "HS1S2     \n",
      "Lungs clear      \n",
      "Abdomen soft nontender     \n",
      "LIF mass 5FB, non-tender    \n",
      "Calves supple no oedema      \n",
      "    \n",
      "Investigations:    \n",
      "\n",
      "\n",
      "Assessment:    \n",
      "Recurrent liposarcoma     \n",
      "- PD post 1L Caelyx    \n",
      "- PR after 3# Gem/Tax; PR after 6# Gem/Tax > new lung changes at the time indeterminate for cancer VS infective changes > biopsy was planned for initially but delayed \n",
      "\n",
      "- Nov 24: scan shows the R LL changes and subcarinal changes are resolving/improving, hence likely infective \n",
      "       \n",
      "- March 25: PD > eribulin \n",
      "\n",
      "now due #3\n",
      "\n",
      "Iron deficiency anemia  \n",
      "s/p Ferinject 09/2023, 06/2024  \n",
      "\n",
      "COMMS\n",
      "\n",
      "push on #3 and scan for response evaluation\n",
      "\n",
      "agreed \n",
      "\n",
      "top up 1 PCT\n",
      "\n",
      "advised to elevate legs for the edema at night \n",
      "; Intraabdominal dedifferentiated sarcoma\n",
      "11.10.22 Right retroperitoneal liposarcoma tumor with right hemicolectomy, right kidney and right ureter:\n",
      "pT4 Dedifferentiated liposarcoma, size 280mm, grade 3\n",
      "No tumor invasion into the colon, kidney or ureter.\n",
      "Benign kidney cysts noted.\n",
      "Colonic diverticula present.\n",
      "Tumor is present at the exposed radial margin \n",
      "\n",
      "09/2023: Relapsed\n",
      "(Bx proven and decided for expectant management)\n",
      "\n",
      "05/01/24 C1 Caelyx\n",
      "01/02/24 C2 Caelyx\n",
      "01/03/24 C3 Caelyx\n",
      "CT: PD \n",
      "30/03/24 C1 Gem/Tax\n",
      "20/04/24 C2 Gem/Tax\n",
      "18/05/24 C3 Gem/Tax\n",
      "CT: PR\n",
      "15/06/24 C4 Gem/Tax\n",
      "06/07/24 C5 Gem/Tax\n",
      "20/07/24 C6  Gem/Tax\n",
      "CT: Primary mass PR but new lung changes, possible infective\n",
      "\n",
      "Past Medical History:\n",
      "1. BPH with ARU s/p TURP April 2015\n",
      "2. Diverticular bleed 2015\n",
      "3. Asthma on symbicort\n",
      "4. LBGIT likely diverticular bleed 01/2023 requires clips \n",
      "5. Small incidental  aneurysm noted at the bifurcation of celiac artery\n",
      "6. Solitary function left kidney\n",
      "\n",
      "Covid-19 status\n",
      "09.04.21 Pfizer\n",
      "25.04.21 Pfizer\n",
      "23.10.21 Pfizer\n",
      "10.08.22 Covid-19 infection\n",
      "\n",
      "Contact\n",
      "Patient 82621965\n",
      "Paul (Son) 97772227\n",
      "Abigail 88783932; ATU MO Review \n",
      "\n",
      "Wong Siew Tat S1189955B \n",
      "68 year old male \n",
      "ATU yesterday for C3D8 eribulin, today for blood transfusion \n",
      "Low grade fevers 37.8 - 37.9 \n",
      "\n",
      "\n",
      "On Review \n",
      "Feeling tired but otherwise well\n",
      "First time noticing fevers \n",
      "No chills rigors \n",
      "No sore throat/ core/ runny nose \n",
      "No abdominal pain/ diarrhoea/ constipation \n",
      "No haematuria/ dysuria \n",
      "\n",
      "Noted white cells raised at 20.33  yesterday \n",
      "\n",
      "Objective \n",
      "T 37.8 \n",
      "HR 98 \n",
      "RR 19 \n",
      "BP 119/67 \n",
      "Sats 96% on RA \n",
      "\n",
      "On Examination \n",
      "Alert, walked to ATU \n",
      "H S1 S2 \n",
      "Lungs clear \n",
      "Abdomen - mass palpated \n",
      "Calves supple mild pedal oedema (patient says this is normal, will frequently elevate leg)\n",
      "{'diagnosis': 'Rectal Adenocarcinoma', 'stage': 'III'} Explained goals/benefits of adding avastin , \n",
      "Consented, signed \n",
      "-\n",
      "CA rectum (above reflection) adjuvant chemo\n",
      "pT4a N2b (<DATE> + 0<DATE>) Mx L1 V0 Pn1 Bd3 R0\n",
      "robotic LAR (<DATE>)\n",
      "XELOX \n",
      "\n",
      "1. left knee ?OA -> advised surgery by PTE surgeon not seen yet -> requested to see <HOSPITAL> Ortho (was scheduled <DATE> will see ortho on at <HOSPITAL> <DATE>) \n",
      "2. previous haemorrhoidectomy\n",
      "\n",
      "Dgt: <ID>\n",
      "Own: <ID>; <PATIENT>\t<ID>\t67\tChinese\tMALE\tSUB\n",
      " \n",
      "Assessment (Brief Summary)\n",
      " \n",
      "Met CA rectum (above reflection) -- concurrent TB & metastatic disease to the lung\n",
      " \n",
      "Initial : pT4a N2b (<DATE> + 0<DATE>) Mx L1 V0 Bd3 R0\n",
      "robotic LAR (<DATE>); \n",
      "FM1 Roche (<DATE>): KRAS wt, NRAS Q61R, APC 2035fs*, R232* E1309fs*4 CUL4A amplifaction FGF14 amplification FLT3 IRS2 amplifcation KDM5A amplifiucation PBRM1 splice site SOX9 C72fs*190 TP53 R213*\n",
      "adjuvant XELOX #2 (adm I/O 2ry adhesions) Xelox #8 <DATE>   \n",
      "   \n",
      "Recurrent Small Bowel Obstruction adhesions adm <DATE> & <DATE>   \n",
      " \n",
      "CT TAP (<DATE>): New, tiny right pulmonary nodules -- indeterminate\n",
      "Adm <HOSPITAL> <DATE>: with adhesion colic \n",
      "CT-TAP (<DATE>): small bowel I/O (adhesions); larger and new lung nodules (too small to Bx)\n",
      " \n",
      "Treatment Hx: \n",
      "XELIRI #1 <DATE>; #2 <DATE>; COVID-19 neutropenic shock (? Bacterial infection ) MICU NOA briefly <DATE>\n",
      "Bev/XELIRI # 5 Irinotecan #6 Bev/irinotecan #7 --> CT <DATE> : SD; stable RUL 0.3 RML 0.3, lingular 0.4, RLL 0.9\n",
      " \n",
      " \tAtezo/XL092 : stella\tBev/Xelox #1 <DATE>\n",
      "#2 <DATE>\n",
      "#3 <DATE>\tBev/XELIRI # 8 <DATE>\n",
      "#9 <DATE> #10 <DATE>\n",
      "XL092\tstart <DATE>\n",
      "paused <DATE> (Gastroenteriitis)\n",
      "#2 16/2/24 to 20/2/24\n",
      "#3: restart 7/3\t \t \n",
      "Atezo\t1200\n",
      "#1 18/1 ; #2 : 16/2\n",
      "#3 7/3\t \t \n",
      "CEA\t \t \t \n",
      " \tCT 1/3: mostly SD lung, some larger\n",
      "cavitatory lesions ? Superimposed infection\t \tCT 10/10/23: PD\n",
      " \t21/3: 31\t24/10 10.5 \n",
      "14/11 16.1\n",
      "13/12: 17.9\t \n",
      " \tCT: points to PD\tCT: PD\t \n",
      " \t \tIncrease in size of most of bilateral pulmonary metastases\t \n",
      "upper lobes bilaerally\tIncrease cavitory masses with thick irregular rims in the upper lobe bilaterally \n",
      "with coalesced lesions in the upper subpleural masses\n",
      "pTB vs metastases\t \t \n",
      "LUL\t \t \t \n",
      "LUL\t \t \t \n",
      " \t \t \t \n",
      "LUL\t \t3.1 vs 2.7\tnew 3.5 cm \n",
      "(mass like onsolidation internal cavitation)\n",
      "LUL\t1.2 vs 0.7\t \t0.3 new\n",
      "LLL\t1.0 vs 0.7\t \t0.9 new\n",
      "RLL\t \t \t0.4 new\n",
      "RLL\t \t \t0.9 (slightly larger)\n",
      "LLL\t1.2, SD\t \t1.1 (larger conglomerate)\n",
      "RUL\t \t0.5 PD\t0.4 , SD\n",
      "RML \t \t0.6 PD\t0.3 SD\n",
      "Left lingula\t \t \t0.5 SD\n",
      "Right hilar LN\t \t0.8 vs 0.5\t \n",
      "Effusions\t \t \t \n",
      "fluid shift\t \t \t \n",
      " \n",
      "On STELLA trial, randomized to XL092/Atezolizumab started on 18/1/24\n",
      "Admitted 27-31/1/24 with Gastroenteritis and hyponatremia\n",
      "Admitted 20-23/2/24 with intestinal obstruction secondary to adhesions\n",
      " \n",
      "Atezo #18/1/24 paused XL 26/1 due to fever/GE \n",
      "XL: Restart 15/2\n",
      "#2 16/2/24 \n",
      "Stop 20/2 \n",
      " \n",
      "Admitted 25/3 to 17/4: sputum AFB (3+) ; PCR (+) culture neg -- see bleow \n",
      " \n",
      "closed loop small bowel obstruction secondary to adhesions \n",
      "Exploratory laparotomy, adhesiolysis, small bowel resection and double barrel enteroenterostomy (31/03/24) \n",
      "made to resect and exteriorize as double barrel enteroenterostomy (previous avastin)\n",
      "Histo: Small bowel resection: Serositis focal granulomatous colitis. No vasculitis, thromboembolic material or malignancy. \n",
      " \n",
      " \tTAS102 #1  28/5\n",
      "Bev/TAS102 # 2 26/6 & 10/7\t \n",
      "TAS102\t40/45\t \n",
      "CEA\t \t \n",
      " \t28/5 : 81 \n",
      "25/6: 121\t7/5 : 84\n",
      " \t \tCT 17/5 PD\n",
      "upper lobes bilaerally\tsmaller cavitary lung lesions & adjacent consolidations seen LUL & apical LLL e.g. LUL to 1.3 cm \t \n",
      "LUL\t \tNew 1.0\n",
      "LUL\t \t1.0 from 0.5\n",
      " \t \t worsening of patchy cavitatory consolidations superimposed infection/inflammation vs lymphangitis \n",
      "carcinomatosis\n",
      "LUL\t \t \n",
      "LUL\t \t \n",
      "LLL\t \t \n",
      "RLL\t1.3, SD\t \n",
      "RLL\t \t \n",
      "LLL\t1.3 , SD\t \n",
      "RUL\t \t \n",
      "RML \t \t \n",
      "Left lingula\t \t \n",
      "Right hilar LN\t \t \n",
      "Effusions\t \tless left, resolved right\n",
      "fluid shift\t \tStable diffuse subcutaneous and intra-abdominal fat stranding\n",
      " \n",
      " \tTAS 102 #7 21/11 #8 19/12\tTAS102 #5 19/9\n",
      "#6 24/10\tTAS 102 #422/8\tBev/TAS102 #3 23/7\n",
      "Admitted for Acute PE Aug-24\tTAS102 #1  28/5\n",
      "Bev/TAS102 # 2 26/6 & 10/7\n",
      "Bev\t \t \t \t200\t190\n",
      "TAS102\t \t \t40/45\t40/45\t40/45\n",
      "CEA\t \t \t \t \t \n",
      " \t \t \t \t \t28/5 : 81 \n",
      "25/6: 121\n",
      " \t \t \t \t \t \n",
      " \tCT 16/1/25\tCT 13/11\tCT 12/9\t \tCT 16/7\n",
      "upper lobes bilaerally\t \t \t \t \tsmaller cavitary lung lesions & adjacent consolidations seen LUL & apical LLL e.g. LUL to 1.3 cm \n",
      "LUL\t \t \t \t \t \n",
      "LUL\t \t \t \tCT PA 1/8/24: \t \n",
      " \t \tr\n",
      "{'diagnosis': 'Pancreatic adenocarcinoma', 'stage': 'IV'} Medical history \n",
      "\n",
      "1. HTN\n",
      "2. OA of bilateral knees \n",
      "3. Prior L meniscus surgery done; <PATIENT> <HOSPITAL>\n",
      "<ID>i\n",
      "67 / Chinese / Male\n",
      "NKDA\n",
      "\n",
      "1. metastatic likely pancreatic adenocarcinoma  \n",
      "- SOD: Pancreas, bilobar liver, paraspinal, spine \n",
      "\n",
      "- LFT ALP 590 > 547 > 593 ALT 161 > 147 >158  AST 108 > 93 > 91 \n",
      "- GGT 787 > 892 \n",
      "- CT TAP (<DATE>): \n",
      "> There are numerous nodules/masses in the liver . Largest lesion in segment VIII  \n",
      "(6.9 cm) (series 7, image 19) with another sizeable lesion in segment III (5.3 cm)  \n",
      "(series 7, image 27). Hepatic and portal veins appear grossly patent. \n",
      "> Hypoenhancing mass epicentre at the pancreatic tail invading the splenic  hilum (5.0 cm x 4.6 cm) (series 7, image 33). It is abutting the left kidney upper  \n",
      "pole. There is obliteration of the adjacent splenic vein. \n",
      "> Left adrenal nodule suspicious for metastasis (2.2 cm) (series 7, image 32) gland  \n",
      "is unremarkable. \n",
      "> Small enhancing polyp in the gallbladder (0.7 cm) (series 7, image 50).No biliary dilatation. Subcentimetre hypodensities in both kidneys are too small to characterise. No hydronephrosis \n",
      "> Prominent borderline enlarged retroperitoneal and upper abdominal lymph nodes which are suspicious for metastases. For example portocaval node (0.9 cm) (series 7, image 39) and aorto caval node (0.7 cm) (series 7, image 43) \n",
      "> Heterogeneous nodule in the left adductor minimus suspicious for intramuscular metastasis  \n",
      "(2.3 cm) (series 7, image 142). Intramuscular metastases also noted in the left paraspinal  \n",
      "muscle (6.0 cm) (series 10, image 60) \n",
      "- Tumor markers <DATE>:  CA 19-9 >10000 CEA 583 AFP 3.2  \n",
      "- s/p US guided core biopsy of L thoracolumbar paraspinal intramuscular lesion by IR <DATE>\n",
      ">Histology: Metastatic adenocarcinoma deposits, likely metastasis from pancreaticobiliary mass\n",
      ">MMR IHC: MSI immunoexpression is normal (MLH-1, MSH-2, MSH-6, PMS-2: Normal)\n",
      "- s/p C1 mFOLFIRINOX on <DATE> \n",
      "- s/p Insertion of R Port-a-cath <DATE>05/25\n",
      " \n",
      "Complicated by  \n",
      "(A) Impending liver visceral crisis  \n",
      "- G1 transaminitis, rising Tbil, liver synthetic function still preserved \n",
      "- TBil trend stable inpatient 25 > 28 > 34 > 27 \n",
      "\n",
      "(B) L L3/L5 Radiculopathy from epidural/bone mets \n",
      "- p/w with ongoing pain and numbness along LL \n",
      "- F/U with OTO for possible sciatic, planned for MRI in May 25  \n",
      "- Lumbar X-RAY: Transitional vertebra at the lumbosacral junction. Alignment of the lumbar spine is satisfactory. No dynamic instability on the stress views. Vertebral body heights are maintained. Lumbar spondylotic changes present as evidenced by marginal osteophytes, endplate sclerosis and facet joint arthrosis. \n",
      "- MRI L-S (06/05/25) done in private radiology \n",
      "> Transitional vertebra at the LS junction with partial sacralization of L5 and anomalous articulation of the L5 transverse processes with the sacral ala. The last unfused vertebra body is L5.  \n",
      "> On the limit localizer counter screening sequences, T2-weighted hyperintense signal is seen in the T5 and T7 vertebrae bodies.  \n",
      "> There is satisfactory alignment of the lumbar spine with preservation of the lumbar lordosis. No spondylolisthesis or spondylolysis is seen.  \n",
      "> Endplate osteophytes are seen at a few levels in th lumbar spine. T1-weighted mildly hypointense, T2-weighted hyperintense signal in the T12 vertebrae body, left L3 vertebrae body with involvement of the left pedicle and facet and in the left L5 vertebrae body extending to the transverse process and in the central and left S1 and S2 vertebrae, left iliac bone and a small focus of signal abnormality in the posterior right iliac bone are suspicious for marrow infiltration and osseous metastasis. Small 5 mm and 7 mm T1-weighted, STIR hyperintense foci in the upper L2 and L4 vertebrae respectively are suspicious for metastatic deposits.   \n",
      "- MRI brain & whole spine (11/5/25) \n",
      "> Multiple enhancing osseous lesions seen throughout the entire thoracolumbar spine and sacrum are suspicious for bone metastases. No pathological fracture. There is extraosseous extradural soft tissue seen occupying the left ne; Medical history \n",
      "\n",
      "1. HTN\n",
      "2. OA of bilateral knees \n",
      "3. Prior L meniscus surgery done; ATU MO \n",
      "Review ivo screening had chest pain this morning - see screening nurse input\n",
      "\n",
      "mPDAC SOD liver, spine, paraspine, pancreas\n",
      "s/p #3 FOFIRINOX 18/6 for restaging 26/6/25, \n",
      "\n",
      "IV albumin today and off pump \n",
      "\n",
      "English speaking \n",
      "Came with wife\n",
      "\n",
      "HOPC\n",
      "Chest pain this morning\n",
      "1150H onset\n",
      "Chest pain (new) never had such sensation before\n",
      "Previously had GERD like sx and poor appetite but this feels different\n",
      "\n",
      "Central/ epigastric region\n",
      "No radiation to back or to arm or jaw\n",
      "A/w diaphroesis and mild SOB\n",
      "Lasted about 20 mins\n",
      "Couldnt eat lunch because of the pain , was severeity 7-8 out of 10.\n",
      "Describes as some one pressing on his chest\n",
      "\n",
      "This CP occured at rest, while lying in his bed going to about to eat lunch \n",
      "didn't eat lunch because so bad\n",
      "Mild acid brash \n",
      "Took some omeprazole \n",
      "Resovled after about 20 min + \n",
      "Now no pain\n",
      "\n",
      "Could walk at home without worsening symptoms \n",
      "\n",
      "Impression and Plans below conveyed to patient and wife - agreeable w plans\n",
      "\n",
      "\n",
      "OE/\n",
      "ECG NSR no isch changes \n",
      "\n",
      "HR 99-107\n",
      "BP 134/77 SPO2 100 RA Afeb\n",
      "\n",
      "\n",
      "Alert\n",
      "Came in WC\n",
      "Pulse strong regular\n",
      "HS120\n",
      "Lungs clear\n",
      "C supple\n",
      "COmfortable speaking full sentences on room air\n",
      "Non diaphoretic\n",
      "\n",
      "Impression\n",
      "1. Atypical CP for evaluation TRO AMI (unlikely)\n",
      "Ddx GERD /gastritis triggered by delayed anti-emetic PO dexa (4mg BD 3/7 From 18/6)\n",
      "B/g HTN, no previous cardiac evaluation or cardiac hx\n",
      "\n",
      "B/g mPDAC on FOLFIRINOX (#3 given18/6) \n",
      "\n",
      "P\n",
      "Troponin x1 set KIV 2nd set in 4h if first is abnormal\n",
      "Proceed with IV albumin\n",
      "If first set trop flat then can off pump after Albumin and discharge with GERD meds\n",
      "Inform if recurrent chest pain - to do another ECG if so\n",
      "Omeprazole 40mg OM for 2 weeks + Mylanta; ATU MO \n",
      "Review ivo screening had chest pain this morning - see screening nurse input\n",
      "\n",
      "mPDAC SOD liver, spine, paraspine, pancreas\n",
      "s/p #3 FOFIRINOX 18/6 for restaging 26/6/25, \n",
      "\n",
      "IV albumin today and off pump \n",
      "\n",
      "English speaking \n",
      "Came with wife\n",
      "\n",
      "HOPC\n",
      "Chest pain this morning\n",
      "1150H onset\n",
      "Chest pain (new) never had such sensation before\n",
      "Previously had GERD like sx and poor appetite but this feels different\n",
      "\n",
      "Central/ epigastric region\n",
      "No radiation to back or to arm or jaw\n",
      "A/w diaphroesis and mild SOB\n",
      "Lasted about 20 mins\n",
      "Couldnt eat lunch because of the pain , was severeity 7-8 out of 10.\n",
      "Describes as some one pressing on his chest\n",
      "\n",
      "This CP occured at rest, while lying in his bed going to about to eat lunch \n",
      "didn't eat lunch because so bad\n",
      "Mild acid brash \n",
      "Took some omeprazole \n",
      "Resovled after about 20 min + \n",
      "Now no pain\n",
      "\n",
      "Could walk at home without worsening symptoms \n",
      "\n",
      "Impression and Plans below conveyed to patient and wife - agreeable w plans\n",
      "\n",
      "Subsequently  noted from SN patient requested for PO Maxalon \n",
      "\n",
      "\n",
      "OE/\n",
      "ECG NSR no isch changes \n",
      "\n",
      "HR 99-107\n",
      "BP 134/77 SPO2 100 RA Afeb\n",
      "\n",
      "\n",
      "Alert\n",
      "Came in WC\n",
      "Pulse strong regular\n",
      "HS120\n",
      "Lungs clear\n",
      "C supple\n",
      "COmfortable speaking full sentences on room air\n",
      "Non diaphoretic\n",
      "\n",
      "Impression\n",
      "1. Atypical CP for evaluation TRO AMI (unlikely)\n",
      "Ddx GERD /gastritis triggered by delayed anti-emetic PO dexa (4mg BD 3/7 From 18/6)\n",
      "B/g HTN, no previous cardiac evaluation or cardiac hx\n",
      "\n",
      "B/g mPDAC on FOLFIRINOX (#3 given18/6) \n",
      "\n",
      "P\n",
      "Troponin x1 set KIV 2nd set in 4h if first is abnormal\n",
      "Proceed with IV albumin\n",
      "If first set trop flat then can off pump after Albumin and discharge with GERD meds\n",
      "Inform if recurrent chest pain - to do another ECG if so\n",
      "Omeprazole 40mg OM for 2 weeks + Mylanta\n",
      "\n",
      "; ATU MO \n",
      "Review ivo screening had chest pain this morning - see screening nurse input\n",
      "\n",
      "mPDAC SOD liver, spine, paraspine, pancreas\n",
      "s/p #3 FOFIRINOX 18/6 for restaging 26/6/25, \n",
      "\n",
      "IV albumin today and off pump \n",
      "\n",
      "English speaking \n",
      "Came with wife\n",
      "\n",
      "HOPC\n",
      "Chest pain this morning\n",
      "1150H onset\n",
      "Chest pain (new) never had such sensation before\n",
      "Previously had GERD like sx and poor appetite but this feels different\n",
      "\n",
      "Central/ epigastric region\n",
      "No radiation to back or to arm or jaw\n",
      "A/w diaphroesis and mild SOB\n",
      "Lasted about 20 mins\n",
      "Couldnt eat lunch because of the pain , was severeity 7-8 out of 10.\n",
      "Describes as some one pressing on his chest\n",
      "\n",
      "This CP occured at rest, while lying in his bed going to about to eat lunch \n",
      "didn't eat lunch because so bad\n",
      "Mild acid brash \n",
      "Took some omeprazole \n",
      "Resovled after about 20 min + \n",
      "Now no pain\n",
      "\n",
      "Could walk at home without worsening symptoms \n",
      "\n",
      "Impression and Plans below conveyed to patient and wife - agreeable w plans\n",
      "\n",
      "Subsequently  noted from SN patient requested for PO Maxalon \n",
      "\n",
      "\n",
      "OE/\n",
      "ECG NSR no isch changes \n",
      "\n",
      "HR 99-107\n",
      "BP 134/77 SPO2 100 RA Afeb\n",
      "\n",
      "\n",
      "Alert\n",
      "Came in WC\n",
      "Pulse strong regular\n",
      "HS120\n",
      "Lungs clear\n",
      "C supple\n",
      "COmfortable speaking full sentences on room air\n",
      "Non diaphoretic\n",
      "\n",
      "Impression\n",
      "1. Atypical CP for evaluation TRO AMI (unlikely)\n",
      "Ddx GERD /gastritis triggered by delayed anti-emetic PO dexa (4mg BD 3/7 From 18/6)\n",
      "B/g HTN, no previous cardiac evaluation or cardiac hx\n",
      "\n",
      "B/g mPDAC on FOLFIRINOX (#3 given18/6) \n",
      "\n",
      "P\n",
      "Troponin x1 set KIV 2nd set in 4h if first is abnormal\n",
      "Proceed with IV albumin\n",
      "If first set trop flat then can off pump after Albumin and discharge with GERD meds\n",
      "Inform if recurrent chest pain - to do another ECG if so\n",
      "Omeprazole 40mg OM for 2 weeks + Mylanta\n",
      "\n",
      "====\n",
      "EDIT 1600H\n",
      "\n",
      "1st set trop completely flat\n",
      "\n",
      "Impression\n",
      "GERD/ Gastritis 2' Steroid induced\n",
      "\n",
      "P\n",
      "Discharge after IV albumin finishes\n",
      "Return advice given\n",
      "GERD meds  + Domperidone; ATU MO \n",
      "Review ivo screening had chest pain this morning - see screening nurse input\n",
      "\n",
      "mPDAC SOD liver, spine, paraspine, pancreas\n",
      "s/p #3 FOFIRINOX 18/6 for restaging 26/6/25, \n",
      "\n",
      "IV albumin today and off pump \n",
      "\n",
      "English speaking \n",
      "Came with wife\n",
      "\n",
      "HOPC\n",
      "Chest pain this morning\n",
      "1150H onset\n",
      "Chest pain (new) never had such sensation before\n",
      "Previously had GERD like sx and poor appetite but this feels different\n",
      "\n",
      "Central/ epigastric region\n",
      "No radiation to back or to arm or jaw\n",
      "A/w diaphroesis and mild SOB\n",
      "Lasted about 20 mins\n",
      "Couldnt eat lunch because of the pain , was severeity 7-8 out of 10.\n",
      "Describes as some one pressing on his chest\n",
      "\n",
      "This CP occured at rest, while lying in his bed going to about to eat lunch \n",
      "didn't eat lunch because so bad\n",
      "Mild acid brash \n",
      "Took some omeprazole \n",
      "Resovled after about 20 min + \n",
      "Now no pain\n",
      "\n",
      "Could walk at home without worsening symptoms \n",
      "\n",
      "Impression and Plans below conveyed to patient and wife - agreeable w plans\n",
      "\n",
      "Subsequently  noted from SN patient requested for PO Maxalon \n",
      "\n",
      "\n",
      "OE/\n",
      "ECG NSR no isch changes \n",
      "\n",
      "HR 99-107\n",
      "BP 134/77 SPO2 100 RA Afeb\n",
      "\n",
      "\n",
      "Alert\n",
      "Came in WC\n",
      "Pulse strong regular\n",
      "HS120\n",
      "Lungs clear\n",
      "C supple\n",
      "COmfortable speaking full sentences on room air\n",
      "Non diaphoretic\n",
      "\n",
      "Impression\n",
      "1. Atypical CP for evaluation TRO AMI (unlikely)\n",
      "Ddx GERD /gastritis triggered by delayed anti-emetic PO dexa (4mg BD 3/7 From 18/6)\n",
      "B/g HTN, no previous cardiac evaluation or cardiac hx\n",
      "\n",
      "B/g mPDAC on FOLFIRINOX (#3 given18/6) \n",
      "\n",
      "P\n",
      "Troponin x1 set KIV 2nd set in 4h if first is abnormal\n",
      "Proceed with IV albumin\n",
      "If first set trop flat then can off pump after Albumin and discharge with GERD meds\n",
      "Inform if recurrent chest pain - to do another ECG if so\n",
      "Omeprazole 40mg OM for 2 weeks + Mylanta\n",
      "\n",
      "====\n",
      "EDIT 1600H\n",
      "\n",
      "1st set trop completely flat\n",
      "Feels improvement w maxalon (that he requested earlier)\n",
      "\n",
      "Impression\n",
      "GERD/ Gastritis 2' Steroid induced\n",
      "\n",
      "P\n",
      "Discharge after IV albumin finishes\n",
      "Return advice given\n",
      "GERD meds  + Domperidone\n",
      "{'diagnosis': 'cancer site', 'stage': 'cancer stage'} Oncology Hx\n",
      "Right frontal lobe gliosarcoma\n",
      "Resected on <DATE> by <HCW>, <HOSPITAL>\n",
      "RT + temozolomide - <DATE> -> <DATE>- > adjuvant temozolomide\n",
      "\n",
      "para-oesophageal/esophageal soft tissue nodule with internal calcifications - non FDG avid, for OGD \n",
      "\n",
      "Other med hx\n",
      "1. gout; \n",
      "S; Feels ok. No fall.  No seizure\n",
      "        \n",
      "O;  Wt 68 ,1   -> 67.3 kg   -> 66.5 kg  \n",
      "O/E alert, lucid           \n",
      "Speech  - hesitant           \n",
      "Scalp wound clean           \n",
      "Power full       \n",
      "\n",
      "MRI brain <DATE>\n",
      "Since MRI of <DATE>:\n",
      "\n",
      "1. Interval increase in size and diffusion restriction of the enhancing right corpus \n",
      "callosal lesion, suspicious for tumor progression. If there has been prior SRS to \n",
      "this lesion, it may also represent radiation necrosis.\n",
      "2. No abnormal enhancement in the right frontal lobe surgical site.\n",
      "3. Stable non enhancing tumour in the right posterior insular cortex, likely a low \n",
      "grade glioma.\n",
      "\n",
      " \n",
      "D/w patient and wife, MRI shows increasing corpus callosum lesion, tumour versus radiation necrosis. Discuss about PET-FET scan. Patient is agreeable to resume temozolomide for now, will monitor for repeat MRI in 2 months. They understand and are agreeable with plan. \n",
      "    \n",
      "   \n",
      "  \n",
      " \n",
      "; \n",
      "S; Feels ok. No fall.  No seizure\n",
      "        \n",
      "O;  Wt 68 ,1   -> 67.3 kg   -> 66.5 kg  \n",
      "O/E alert, lucid           \n",
      "Speech  - hesitant           \n",
      "Scalp wound clean           \n",
      "Power full       \n",
      "\n",
      "MRI brain <DATE>\n",
      "Since MRI of <DATE>:\n",
      "\n",
      "1. Interval increase in size and diffusion restriction of the enhancing right corpus \n",
      "callosal lesion, suspicious for tumor progression. If there has been prior SRS to \n",
      "this lesion, it may also represent radiation necrosis.\n",
      "2. No abnormal enhancement in the right frontal lobe surgical site.\n",
      "3. Stable non enhancing tumour in the right posterior insular cortex, likely a low \n",
      "grade glioma.\n",
      "\n",
      " \n",
      "D/w patient and wife, MRI shows increasing corpus callosum lesion, tumour versus radiation necrosis. Discuss about PET-FET scan. Patient is agreeable to resume temozolomide for now, will monitor for repeat MRI in 2 months. They understand and are agreeable with plan. \n",
      "Also updated son, <PATIENT>, through phone.\n",
      "    \n",
      "   \n",
      "  \n",
      " \n",
      "; Oncology Hx\n",
      "Right frontal lobe gliosarcoma, b-raf wild type\n",
      "Resected on <DATE> by <HCW>, <HOSPITAL>\n",
      "RT + temozolomide - <DATE> -> <DATE>- > adjuvant temozolomide\n",
      "\n",
      "para-oesophageal/esophageal soft tissue nodule with internal calcifications - non FDG avid, for OGD \n",
      "\n",
      "Other med hx\n",
      "1. gout; Has left sided weakness for one week, worsening over past 4 daysn, ot sleeping well at night. has headache. memory not so good, also has intermittent confusion noticed by wife\n",
      "Not able to walk\n",
      "\n",
      "         \n",
      "O;  Wt 68 ,1   -> 67.3 kg   -> 66.5 kg   \n",
      "O/E alert, lucid            \n",
      "Speech  - hesitant            \n",
      "Scalp wound clean            \n",
      "Power full        \n",
      "\n",
      "D/w patient, wife, and son, explained that symptoms are likely due to disease progression. Advise for admission, urgent MRI brain. Treatment options include switching to bevacizumab/lomustine or stat-3 inhibitor clinical trial. They understand and are agreeable with plan.\n",
      "\n",
      "Also s/w patient's son and wife separately, patient may deteriorate rapidly from tumour progression, prognosis could be +/- 6 months depending on how he responds to further therapy. They understand.\n",
      " \n",
      "\n",
      "{'diagnosis': 'Pancreatic adenocarcinoma', 'stage': 'Metastatic'} PAST MEDICAL HISTORY \n",
      "1. HTN  \n",
      "2. DM \n",
      "- ketoacidosis <DATE> admission contributed by predominantly by starvation ketosis, SGLTi (Last dose <DATE>)   \n",
      "- also insulinopenic with  newly diagnosed HOP Ca with worsening of DM control from 7.3% (<DATE>) -> 9.1% (<DATE>) \n",
      "3. Minor CAD - on aspirin  \n",
      "4. BPH  \n",
      "5. Gout on allopurinol\n",
      "6. Hyperlipidemia \n",
      "\n",
      "\n",
      "\n",
      "--\n",
      "HPB Br<PATIENT> Goh\n",
      "65 year old Chinese Male \n",
      "Stays with wife, daughter, son-in-law grandson \n",
      "Recently stopped work as grab driver after dx\n",
      "Non-smoker, non-drinker \n",
      "Has inpatient hospitalization insurance nil rider \n",
      "FHx: Brother - Gastric cancer in old age \n",
      "NOK: Wife <PATIENT> <ID>\n",
      "\n",
      "F1 (Shining Tower): KRAS G12V MT, MTAP/CKDN2B loss, nil alterations in BRCA1/2; Reason for visit: Review for #5<DATE>6 mFOLFIRINOX  \n",
      "  \n",
      "65/Chines/Male, stays with wife, daughter and family, Ex-grab driver  \n",
      "PMHx: 1. HTN, 2. DM, 3. Minor CAD on aspirin, 4. BPH, 5. Gout, 6. Hyperlipidemia 7. ?Prostate lesoin\n",
      "  \n",
      "Oncological history  \n",
      "De novo Metastatic Pancreatic cancer > Liver mets  \n",
      "<DATE> Referred from OPS to Gastro for LOW/LOA since around <DATE> (3 months), 84> 74 kg  \n",
      "> 26.02.<DATE> CTTAP: 3.1 x 2.6 cm HOP mass with upstream biliary obstruction, multiple hypodense lesions in liver, largest in segment 6 measuring 2.2 x 2.0 cm suspicious for mets   \n",
      "> 08.<DATE> Admitted via ED with fever and juandice; also notedto have euglycaemia DKA   \n",
      "> 09.<DATE>.<DATE> CA 19-9 3954, CEA 18.6   \n",
      "> 13.<DATE>.<DATE> ERCP + PD stent insertion + sphincterotomy + insertion of FC SEMS   \n",
      "> 13.<DATE> EUS FNB: mass in HOP measuring 45 c 30 mm   \n",
      "#Histo: Adenoca, proficient MMR expression   \n",
      "> 14.<DATE>  Liver biopsy   \n",
      "#Histo: Adenoca, PB/upper GI primary   \n",
      "> <DATE> Recurrence of jaundice before chemotherapy initiation  \n",
      "> <DATE>.<DATE> ERCP + PD stent removal + CBD trawl; post-procedure cx by E coli bacteraemia likely 2' GI translocation  \n",
      ">> completed <DATE> days Meropenem 08.04 - 21.04  \n",
      "> 12.04.2025 CT reported in view of rising bilirubin  \n",
      "> 13.04.2025 ERCP + removal of metal stent and reinsertion of new uncovered biliary stent  \n",
      "  \n",
      "Treatment 18.04.2025 #1 mFOLFIRINOX , SD except one peripancratic node post #4 (CA 19-9 otherwise responding)\n",
      "  \n",
      "F1 (Shining Tower): KRAS G12V MT, MTAP/CKDN2B loss, nil alterations in BRCA1/2  \n",
      "     \n",
      "==   \n",
      "Symptoms   \n",
      "29.04: Tolerated #1 mFOLFIRINOX okay  \n",
      "nil diarrhoea, but mainly affected by dysuegsia and poor apeptite, nil nausea/vomiting  \n",
      "trying resource fruit recommended by relative  \n",
      "eats only few spoonfuls/half shares otherwise  \n",
      "Keen to try olanzapine  \n",
      "13.05: \n",
      "Gout better after 2 days \n",
      "Appetite better with Olanzapine eating better! \n",
      "Feeling mcuh better this time \n",
      "Some mild blood stains on wiping \n",
      "27.05: Saw Urology for prostate lesion - to defer biopsy in view of mPDAC\n",
      "BO okay\n",
      "Appetite fari still not so good but mainitaining weight\n",
      "Keen to do LPA - will approach GP\n",
      "10.06: Admitted during #4 because of low K but quickly replete\n",
      "Some pain radiating to the back\n",
      "  \n",
      "On examination   \n",
      "Wt 61.9 (10 June 2025)\n",
      "Wt 61.0 (27 May 2025)\n",
      "Wt 61.7 (13 May 2025) \n",
      "Wt 61.8 kg (29 April 2025)  \n",
      "Wt 67.8 kg (16 March 2025)   \n",
      "ECOG 1   \n",
      "Seen with wife, and daughter \n",
      "Mandarin-speaking   \n",
      "No nodes felt    \n",
      "H  S1S2   \n",
      "Lclear   \n",
      "A soft NT   \n",
      "Calves supple nil edema   \n",
      "   \n",
      "Investigations   \n",
      "FBC RP LFT okay\n",
      "CTTAP 06.2025 (after #4 mFOLFIRINOX)\n",
      "1. Interval increase in the peripancreatic adenopathy, suspicious for nodal metastasis.  \n",
      "2. Largely stable ill-defined bilobar hepatic lesions, suspicious for hepatic metastases. \n",
      "3.There is a new prominent subcentimeter common hepatic node that is indeterminate  \n",
      "and attention on follow up to exclude early adenopathy is suggested.   \n",
      "4. Stable pancreatic head mass, consistent with cytology proven pancreatic adenocarcinoma  (13Mar 25). Interval increase in pancreatic ductal dilatation.   \n",
      "\n",
      "\n",
      "Impression  \n",
      "Metastatic head of pancreas adenoca > liver mets    \n",
      "Complicated by:   \n",
      "A. Biliary obstruction and cholangitis   \n",
      "- s/p   ERCP+PD stent insertion+total pancreatic sphincterotomy+ needle knife precut sphincterotomy+ insertion of FCSEMS 13/3/25   \n",
      "B. Ketoacidosis likely multifactorial    \n",
      "- contributed by predominantly by starvation ketosis, SGLTi (Last dose 7/3/25)     \n",
      "- however also insulinopenic with  newly diagnosed HOP Ca with worsening of DM control from 7.3% (Jan 25) -> 9.1% (March 25)   \n",
      "   \n",
      "Comms in ward March2 025   \n",
      "Introduced myself from DMO   \n",
      "Explained imaging worrisome for pancreatic cancer with spread to liver   \n",
      "Pancreatic head lesion has resulted in obstruction and infection which is why he went for stent insertion yesterday   \n",
      "Currently LFT improving but still not back to baseline   \n",
      "Will n; preclerking patient not seen yet - TCU 10.06.2025\n",
      "\n",
      "Reason for visit: Review for #5/6 mFOLFIRINOX  \n",
      "  \n",
      "65/Chines/Male, stays with wife, daughter and family, Ex-grab driver  \n",
      "PMHx: 1. HTN, 2. DM, 3. Minor CAD on aspirin, 4. BPH, 5. Gout, 6. Hyperlipidemia 7. ?Prostate lesoin\n",
      "  \n",
      "Oncological history  \n",
      "De novo Metastatic Pancreatic cancer > Liver mets  \n",
      "02.2025 Referred from OPS to Gastro for LOW/LOA since around Nov 2024 (3 months), 84> 74 kg  \n",
      "> 26.02.2025 CTTAP: 3.1 x 2.6 cm HOP mass with upstream biliary obstruction, multiple hypodense lesions in liver, largest in segment 6 measuring 2.2 x 2.0 cm suspicious for mets   \n",
      "> 08.03.2025 Admitted via ED with fever and juandice; also notedto have euglycaemia DKA   \n",
      "> 09.03.2025 CA 19-9 3954, CEA 18.6   \n",
      "> 13.03.2025 ERCP + PD stent insertion + sphincterotomy + insertion of FC SEMS   \n",
      "> 13.03.2025 EUS FNB: mass in HOP measuring 45 c 30 mm   \n",
      "#Histo: Adenoca, proficient MMR expression   \n",
      "> 14.03.2025  Liver biopsy   \n",
      "#Histo: Adenoca, PB/upper GI primary   \n",
      "> 04.2025 Recurrence of jaundice before chemotherapy initiation  \n",
      "> 06.04.2025 ERCP + PD stent removal + CBD trawl; post-procedure cx by E coli bacteraemia likely 2' GI translocation  \n",
      ">> completed 14 days Meropenem 08.04 - 21.04  \n",
      "> 12.04.2025 CT reported in view of rising bilirubin  \n",
      "> 13.04.2025 ERCP + removal of metal stent and reinsertion of new uncovered biliary stent  \n",
      "  \n",
      "Treatment 18.04.2025 #1 mFOLFIRINOX , SD except one peripancratic node post #4 (CA 19-9 otherwise responding)\n",
      "  \n",
      "F1 (Shining Tower): KRAS G12V MT, MTAP/CKDN2B loss, nil alterations in BRCA1/2  \n",
      "     \n",
      "==   \n",
      "Symptoms   \n",
      "29.04: Tolerated #1 mFOLFIRINOX okay  \n",
      "nil diarrhoea, but mainly affected by dysuegsia and poor apeptite, nil nausea/vomiting  \n",
      "trying resource fruit recommended by relative  \n",
      "eats only few spoonfuls/half shares otherwise  \n",
      "Keen to try olanzapine  \n",
      "13.05: \n",
      "Gout better after 2 days \n",
      "Appetite better with Olanzapine eating better! \n",
      "Feeling mcuh better this time \n",
      "Some mild blood stains on wiping \n",
      "27.05: Saw Urology for prostate lesion - to defer biopsy in view of mPDAC\n",
      "BO okay\n",
      "Appetite fari still not so good but mainitaining weight\n",
      "Keen to do LPA - will approach GP\n",
      "10.06: Admitted during #4 because of low K but quickly replete\n",
      "Otherwise tolerated chemotherapy okay\n",
      "  \n",
      "On examination   \n",
      "Wt ___ (10 June 2025)\n",
      "Wt 61.0 (27 May 2025)\n",
      "Wt 61.7 (13 May 2025) \n",
      "Wt 61.8 kg (29 April 2025)  \n",
      "Wt 67.8 kg (16 March 2025)   \n",
      "ECOG 1   \n",
      "Seen with wife, and daughter \n",
      "Mandarin-speaking   \n",
      "No nodes felt    \n",
      "H  S1S2   \n",
      "Lclear   \n",
      "A soft NT   \n",
      "Calves supple nil edema   \n",
      "   \n",
      "Investigations   \n",
      "Bloods ___\n",
      "CTTAP 06.2025 (after #4 mFOLFIRINOX)\n",
      "1. Interval increase in the peripancreatic adenopathy, suspicious for nodal metastasis.  \n",
      "2. Largely stable ill-defined bilobar hepatic lesions, suspicious for hepatic metastases. \n",
      "3.There is a new prominent subcentimeter common hepatic node that is indeterminate  \n",
      "and attention on follow up to exclude early adenopathy is suggested.   \n",
      "4. Stable pancreatic head mass, consistent with cytology proven pancreatic adenocarcinoma  (13Mar 25). Interval increase in pancreatic ductal dilatation.   \n",
      "\n",
      "\n",
      "Impression  \n",
      "Metastatic head of pancreas adenoca > liver mets    \n",
      "Complicated by:   \n",
      "A. Biliary obstruction and cholangitis   \n",
      "- s/p   ERCP+PD stent insertion+total pancreatic sphincterotomy+ needle knife precut sphincterotomy+ insertion of FCSEMS 13/3/25   \n",
      "B. Ketoacidosis likely multifactorial    \n",
      "- contributed by predominantly by starvation ketosis, SGLTi (Last dose 7/3/25)     \n",
      "- however also insulinopenic with  newly diagnosed HOP Ca with worsening of DM control from 7.3% (Jan 25) -> 9.1% (March 25)   \n",
      "   \n",
      "Comms in ward March2 025   \n",
      "Introduced myself from DMO   \n",
      "Explained imaging worrisome for pancreatic cancer with spread to liver   \n",
      "Pancreatic head lesion has resulted in obstruction and infection which is why he went for stent insertion yesterday   \n",
      "Currently LF\n",
      "{'diagnosis': 'Hepatocellular carcinoma', 'stage': 'Stage 3B'} ===PMHx===\n",
      "1. Hyperlipidaemia\n",
      "2. Hypertension\n",
      "3. Type 2 diabetes mellitus\n",
      "- HbA1c 6.6% <DATE>\n",
      "4. Ischaemic heart disease\n",
      "- CAG (<DATE>): \n",
      "LM: Patent; LAD: mLAD 90 %, immediately after D1 (moderate size); LCx: patent; RCA: dominant large, patent\n",
      "LV gram: EF 65%. Normal LV function\n",
      "- Underwent successful POBA and PCI/ DES 2.75x18mm to mLAD on <DATE> \n",
      "- TTE <DATE>\n",
      "LVEF 65%, no RWMA.\n",
      "Aortic valve sclerosis. \n",
      "5. Asthma- Does not need prednisolone before CT \n",
      "\n",
      "Oncology\n",
      "BCLC A \n",
      "CP A \n",
      "Non Hep B/C \n",
      "Likely Non alcoholic steatohepatiis\n",
      "T4NxM0 (Stage 3B)\n",
      "\n",
      "s/p Adjuvant Atezo + Bev X 1 year (IMBRAVE 050) \n",
      "\n",
      "Relapsed in lung <DATE> - biopsy proven \n",
      "s/p RFA on <DATE>. \n",
      "\n",
      "<DATE> and <DATE> \n",
      "Progressive lung lesions. \n",
      "Asymptomatic. \n",
      "\n",
      "<DATE>: \n",
      "Progressive lung lesions. \n",
      "New liver lesion. \n",
      "Started on Lenvatinib \n",
      "\n",
      "<DATE> - <DATE> \n",
      "Regression of lung lesions \n",
      "\n",
      "<DATE> \n",
      "Gp3 +ve eligible for TCD (trial not active anymore) \n",
      "Increase in one lung mets\n",
      "\n",
      "<DATE> and <DATE> \n",
      "Stable lung disease\n",
      "\n",
      "<DATE> \n",
      "- Progressive lung and liver lesions. Remain small volume.\n",
      "\n",
      "<DATE> - s/p segment IV TACE; 2nd Line Nivolumab and Ipilimumab \n",
      "\n",
      "Had 3 doses of Nivolumab and Ipilimumab \n",
      "\n",
      "\n",
      "Feels tired this 1 week. \n",
      "Some non specific discomfort back of his head. \n",
      "No visual change. \n",
      "No postural symptoms. \n",
      "Eats well still. \n",
      "No respiratory symptoms. \n",
      "\n",
      "\n",
      "\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "<DATE>\tHb: 13.5(L), WBC: 7.30, Hct: 41.3, Plt: 101(L). \n",
      "<DATE>\tNeut: 44.0% , Neut Abs: 3.21, MCV: 88.1% , Lymph: 27.0% , Mono: 11.5% (H), Eos: 14.9% (H), Baso: 2.6% (H). \n",
      "<DATE>\tNa: 137, K+: 4.6, Cl: 105, HCO3: 27.9, Urea: 5.7, Cre: 89, Glu:7.9. \n",
      "<DATE>\tTP: 61(L), Alb: 35(L), Bil: 12, AST: 55(H), ALT: 51, ALP: 106(H). \n",
      " \n",
      "\n",
      "Imp: adrenal insufficiency from Nivolumab and Ipilimumab \n",
      "Low TSH , normal Ft4. \n",
      "\n",
      "explained to patient that this is irAE. \n",
      "AFP < 2,7. \n",
      "IO effect tend to be durable hence no rush to continue IO. \n",
      "Would suggest stopping CTLA - 4 and be on Nivolumab alone. \n",
      "But can rest a few weeks and have hydrocortisone repleted. \n",
      "Agreeable. \n",
      "\n",
      "Return advice given. \n",
      "\n",
      "{'diagnosis': 'Pancreatic adenocarcinoma', 'stage': 'Stage IV'} Locally advanced unresectable head of pancreas adenocarcinoma\n",
      "(SMV 180degrees, main PV partial thrombi, >180 degrees common hepatic artery and porto-splenic confluence)\n",
      "pMMR\n",
      "- mFOLFIRINOX (<DATE>) >  PR\n",
      "admitted for Strep Anginosis bacteremia (<DATE>)\n",
      "- indeterminate liver lesion (<DATE>), unable to biopsy > empirical treatment with antibiotics > continue on FOLFIRI (<DATE>)\n",
      "- liver PD (<DATE>)\n",
      "\n",
      "\n",
      "MEDICAL HISTORY\n",
      "1. Cancer-associated left PV bland thrombus (<DATE>) \n",
      "> on lifelong apixaban\n",
      "2. Diabetes (<DATE>)\n",
      "3. Depression on Fluvoxamine on f/u with PSY in <HOSPITAL>\n",
      "\n",
      "Genetics testing:\n",
      "No pathogenic variant in any of the 80 genes tested.\n",
      "2 Variants of Uncertain Significance (VUS).\n",
      "ATM, c.3106T>C (p.Phe1036Leu),  heterozygous VUS \n",
      "MLH3 , c.3514del (p.Ile1172Phefs*14) , heterozygous, VUS \n",
      "\n",
      "\n",
      "DRUG ALLERGY: NAPROXEN\n",
      "G1 HSR to oxaliplatin with mild rash > needs IV diphenhydramine 25mg premed; \n",
      "\n",
      "PD with liver metastases  \n",
      "started on Gemcitabine/Abraxane \n",
      " \n",
      "Symptoms: \n",
      "no fever  \n",
      "no abdominal symptoms \n",
      "eating well \n",
      "G1 numbness in fingertips \n",
      " \n",
      "Physical Examination: \n",
      "BP 112 / 73mmHg (<DATE> 13:59:00)   Ht: 158 cm (<DATE> 09:52:40)  Wt: 59.9 kg (<DATE> 09:52:40)  \n",
      "General: Well appearing, Non toxic.  \n",
      "lungs clear \n",
      "abdo soft, non-tender, no mass \n",
      "no pedal edema  \n",
      " \n",
      "Investigations: \n",
      "CA19-9 9401 > 10000 > 4649 > 3660 > 1885 > 619 > 230 > 156 > 131 > 148 > 82.3 > 52.6 > 55.4 > 61.2 \n",
      "CRP 3.3 > 23 > 7.2 \n",
      " \n",
      "ANC 3.53 > 3.04 > 1.69 >  \n",
      " \n",
      " \n",
      "CT chest abdomen pelvis (<DATE>):  \n",
      "Since <DATE>: \n",
      "1. Grossly stable pancreatic tumour with pancreatic ductal dilatation and atrophy. Known vascular involvement of the GDA.  \n",
      "2. Stable liver segment 8 and segment 4A/8 lesions suspicious for metastases. The rest of the scattered small bilobar liver lesions are better delineated on MRI.  \n",
      "3. Biliary stent in situ with grossly stable dilatation of the biliary tree. \n",
      "4. Stable prominent periportal node. \n",
      "5. New patchy ground-glass changes in bilateral lower lobes could be infective/inflammatory in nature; for clinical correlation and follow-up.  \n",
      " \n",
      "MRI liver (3/4/25): \n",
      "Since MRI Liver (Liver Specific Contrast) 05-Feb-2025, \n",
      "New enhancing hepatic lesion in dome of liver segment 8 suspicious for metastasis.  \n",
      "Stable lesions in segment 2 and 4A/8 are suspicious for metastasis.  \n",
      "New indeterminate lesions in right lobe raises possibility for metastases \n",
      "Stable pancreatic head tumour.    \n",
      "Stable periportal lymph node, suspicious for nodal disease.  \n",
      " \n",
      "Assessment: Fit for treatment  \n",
      " \n",
      " \n",
      "Explained scans \n",
      "liver metastases progression \n",
      "discussed second line option with Gemcitabine abraxane \n",
      "Side effects include: nausea/vomiting , hair loss, cytopenias, fatigue, risk of infection, risk of bleeding, constipation, diarrhea, mucositis, rash/ itch, fluid retention, neuropathy/ numbness, abnormal liver and kidney function, cardiac complications, allergic reactions etc  \n",
      "clinical trial options and liver biopsy also discussed \n",
      "agreeable to proceed with chemotherapy.\n",
      "\n",
      "\n",
      "Plan\n",
      "Continue #3 Gem/Abraxane \n",
      "TCU 4 weeks \n",
      "\n",
      "FBC, UECr, LFT, 19.9, CT    Bf\n",
      "\n",
      "{'diagnosis': 'Sigmoid Colon Adenocarcinoma', 'stage': 'IIIC'} -\n",
      "Oncological History:\n",
      "1. Recurrent Metastatic Sigmoid Adenocarcinoma       \n",
      "- SSTP: MSS, NRAS MT \n",
      "- p/w intestinal obstruction in <DATE>        \n",
      "- s/p HAR and defunctioning ileostomy 9 <DATE> under <HCW>        \n",
      "- Stage IIIC: pT4aN2a(<DATE>, apical LN+)Mx G2 sigmoid adenocarcinoma - MSS, NRAS mutant (G12C), PNI+, LVI-, margins clear, 3 tumour deposits present        \n",
      "- s/p #1 and 2 XELOX (<DATE> postop) -> oxaliplatin dropped from #3 due to HSR  (G3 with angiooedema + palpitations req. admission)\n",
      "- Completed #8 Xeloda <DATE>    \n",
      "- Relapsed <DATE>: p/w abdo bloatedness        \n",
      "  > CT showed ascites, Right ovarian mass        \n",
      "- Underwent THBSO with omentectomy <DATE>         \n",
      "- Completed 8 cycles FOLFIRI (<DATE> - <DATE>)      \n",
      "- CT <DATE> > small indeterminate lung nodules >> decided for treatment break    \n",
      "- CT <DATE> > NED since    \n",
      "- OGD/Colono <DATE> - NED\n",
      "- PET <DATE> - NED\n",
      "- <DATE> - Peritoneal recurrence (DFI 21m since last chemo, 26m since last surgery)\n",
      "MDT: low volume peritoneal disease, wouldnt recommend CRS/HIPEC at this point in time \n",
      "- <DATE>: CRS/HIPEC (Mitomycin 14mg absolute)\n",
      "- <DATE>: Recurred in liver and peritoneum. 3L XELIRI-Bev >> PR after #4 >> PR after #8\n",
      "- <DATE>-<DATE>24: Chemo break\n",
      "- <DATE>24: #1 XELIRI-Bev\n",
      "- chemo break until <DATE>\n",
      "- rechallenge XELIRI/Bev post #4\n",
      "====================================================\n",
      "Other medical problem ; \n",
      "1. MMG (<DATE>) showed left UOQ microcals, on follow-up with breast surgery\n",
      "====================================================\n",
      "Stays with husband and Samantha; Daughter Shandie is married with two children (4 and 1)\n",
      "Daughter - Shandie 98807700 (older dgt that is married); \n",
      "seen on behalf of kennedy      \n",
      "-                    \n",
      "NCCS DMO GI Outram Campus - Dr Kennedy NG         \n",
      "-         \n",
      "Reason for visit: Mets recurrent resected colon CA                 \n",
      "Review: XELIRI/bev\n",
      "-                       \n",
      "Came alone    \n",
      "=======================================================================        \n",
      "SUBJECTIVE:          \n",
      "has G1-2 PPE prefer to have lower dose of cape  \n",
      "noted for scan     \n",
      "=======================================================================        \n",
      "OBJECTIVE:         \n",
      "                             \n",
      "Weight 47.8kg > 47.1kg > 47.1kg   > 46.8kg > 47.4kg > 46.8 kg > 42.1 kg (lost weight) > 45.3 kg > 46.0 kg > 45.4 > 43.2 kg >> 44.3kg         \n",
      "Alert, comfortable                             \n",
      "HS S1 S2                             \n",
      "L Clear                             \n",
      "A SNT BS+                              \n",
      "Calves supple                      \n",
      "=======================================================================        \n",
      "INVESTIGATIONS:          \n",
      "                  \n",
      "Relevant Investigations:                        \n",
      "OGD/Colono 15/11/21 - NED                         \n",
      "                           \n",
      "CEA  98.1 > 207  > 56.1 > 48.7 > 43.4  > 12.2 > 239 > 98.5 > 87 > 68.2 >> 49.3    \n",
      "CA125 23.3  > 23.5 > 27.3 > 25.8 > 27  > 22 > 33.7        \n",
      "CA19-9 90.4  > 163 > 34.9 > 21.2 > 18.6 > 12.7 > 239 > 58       \n",
      "    \n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "09/06/25\tHb: 12.7, WBC: 4.74, Hct: 39.0, Plt: 143. \n",
      "09/06/25\tNeut: 61.8% , Neut Abs: 2.93, MCV: 99.2% (H), Lymph: 24.5% , Mono: 11.0% (H), Eos: 2.1% , Baso: 0.6% . \n",
      "09/06/25\tNa: 141, K+: 4.2, Cl: 102, HCO3: 29.6(H), Urea: 5.3, Cre: 72, Glu:7.4. \n",
      "09/06/25\tTP: 65(L), Alb: 41, Bil: 22, AST: 34, ALT: 15, ALP: 146(H). \n",
      "09/06/25\tCEA: 522(H). \n",
      "\n",
      "   \n",
      "CTTAP Nov 24:   \n",
      "1. Interval increase in size of multiple bilateral pulmonary nodules, suspicious    \n",
      "for metastasis.    \n",
      "2. Interval decrease in size of segment 5/8 ill-defined hepatic hypodense lesion     \n",
      "with stable surrounding intrahepatic ductal dilatation and capsular retraction, suspicious     \n",
      "for hepatic metastasis with treatment.    \n",
      "3. Status-post high anterior resection for sigmoid colon cancer (January 2018) followed     \n",
      "by ileostomy reversal (April 2019). No evidence of local recurrence at bowel anastomosis.    \n",
      "4. Status-post total hysterectomy with bilateral salpingo-oophorectomy (THBSO) and     \n",
      "omentectomy for ovarian metastases(March 2020) followed by CRS (bilateral paracolic     \n",
      "peritonectomy, peritoneal nodules excision and completion omentectomy) and HIPEC(September     \n",
      "2022). No new discrete peritoneal nodule or definite evidence of local recurrence     \n",
      "at vaginal vault.    \n",
      "  \n",
      "=======================================================================        \n",
      "IMPRESSION:                       \n",
      "Low volume liver and lung lesions  - mixed response on capecitabine maintenance   \n",
      "previously had 8 cycles of XELIRI/bev with good PR (from April- end Sept 24)        \n",
      "                 \n",
      "30.09.22: CRS/HIPEC (Mitomycin 14mg absolute)                    \n",
      "Rising tumour markers                  \n",
      "Feb23: Recurred                 \n",
      "=======================================================================                   \n",
      "COMMS:             \n",
      "Explained that dominant lesion is the liver. Can consider loco-regional therapy to it.          \n",
      "Lung lesions are very small and we could save systemic therapy for subsequent opportunities if there is heavier burden.          \n",
      "Alternative of systemic therapy upfront.          \n",
      "=======================================================================        \n",
      "       \n",
      "       \n",
      "       \n",
      "        \n",
      "\n",
      "{'diagnosis': 'Melanoma of the skin', 'stage': 'Stage IIIB'} Oncological history:\n",
      "Acral lentiginous melanoma (pT4b N1b)\n",
      "   -Breslow thickness 1.8mm, Clarke level IV, no ulceration (in this specimen)\n",
      "   -Breslow thickness 7.5mm, Clarke level V, with ulceration (in previous biopsy\n",
      "   <DATE>-<DATE>PB<ID>30)\n",
      " -Margins not involved (please refer to microscopic description)\n",
      "\n",
      "NRAS (NM_<ID>), Exon3, c.182A>G p.(Gln61Arg) [p.(Q61R)]\n",
      "   AF: 7.00%\n",
      "\n",
      "Primary site: Right sole, s/p wide excision \n",
      "- surgery done <DATE>\n",
      "- requiring VAC dressing \n",
      "\n",
      "\n",
      "\n",
      "Past Medical History;\n",
      "1) Hypertension\n",
      "2) Hyperlipidemia\n",
      "3) Diabetes Mellitus\n",
      "4) Bipolar Disorder \n",
      "5) Psoriaisis\n",
      "6) Left total knee replacement <DATE>; ; Pre-Clerking for <DATE> clinic [Patient not seen yet]\n",
      "\n",
      "New patient \n",
      "\n",
      "Referred from: <HOSPITAL><HCW>\n",
      "Reason for referral:  Newly diagnosed acral lentiginous melanoma, for consideration of adjuvant immunotherapy \n",
      "\n",
      "59 year old Chinese man \n",
      "\n",
      "\n",
      "Presenting complaint:\n",
      "Right foot sole lesion \n",
      "\n",
      "Hx of presenting complaint:\n",
      "has been there for many years, not increasing in size\n",
      "was initially known to <HOSPITAL> Derm \n",
      "s/p excision biopsy on <DATE>, and histology yielded melanoma \n",
      "\n",
      "Progress:\n",
      "- s/p wide excision of right sole melanoma, with application of vac dressing; sentinel lymph node biopsy on  <DATE>     \n",
      "\n",
      "Intra-op findings:\n",
      "s/p wide excision of right sole melanoma, with application of vac dressing; sentinel lymph node biopsy \n",
      "b/g of Right sole melanoma (1.6x1.5cm) - Acral melanoma pT4b\n",
      "s/p excision biopsy on <DATE>\n",
      "\n",
      "hyperpigmented lesion at the right plantar aspect with irregular margins; no satellite lesions\n",
      "resultant defect at 6 x 6.5 cm\n",
      "2 cm margins around the tumor, FS sent - 12, 2, 4, 6, 8, 10 oclock - All negative\n",
      "SLN: (+) right inguinal node on scintigraphy; (+) 2 blackish, confluent nodes at the right inguinal area excised, ex vivo count of node 355/sec\n",
      "\n",
      "Histopathology:\n",
      "DIAGNOSIS\n",
      "   (A) Right sole 12 o'clock, for frozen section :}\n",
      "   (B) Right sole 2 o'clock, for frozen section :}\n",
      "   (C) Right sole 4 o'clock, for frozen section :}\n",
      "   (D) Right sole 6 o'clock, for frozen section :}\n",
      "   (E) Right sole 8 o'clock, for frozen section :}\n",
      "   (F) Right sole 10 o'clock, for frozen section :}\n",
      "   Negative for in situ and invasive melanoma\n",
      "   \n",
      "   (G) Right sentinel lymph node:\n",
      "   One lymph node; positive for metastatic melanoma (1/1)\n",
      "   - largest metastatic deposit measures 8.9mm\n",
      "   \n",
      "   (H) Right sole, wide excision:\n",
      "   Acral lentiginous melanoma (pT4b N1b)\n",
      "   -Breslow thickness 1.8mm, Clarke level IV, no ulceration (in this specimen)\n",
      "   -Breslow thickness 7.5mm, Clarke level V, with ulceration (in previous biopsy\n",
      "   10SH25-1980 / 25PB7230)\n",
      "   -Margins not involved (please refer to microscopic description)\n",
      "   \n",
      "   Comment: SSTP melanoma has been requested.\n",
      " \n",
      "FROZEN SECTION DIAGNOSIS\n",
      "   (AFS) Right sole 12 o'clock:\n",
      "   (BFS) Right sole 2 o'clock:\n",
      "   (CFS) Right sole 4 o'clock:\n",
      "   (DFS) Right sole 6 o'clock:\n",
      "   (EFS) Right sole 8 o'clock:\n",
      "   (FFS) Right sole 10 o'clock:\n",
      "   All margins without evidence of melanoma.\n",
      "\n",
      "NRAS (NM_002524.4), Exon3, c.182A>G p.(Gln61Arg) [p.(Q61R)]\n",
      "   AF: 7.00%\n",
      "\n",
      "Other investigations: \n",
      "CT TAP 10/3/25\n",
      "No definitive evidence of metastasis.\n",
      "\n",
      "MDT 12/3/25\n",
      "Recommendation: Wider excision and sentinel LN biopsy. Surveillance for gluteus lipomatous lesion. \n",
      "\n",
      "However, while op was planned for 14th April, cancelled on 14th due to active URTI \n",
      "hence relisted for wide escision of right sole melanoma SLNB kiv recon 9th May 2025 \n",
      "\n",
      "Discussed at NCCS Sarcoma Tumor board on 17th June 2025, for consideration of adjuvant immunotherapy \n",
      "\n",
      "==============================\n",
      "Past Medical History;\n",
      "1) Hypertension\n",
      "2) Hyperlipidemia\n",
      "3) Diabetes Mellitus\n",
      "4) Bipolar Disorder \n",
      "5) Psoriaisis\n",
      "6) Left total knee replacement \n",
      "\n",
      "\n",
      "Medications:\n",
      "NKDA \n",
      "\n",
      "Telmisartan 80mg OM\n",
      "Amlodipine 10mg OM\n",
      "Atorvastatin 40mg ON\n",
      "Omeprazole 20mg OM\n",
      "Arcoxia 60mg OM\n",
      "\n",
      "==============================\n",
      "Family History:\n",
      "\n",
      "\n",
      "\n",
      "Social History:\n",
      "Smoker\n",
      "- 1 pack/ day\n",
      "No alcohol \n",
      "works as storeman with Nestle \n",
      "Single \n",
      "stays alone in 2-room HDB Flat prior to this \n",
      "3rd of 6 siblings\n",
      "- parents demised \n",
      "\n",
      "Eldest sister Poh Choo 91763273 \n",
      "\n",
      "\n",
      "Finances:\n",
      "Covered by company insurance \n",
      "\n",
      "\n",
      "==============================\n",
      "Currently,\n",
      "\n",
      "\n",
      "\n",
      "o/e:\n",
      "ECOG\n",
      "\n",
      "Height\n",
      "Weight\n",
      "BSA\n",
      "\n",
      "H\n",
      "Lungs \n",
      "Abdomen\n",
      "Calves\n",
      "\n",
      "Lymph Nodes\n",
      "\n",
      "Neuro Examination: \n",
      "Reflexes \n",
      "Biceps 2+/2+\n",
      "Triceps 2+/2+\n",
      "Supinator 2+/2+\n",
      "Knee 2+/2+\n",
      "Ankle 2+/2+\n",
      "\n",
      "Plantars downgoing bilaterally\n",
      "\n",
      "Power:\n",
      "Right Shoulder Abduction/Adduction 5/5\n",
      "Left Shoulder Abduction/Adduction 5/5\n",
      "Right Elbow Flexion/Extension 5/5\n",
      "Le; \n",
      "{'diagnosis': 'Endometrial', 'stage': 'IVC'} Reason for visit: First visit for discussion of palliative chemo \n",
      "Came with: daughter <PATIENT> \n",
      "Speaks: English \n",
      "$: Nil \n",
      "\n",
      "67 year-old, widowed\n",
      "post menopausal since 49 \n",
      "PS: ECOG \n",
      "NKDA\n",
      "Non smoker, non drinker \n",
      "Married with 4 children (2 sons 2 daughters) \n",
      "lives with 2 of her children \n",
      "worked as chef in a school - retired for 2 years \n",
      "\n",
      "FMHx: \n",
      "Father - throat Ca\n",
      "Sister - Ovarian Ca - too frail for chemo \n",
      "\n",
      "Past Medical History/Past Surgical History:\n",
      "1. IHD \n",
      "S/p <DATE> Cath\n",
      "- pLAD 20%, D1 60%, LCx 65%, pRCA 70%, mRCA 80%, with POBA to proximal to mid- RCA.\n",
      "S/p <DATE> Cath\n",
      "- pLAD 30%, D1 60%, OM1 75%, mRCA 50%. DES inserted to OM1\n",
      "- TTE <DATE>: Normal LVEF 55%. GLS -16.2%. Normal left ventricular systolic function. No RWMA. Aortic valve moderately calcified. Trivial aortic regurgitation. Moderate aortic stenosis. Peak AVG 36mmHg.\n",
      "- Angina Marc24: Repeat Coros <DATE>, DCB angioplasty to distal LCx/OM2\n",
      "2. Mod AS \n",
      "3. DM HLD HTN \n",
      "4. Previous pT2(25mm)N0(0/4) G3 IDC (ER/PR0 HER2 3+ 90%)   \n",
      "- s/p Left wide excision and SLNB <DATE>\n",
      "- s/p adjuvant chemotherapy #6 (taxotere/carboplatin/trastuzumab) - completed ? <DATE>\n",
      "- s/p adjuvant RT <DATE> - completed <DATE> \n",
      "- latest BL US Breast <DATE>: No local recurrence - cystic structure likely seroma, repeat imaging scheduled <DATE>\n",
      "\n",
      "Drug History:\n",
      "- \n",
      "\n",
      "Oncological presentation\n",
      "1. Newly diagnosed de novo metastatic FIGO Stage IVC HGS Endometrial Ca, p53m, further moleucular pending\n",
      "SOD: lungs, adrenal, lymph nodes \n",
      "- CT TAP (<DATE>):  large 10.0 x 8.2 x 11.5 cm heterogeneously enhancing mass in the pelvis likely represent second primary malignancy. The uterus is not seen separately. The mass is also not seen separate from the lower rectum. Pathological lymph nodes along the pelvic side walls bilaterally as well as in the retroperitoneum. A 0.8 x 0.7 cm nodule in the left adrenal gland is also likely of metastatic etiology. Multiple scattered pulmonary nodules of varying sizes compatible with metastasis. Enlarged mediastinal and hilar lymph nodes in the right paratracheal, tracheobronchial, precarinal, prevascular, subcarinal regions are also pathological.\n",
      "- s/p right lung biopsy 10/6/25: high grade adenocarcinoma with solid, complex glandular and papillary architecture, PAX8 WT1 +ve, P53m, GATA 3 TTF-1 -ve\n",
      "- AFP 3 CA 125 77 CEA 1 bHCG 6 CA 19-9 7 CA 153 30\n",
      "\n",
      "cx by \n",
      "A. R common iliac vein external compression from tumour, US DVT no thrombosis, d/w VAS no indx for OAC \n",
      "B. Obstructive uropathy with dilatation of R prox ureter/pelvic calyceal system sec to compression from pelvic mass \n",
      "S/p Right PCN 9/6/25, due for 3 monthly change under IR \n",
      "\n",
      "====\n",
      "Subjective\n",
      "Well\n",
      "walked in \n",
      "presented with leg swelling \n",
      "no GI symptoms \n",
      "no PV bleed\n",
      "appetite ok \n",
      "weight stable\n",
      "no respiratory symptoms \n",
      "\n",
      "\n",
      "Examination:\n",
      "Ht (cm) 150 \n",
      "Wt (kg) 55\n",
      "ECOG 0 \n",
      "H S1S2\n",
      "L Clear\n",
      "A SNT no masses\n",
      "\n",
      "Declined VE \n",
      "\n",
      "Investigations:\n",
      "Hep B sAg -ve \n",
      "\n",
      "Assessment:\n",
      "1. Fit for treatment \n",
      "\n",
      "Communications:\n",
      "Explained diagnosis of de novo metastatic endometrial Ca/ Ca of Gynae origin\n",
      "will discuss radiology at TB tomorrow for consensus\n",
      "will also need early Gynae review \n",
      "it is no longer operable and curative resection is not an option \n",
      "Mainstay of management will be chemotherapy \n",
      "Explained that given this is stage four disease, intention of chemotherapy is not to cure but to control disease\n",
      "unfortunately curative therapy is not possible at this point, however treatment will assist in alleviating symptoms, controlling spread and extending prognosis\n",
      "there is no guarantee that chemotherapy will be successful, response rates varies between individuals\n",
      "Offered treatment with 6 cycles of Paclitaxel/CBDA. As per GOG 209, when compared with TAP had non inferior ORR PFS and OS but a better tolerability profile with less thrombocytopenia, nausea and vomiting and diarrheoa. Addition of Bev can be considered as per the phase 2 MITO End2 trial in which addition of anti-VEGF failed ot\n",
      "{'diagnosis': 'Non-Small Cell Lung Cancer', 'stage': 'Stage IV'} ===Onco Hx===\n",
      "1. pT1N1a (<DATE>) caecal adenocarcinoma \n",
      "- s/p laparoscopic right hemicolectomy on <DATE>; s/p #8 capecitabine (last dose <DATE>) \n",
      "- Last Colonoscopy <DATE>\n",
      "- No local recurrence\n",
      "- 2 X 3mm rectal polyp - Sessile adenoma with low grade dysplasia\n",
      "\n",
      "2. Recurrent metastatic (initial cT1bN2) left ingula NSCLC\n",
      "- TPS 95%,  KRAS pG12V, TP53 p.C176F, FISH negative]\n",
      "> Declined surgery, previously offered SBRT but pt opted for TCM\n",
      "> Not a candidate for chemo-RT in view of age and comorbidities\n",
      "> Completed radical RT 50Gy/20# on <DATE>\n",
      "> PD <DATE>\n",
      "> 1L Pembro started <DATE>\n",
      "\n",
      "===PHx===\n",
      "1. DM\n",
      "2. HTN\n",
      "3. HLD\n",
      "4. Asymmetrical SNHL\n",
      "- had L OME \n",
      "- does not want any MRI scan or further audios done due to financial concerns\n",
      "5. Previous admission for suspected Miller-Fisher syndrome\n",
      "====================================================\n",
      "NKDA\n",
      "$: own <VENDOR> <HOSPITAL><VENDOR> Life \n",
      "Contact nos.:; S/p Pembro #2\n",
      "Tolerated well\n",
      "\n",
      "Bloods:\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "<DATE>\tHb: 15.0, WBC: 7.96, Hct: 44.4, Plt: 160. \n",
      "<DATE>\tNeut: 43.1% , Neut Abs: 3.43, MCV: 88.3% , Lymph: 45.5% (H), Mono: 9.9% , Eos: 1.1% , Baso: 0.4% . \n",
      "<DATE>\tNa: 136, K+: 5.3(H), Cl: 101, HCO3: 27.8, Urea: 8.5(H), Cre: 98, Glu:11.7(H). \n",
      "<DATE>\tTP: 68, Alb: 40, Bil: 14, AST: 20, ALT: 22, ALP: 56. \n",
      "\n",
      "O/E,\n",
      "Alert and comfortable\n",
      "H: s1s2\n",
      "L: clear\n",
      "A: soft, non-tender\n",
      "No pedal oedema\n",
      "Calves supple\n",
      "{'diagnosis': 'cecal adenocarcinoma', 'stage': 'T3N0'} .\n",
      "===ONCO HX===\n",
      "CLR @ <HOSPITAL>: Darius Aw\n",
      "\n",
      "RIF pain x 3d; tender RIF mass on PE (<DATE>)\n",
      "\n",
      "CT AP (<DATE>):\n",
      "Cecal mass with partial ICJ obstruction\n",
      "\n",
      "Colonoscope (<DATE>):\n",
      "Cecal tumour; biopsy focal HGD\n",
      "\n",
      "Lap R-hemicolect (<DATE>)\n",
      "IOF: 10cm tumour; obstructed; LNs in mesentry\n",
      "\n",
      "Histopath (<DATE>):\n",
      "1) Cecal adenoca; G1; T3\n",
      ">> Abcess present; perforation not seen\n",
      "2) LN 0<DATE>; N0\n",
      "3) LVI +ve; PNI -ve; TB low; TD 0; R0\n",
      "4) pMMR\n",
      "\n",
      "===PAST HX===\n",
      "1) HTN\n",
      "2) HLD\n",
      "3) BPH s/p laser enucleation (<DATE>)\n",
      "4) Cholecystectomy >20y \n",
      "5) ?Urethral stricture (<DATE>)\n",
      ">> Difficult IDC; see URO @ <HOSPITAL>\n",
      "6) HBs Ag negative; Anti-HBc Ab negative (<DATE>)\n",
      "\n",
      "===DRUG HX===\n",
      "DA: Enalapril (cough)\n",
      "\n",
      "===SOCIAL HX===\n",
      "Smoking NIL; alcohol NIL\n",
      "Used to work in <VENDOR>; later driving cab\n",
      "Retired 10y\n",
      "Lives spouse, youngest son\n",
      "\n",
      "===FAMILY HX===\n",
      "Children: #1 son; #2 son (<PATIENT>; software engineer)\n",
      "Pt has 4 siblings (2 older sis, 1 older bro; pt is youngest)\n",
      "Older bro died from prostate ca in his 70's\n",
      "\n",
      "===COMMS===\n",
      "1) Explained risk higher than average (<DATE>)\n",
      ">> T3N0 but obstruction & LVI present\n",
      ">> XELOX #8; benefits/side effects; alternatives\n",
      ".; . \n",
      "===SUMMARY=== \n",
      "T3N0 cecal cancer s/p op (<DATE>) \n",
      "Obstructed; abscess present; perforation not seen \n",
      "LVI +ve; pMMR \n",
      " \n",
      "===SUBJECTIVE=== \n",
      "S/B URO @ <HOSPITAL> (<DATE>)\n",
      "Soft stricture of penile urethra --> urethral dilatation done\n",
      "Prescribed trial of Desmopressin\n",
      " \n",
      "===NUTRITION=== \n",
      "Eating normal \n",
      " \n",
      "===FUNCTIONAL=== \n",
      "Waling normal; no falls \n",
      " \n",
      "===PSYCHOSOCIAL=== \n",
      "Not worrying about his cancer all the time \n",
      " \n",
      "===OBJECTIVE=== \n",
      "Ht: 156 cm (<DATE>5)  \n",
      "Wt: 54.6 kg (11-Apr-2025); BSA 1.54 \n",
      " \n",
      "===TESTS=== \n",
      "Cre 80; eGFR 52 (12/4/25)\n",
      "\n",
      "CT chest (31/5/25):\n",
      "1) No mets\n",
      "2) Thyroid nodules with calcification\n",
      "3) Multivessel coronary calcification\n",
      "\n",
      "10/06/25\t\n",
      "Hb: 11.8(L), WBC: 7.60, Hct: 37.6(L), Plt: 266. \n",
      "Neut: 62.4% , Neut Abs: 4.74, MCV: 90.4% , \n",
      "Lymph: 31.1% , Mono: 4.7% , Eos: 1.4% , Baso: 0.4% . \n",
      "Na: 141, K+: 4.8, Cl: 103, HCO3: 29.0, Urea: 7.2(H), Cre: 93, Glu:8.6. \n",
      "TP: 70, Alb: 42, Bil: 8, AST: 39, ALT: 50, ALP: 52. \n",
      "CEA: < 1.8. \n",
      "eGFR 46\n",
      " \n",
      "===ASSESSMENT=== \n",
      "NE \n",
      " \n",
      "===DISCUSSION=== \n",
      "Came with spouse, Wei Fong \n",
      "\n",
      "Explained CT chest\n",
      "Thyroid nodules --> do US\n",
      "Coronary calcification --> offer CVM referral\n",
      "\n",
      "Reminder:\n",
      "Dexa + Desmopressin --> watch Na\n",
      "\n",
      "Requests transfer care to SKH\n",
      "Agrees to proceed with XELOX\n",
      "Agrees to do #1 here, rest at SKH\n",
      "Agrees for US thyroid\n",
      "Wishes to see CVM\n",
      "Prefers to have everything done at SKH\n",
      " \n",
      "===PLAN=== \n",
      "1) #1 OX 150mg; XLD 1.0g bd (11/6/25)\n",
      ">> Dose at around 75%\n",
      "2) Refer Onco @ SKH\n",
      ">> See 3 wks on 1/7/25\n",
      "3) Book #2 XELOX @ SKH on 2/7/25\n",
      "4) FBC, RP, LFT, CEA O/A @ SKH\n",
      "5) Refer CVM when @ SKH\n",
      "6) Arrange US thyroid when @ SKH\n",
      "7) Take chemo consent (done)\n",
      "8) Print today's consult for patient\n",
      ".; . \n",
      "===SUMMARY=== \n",
      "T3N0 cecal cancer s/p op (11/4/25) \n",
      "Obstructed; abscess present; perforation not seen \n",
      "LVI +ve; pMMR \n",
      " \n",
      "===SUBJECTIVE=== \n",
      "S/B URO @ SKH (21/5/25)\n",
      "Soft stricture of penile urethra --> urethral dilatation done\n",
      "Prescribed trial of Desmopressin\n",
      " \n",
      "===NUTRITION=== \n",
      "Eating normal \n",
      " \n",
      "===FUNCTIONAL=== \n",
      "Waling normal; no falls \n",
      " \n",
      "===PSYCHOSOCIAL=== \n",
      "Not worrying about his cancer all the time \n",
      " \n",
      "===OBJECTIVE=== \n",
      "Ht: 156 cm (28-Mar-2025)  \n",
      "Wt: 54.6 kg (11-Apr-2025); BSA 1.54 \n",
      " \n",
      "===TESTS=== \n",
      "Cre 80; eGFR 52 (12/4/25)\n",
      "\n",
      "CT chest (31/5/25):\n",
      "1) No mets\n",
      "2) Thyroid nodules with calcification\n",
      "3) Multivessel coronary calcification\n",
      "\n",
      "10/06/25\t\n",
      "Hb: 11.8(L), WBC: 7.60, Hct: 37.6(L), Plt: 266. \n",
      "Neut: 62.4% , Neut Abs: 4.74, MCV: 90.4% , \n",
      "Lymph: 31.1% , Mono: 4.7% , Eos: 1.4% , Baso: 0.4% . \n",
      "Rest pending\n",
      " \n",
      "===ASSESSMENT=== \n",
      "NE \n",
      " \n",
      "===DISCUSSION=== \n",
      "Came with spouse, Wei Fong \n",
      "\n",
      "Explained CT chest\n",
      "Thyroid nodules --> do US\n",
      "Coronary calcification --> offer CVM referral\n",
      "\n",
      "Reminder:\n",
      "Dexa + Desmopressin --> watch Na\n",
      "\n",
      "Requests transfer care to SKH\n",
      "Agrees to proceed with XELOX\n",
      "Agrees to do #1 here, rest at SKH\n",
      "Agrees for US thyroid\n",
      "Wishes to see CVM\n",
      "Prefers to have everything done at SKH\n",
      " \n",
      "===PLAN=== \n",
      "1) #1 OX 150mg; XLD 1.0g/1.5g (11/6/25)\n",
      ">> Dose at around 75%\n",
      "2) Refer Onco @ SKH\n",
      ">> See 3 wks on 1/7/25\n",
      "3) Book #2 XELOX @ SKH on 2/7/25\n",
      "4) FBC, RP, LFT, CEA O/A @ SKH\n",
      "5) Refer CVM when @ SKH\n",
      "6) Arrange US thyroid when @ SKH\n",
      "7) Take chemo consent (done)\n",
      "8) Print today's consult for patient\n",
      ".; . \n",
      "===SUMMARY=== \n",
      "T3N0 cecal cancer s/p op (11/4/25) \n",
      "Obstructed; abscess present; perforation not seen \n",
      "LVI +ve; pMMR \n",
      " \n",
      "===SUBJECTIVE=== \n",
      "S/B URO @ SKH (21/5/25)\n",
      "Soft stricture of penile urethra --> urethral dilatation done\n",
      "Prescribed trial of Desmopressin\n",
      " \n",
      "===NUTRITION=== \n",
      "Eating normal \n",
      " \n",
      "===FUNCTIONAL=== \n",
      "Waling normal; no falls \n",
      " \n",
      "===PSYCHOSOCIAL=== \n",
      "Not worrying about his cancer all the time \n",
      " \n",
      "===OBJECTIVE=== \n",
      "Ht: 156 cm (28-Mar-2025)  \n",
      "Wt: 54.6 kg (11-Apr-2025); BSA 1.54 \n",
      " \n",
      "===TESTS=== \n",
      "Cre 80; eGFR 52 (12/4/25)\n",
      "\n",
      "CT chest (31/5/25):\n",
      "1) No mets\n",
      "2) Thyroid nodules with calcification\n",
      "3) Multivessel coronary calcification\n",
      " \n",
      "===ASSESSMENT=== \n",
      "NE \n",
      " \n",
      "===DISCUSSION=== \n",
      "Came with spouse, Wei Fong \n",
      "\n",
      "Explained CT chest\n",
      "Thyroid nodules --> do US\n",
      "Coronary calcification --> offer CVM referral\n",
      "\n",
      "Reminder:\n",
      "Dexa + Desmopressin --> watch Na\n",
      "\n",
      "Requests transfer care to SKH\n",
      "Agrees to proceed with XELOX\n",
      "Agrees to do #1 here, rest at SKH\n",
      "Agrees for US thyroid\n",
      "Wishes to see CVM\n",
      "Prefers to have everything done at SKH\n",
      " \n",
      "===PLAN=== \n",
      "1) #1 OX 150mg; XLD 1.0g/1.5g (11/6/25)\n",
      ">> Dose at around 75%\n",
      "2) Refer Onco @ SKH\n",
      ">> See 3 wks on 1/7/25\n",
      "3) Book #2 XELOX @ SKH on 2/7/25\n",
      "4) FBC, RP, LFT, CEA O/A @ SKH\n",
      "5) Refer CVM when @ SKH\n",
      "6) Arrange US thyroid when @ SKH\n",
      "7) Take chemo consent (done)\n",
      "8) Print today's consult for patient\n",
      ".\n",
      "{'diagnosis': 'Endometrial cancer', 'stage': 'IV'} Oncological history\n",
      "1. Likely FIGO IVC endometrial cancer\n",
      "- Dx <DATE> - presented with abdominal pain\n",
      "SOD: uterus, lung, ?L supraclav LN\n",
      "Molecular: pMMR, p53 WT, HER2-ve (1+), ER weak\n",
      "\n",
      "Past Medical History/Past Surgical History:\n",
      "1. Meibomian gland dysfunction\n",
      " \n",
      "nil DM/HTN/HLD/Asthma; Reason for visit: First visit for discussion of palliative systemic therapy\n",
      "Came with: Son\n",
      "Speaks: English\n",
      "$: ___\n",
      "\n",
      "65 year-old female\n",
      "PS: ECOG \n",
      "NKDA\n",
      "Non smoker, non drinker ___\n",
      "Married __ with __ children\n",
      "lives with ___\n",
      "works as ___\n",
      "FMHx: __\n",
      "\n",
      "Past Medical History/Past Surgical History:\n",
      "1. Meibomian gland dysfunction\n",
      "\n",
      "Drug History:\n",
      "\n",
      "Oncological presentation\n",
      "\n",
      "Admitted <DATE> to <DATE> for intermittent abdominal pain\n",
      "\n",
      "CT AP <DATE>\n",
      "1. Bulky uterus with probable fibroids; further evaluation with ultrasound pelvis \n",
      "is recommended for assessment of fibroids and to exclude underlying sinister uterine \n",
      "lesion. \n",
      "\n",
      "2. Fat infiltration of the pancreas with several apparent enhancing pancreatic lesions \n",
      "are indeterminate. No pancreatic ductal dilatation. Further evaluation with MRCP \n",
      "is recommended. \n",
      "\n",
      "3. No overt infective/inflammatory changes are seen in the abdomen and pelvis. No \n",
      "evidence of acute appendicitis.\n",
      "\n",
      "4. Innumerable bilateral pulmonary nodules. Possible considerations include metastatic \n",
      "lesions, less likely infection (? pulmonary tuberculosis) in the absence of infective \n",
      "symptoms. CT chest is recommended.\n",
      "\n",
      "CT Thorax <DATE>\n",
      "1. Multiple bilateral pulmonary nodules are suspicious for metastasis. An infective \n",
      "cause is less likely.  \n",
      "2. No suspicious adenopathy. \n",
      "\n",
      "MRCP <DATE>\n",
      "CONCLUSION\n",
      "\n",
      "1. The pancreatic enhancing foci seen on prior CT study, appear to demonstrate signal \n",
      "and enhancement as the spleen - intrapancreatic accessory spleen / splenules are \n",
      "a consideration. However a pancreatic neoplasm is not completely excluded. As such \n",
      "continued surveillance is advised. Nuclear medicine consultation for sulphur colloid \n",
      "scan can be considered. \n",
      "2. Other findings are as described above. \n",
      "\n",
      "CT AP <DATE>\n",
      "CONCLUSION\n",
      "\n",
      "1. No evidence of bowel obstruction or lymphadenopathy. No collection.\n",
      "\n",
      "2. Lobulated enhancing mass in the region of the lower uterus and cervix is suspicious \n",
      "for neoplasm. No hydronephrosis.\n",
      "\n",
      "3. Multiple bilateral pulmonary nodules suspicious for metastasis- some appear more \n",
      "prominent/larger. Some of the nodules are in perifissural/perilymphatic distribution \n",
      "raising possibility of lymphangitis.\n",
      "\n",
      "4. There is small amount of protal venous gas, uncertain in origin. This may herald \n",
      "focal bowel injury or evolving ischaemia. Of note, no evidence of abnormal bowel \n",
      "wall thickening. No pneumoperitoneum. Continued clinical correlation is suggested.\n",
      "\n",
      "Urine cyto 1/5/25\n",
      "Urine  - Catheter for Cytology:\n",
      "- Rare atypical cells\n",
      "\n",
      "OGD + Colono 9/5/25\n",
      "  Esophagus: irregular Z line, normal esophagus\n",
      "  Stomach: pan-gastritis, IM changes involving antrum and incisura\n",
      "  Duodenum: D1/D2 normal\n",
      "\n",
      "  Nil suspicious lesion seen on OGD\n",
      "\n",
      "  Colonoscopy with distal cap\n",
      "  Loopy colon\n",
      "  GI Genius on withdrawal\n",
      "  Good bowel prep with adequate mucosal visualizaton\n",
      "  Scoped to terminal ileum\n",
      "  TI normal\n",
      "  Multiple diverticular disease especially at ascending colon and sigmoid colon\n",
      "  No overt GI mass to account for malignancy\n",
      "  Retroflexion performed, non-bleeding haemorrhoids seen\n",
      "\n",
      "AFB smear and TB DNA-ve\n",
      "\n",
      "Histo 9/5/25\n",
      "Diagnosis\n",
      "A. Antrum Incisura Biopsy:\n",
      "Active, chronic gastritis\n",
      "H Pylori present\n",
      "Intestinal metaplasia present, moderate\n",
      "Negative for dysplasia and malignancy\n",
      "\n",
      "B. Gastric Body Biopsy:\n",
      "Active, chronic gastritis\n",
      "H Pylori present\n",
      "Negative for intestinal metaplasia, dysplasia and malignancy\n",
      "\n",
      "Histo 13/5/25\n",
      "Diagnosis\n",
      "Pancreatic mass, EUS-guided fine needle biopsy:\n",
      "- Benign pancreatic tissue with lobules of pancreatic acinar cells and \n",
      "adipose tissue\n",
      "\n",
      "Histo 16/5/25\n",
      "Diagnosis\n",
      "A. Left  lung nodule: \n",
      "Non-small cell carcinoma with necrosis (see comment)\n",
      "\n",
      "\n",
      "Although p16 stain is focally positive, p40 is negative (expected to be \n",
      "positive for uterine cervix origin). Vimentin is positive which is by \n",
      "itself non-specific. However, given that no clear cut IHC support for \n",
      "primary and the clinical context of newly    found lower; Reason for visit: First visit for discussion of palliative systemic therapy\n",
      "Came with: Son\n",
      "Speaks: English\n",
      "$: ___\n",
      "\n",
      "65 year-old female\n",
      "PS: ECOG \n",
      "NKDA\n",
      "Non smoker, non drinker ___\n",
      "Married __ with __ children\n",
      "lives with ___\n",
      "works as ___\n",
      "FMHx: __\n",
      "\n",
      "Past Medical History/Past Surgical History:\n",
      "1. Meibomian gland dysfunction\n",
      "\n",
      "Drug History:\n",
      "\n",
      "Oncological presentation\n",
      "\n",
      "Admitted 28 April to 23 May 2025 for intermittent abdominal pain\n",
      "\n",
      "CT AP 28/4/25\n",
      "1. Bulky uterus with probable fibroids; further evaluation with ultrasound pelvis \n",
      "is recommended for assessment of fibroids and to exclude underlying sinister uterine \n",
      "lesion. \n",
      "\n",
      "2. Fat infiltration of the pancreas with several apparent enhancing pancreatic lesions \n",
      "are indeterminate. No pancreatic ductal dilatation. Further evaluation with MRCP \n",
      "is recommended. \n",
      "\n",
      "3. No overt infective/inflammatory changes are seen in the abdomen and pelvis. No \n",
      "evidence of acute appendicitis.\n",
      "\n",
      "4. Innumerable bilateral pulmonary nodules. Possible considerations include metastatic \n",
      "lesions, less likely infection (? pulmonary tuberculosis) in the absence of infective \n",
      "symptoms. CT chest is recommended.\n",
      "\n",
      "CT Thorax 29/4/25\n",
      "1. Multiple bilateral pulmonary nodules are suspicious for metastasis. An infective \n",
      "cause is less likely.  \n",
      "2. No suspicious adenopathy. \n",
      "\n",
      "MRCP 2/5/25\n",
      "CONCLUSION\n",
      "\n",
      "1. The pancreatic enhancing foci seen on prior CT study, appear to demonstrate signal \n",
      "and enhancement as the spleen - intrapancreatic accessory spleen / splenules are \n",
      "a consideration. However a pancreatic neoplasm is not completely excluded. As such \n",
      "continued surveillance is advised. Nuclear medicine consultation for sulphur colloid \n",
      "scan can be considered. \n",
      "2. Other findings are as described above. \n",
      "\n",
      "CT AP 19/5/25\n",
      "CONCLUSION\n",
      "\n",
      "1. No evidence of bowel obstruction or lymphadenopathy. No collection.\n",
      "\n",
      "2. Lobulated enhancing mass in the region of the lower uterus and cervix is suspicious \n",
      "for neoplasm. No hydronephrosis.\n",
      "\n",
      "3. Multiple bilateral pulmonary nodules suspicious for metastasis- some appear more \n",
      "prominent/larger. Some of the nodules are in perifissural/perilymphatic distribution \n",
      "raising possibility of lymphangitis.\n",
      "\n",
      "4. There is small amount of protal venous gas, uncertain in origin. This may herald \n",
      "focal bowel injury or evolving ischaemia. Of note, no evidence of abnormal bowel \n",
      "wall thickening. No pneumoperitoneum. Continued clinical correlation is suggested.\n",
      "\n",
      "Urine cyto 1/5/25\n",
      "Urine  - Catheter for Cytology:\n",
      "- Rare atypical cells\n",
      "\n",
      "OGD + Colono 9/5/25\n",
      "  Esophagus: irregular Z line, normal esophagus\n",
      "  Stomach: pan-gastritis, IM changes involving antrum and incisura\n",
      "  Duodenum: D1/D2 normal\n",
      "\n",
      "  Nil suspicious lesion seen on OGD\n",
      "\n",
      "  Colonoscopy with distal cap\n",
      "  Loopy colon\n",
      "  GI Genius on withdrawal\n",
      "  Good bowel prep with adequate mucosal visualizaton\n",
      "  Scoped to terminal ileum\n",
      "  TI normal\n",
      "  Multiple diverticular disease especially at ascending colon and sigmoid colon\n",
      "  No overt GI mass to account for malignancy\n",
      "  Retroflexion performed, non-bleeding haemorrhoids seen\n",
      "\n",
      "AFB smear and TB DNA-ve\n",
      "\n",
      "Histo 9/5/25\n",
      "Diagnosis\n",
      "A. Antrum Incisura Biopsy:\n",
      "Active, chronic gastritis\n",
      "H Pylori present\n",
      "Intestinal metaplasia present, moderate\n",
      "Negative for dysplasia and malignancy\n",
      "\n",
      "B. Gastric Body Biopsy:\n",
      "Active, chronic gastritis\n",
      "H Pylori present\n",
      "Negative for intestinal metaplasia, dysplasia and malignancy\n",
      "\n",
      "Histo 13/5/25\n",
      "Diagnosis\n",
      "Pancreatic mass, EUS-guided fine needle biopsy:\n",
      "- Benign pancreatic tissue with lobules of pancreatic acinar cells and \n",
      "adipose tissue\n",
      "\n",
      "Histo 16/5/25\n",
      "Diagnosis\n",
      "A. Left  lung nodule: \n",
      "Non-small cell carcinoma with necrosis (see comment)\n",
      "\n",
      "\n",
      "Although p16 stain is focally positive, p40 is negative (expected to be \n",
      "positive for uterine cervix origin). Vimentin is positive which is by \n",
      "itself non-specific. However, given that no clear cut IHC support for \n",
      "primary and the clinical context of newly    found lower\n",
      "{'diagnosis': 'Pancreas', 'stage': 'IV'} PAST MEDICAL HISTORY\n",
      "1. IHD with minor CAD 50% stenosis\n",
      "- routine health screening, alphalipo b was elevated, so was referred to do a CT scan, which showed possible calcifications in coronary arteries > led to coronary angiograms\n",
      "- no intervention (nil stenting/ballooning)\n",
      "2. Hypertension\n",
      "3. Hyperlipidemia\n",
      "4. Slightly high glucose but nil formal diagnosis of diabetes\n",
      "\n",
      "NKDA\n",
      "Long-term medications\n",
      "Plavix \n",
      "Concor\n",
      "Rosuvastatin (combined statin)\n",
      "Aprovel for BP\n",
      "?Azithro\n",
      "\n",
      "KRAS G12R mutation\n",
      "CDK12 -rearrangement \n",
      "HRD -ve \n",
      "MSS \n",
      "TMB 5; \n",
      "\n",
      "<PATIENT>\n",
      "<ID>\n",
      "56 year old Chinese Female\n",
      "\n",
      "SOCIAL HISTORY\n",
      "Partner <PATIENT>, one son\n",
      "Works as Accountant\n",
      "Non-smoker, non-drinker\n",
      "Family history of cancer: Paternal grandfather- late 60s/70s - rectal cancer; \n",
      "\n",
      "PAST MEDICAL HISTORY\n",
      "1. IHD with minor CAD 50% stenosis\n",
      "- routine health screening, alphalipo b was elevated, so was referred to do a CT scan, which showed possible calcifications in coronary arteries > led to coronary angiograms\n",
      "- no intervention (nil stenting/ballooning)\n",
      "2. Hypertension\n",
      "3. Hyperlipidemia\n",
      "4. Slightly high glucose but nil formal diagnosis of diabetes\n",
      "\n",
      "NKDA\n",
      "Long-term medications\n",
      "Plavix \n",
      "Concor\n",
      "Rosuvastatin (combined statin)\n",
      "Aprovel for BP\n",
      "?Azithro\n",
      "\n",
      "ONCOLOGICAL HISTORY\n",
      "Newly diagnosed metastatic pancreatic cancer\n",
      "\n",
      "<DATE> Presented with 1 month of abdominal discomfort and bloatedness but symptoms persistent; LOW of about 5 - 6 kg over 1 - 2 months\n",
      "> Saw private Doctor <HCW>\n",
      "> 10.04<DATE>  CTA/P: 4 cm mass in pancreatic body with dilated MPD, mild ascites, mutliple nodular mases in omentum suspicious for omental disease; 2 peripancreatic LN\n",
      "> 21.04.<DATE> EUS-FNA\n",
      "#Cyto:    \n",
      "     Pancreas body mass, fine needle aspiration:\n",
      "    Malignant cells seen, consistent with adenocarcinoma.\n",
      "    proficient MMR expression\n",
      "\n",
      "\n",
      "---\n",
      "Symptoms\n",
      "Some abdominal bloatedness and weight loss\n",
      "\n",
      "On examination\n",
      "Wt 63.5 kg\n",
      "Well groomed\n",
      "ECOG 0\n",
      "Came with partner <PATIENT>, son, son's girlfriend, 2 siblings\n",
      "Came with husband\n",
      "Speaks English\n",
      "HS1S2\n",
      "Lclear\n",
      "Asoft non-tender\n",
      "Calves supple nil pedal edema\n",
      "\n",
      "Investigations\n",
      "FBC PT/PTT CEA CA 19-9 normal\n",
      "P LFT in private early <DATE> within normal limits\n",
      "\n",
      "\n",
      "She wanted a different Dr to care for her. \n",
      "\n",
      "\n",
      "\n",
      "<DATE> \n",
      "\n",
      "Received #1 mfolfirinox on <DATE>. \n",
      "\n",
      "\n",
      "\n",
      "Pain resolved. \n",
      "Can't sleep \n",
      "BLoatedness \n",
      "\n",
      "\n",
      "\n",
      "2/6/25 \n",
      "\n",
      "#2 Pal mfolfirinox so far \n",
      "\n",
      "\n",
      "Well \n",
      "Insomnia\n",
      "{'diagnosis': 'Lung adenocarcinoma', 'stage': 'IV'} metastatic exon 19 del lung adenocarcinoma( pleural involvement)\n",
      "discussed TB findings\n",
      "suggest metastatic disease\n",
      "discussed osimertinib\n",
      "\n",
      "-> started osi since <DATE>\n",
      "s/p rt to the progressing lesions\n",
      "pd in liver  <DATE> \n",
      "2L ->carbo/pem / denosumab PD in liver after  4cycles\n",
      "3L ->carbo/gem-> pd in liver after 2 cycles\n",
      "-> ablated liver ->rechallenge osi \n",
      "oligopd brain \n",
      "Site name: CNS-METS1 \n",
      "Technique: SRS                  \n",
      "Delivered/Prescribed Dose: 2200 / 2200 cGy \n",
      "Delivered/Prescribed Fractions: <DATE> \n",
      "RT Start/End Date: <DATE> \n",
      "\n",
      "\n",
      "fmi blood \n",
      "-> exon 19 del \n",
      "tp 53 c242fs\n",
      "\n",
      "fmi tissue liver-> \n",
      "EGFR exon 19 deletion (E7 on 19 deletion (E746_A750del), amplification amplification\n",
      "- equivocal†\n",
      "MET amplification\n",
      "CDK4 amplification\n",
      "PIK3CA amplification - equiv amplification - equivocal†\n",
      "SOX2 amplification - equiv amplification - equivocal†\n",
      "ERBB3 amplification\n",
      "MCL1 amplification - equiv amplification - equivocal†\n",
      "NFKBIA amplification\n",
      "NKX2-1 amplification\n",
      "TP53 C242fs*5\n",
      "\n",
      "no insurance; been on osimertinib and tepotinib for 3 weeks \n",
      "\n",
      "mild pitting edema\n",
      "g1 mild intermittent diarrhea\n",
      "nil ulcer\n",
      "g1 fatigue - still running 10km\n",
      "\n",
      "o/e\n",
      "hs dual\n",
      "lungs clear\n",
      "abdomen soft\n",
      "\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "<DATE>\tHb: 14.7, WBC: 5.72, Hct: 42.9, Plt: 220. \n",
      "<DATE>\tNeut: 58.0% , Neut Abs: 3.32, MCV: 91.3% , Lymph: 28.7% , Mono: 9.4% , Eos: 3.7% , Baso: 0.2% . \n",
      "<DATE>\tNa: 139, K+: 3.8, Cl: 103, HCO3: 29.2(H), Urea: 5.5, Cre: 116(H), Glu:5.4. \n",
      "<DATE>\tTP: 71, Alb: 38(L), Bil: 7, AST: 37, ALT: 51, ALP: 78. \n",
      " \n",
      "\n",
      "\n",
      "patient comms\n",
      "-> overall tolerating with insight2\n",
      "-> suggest earlier scan in 2 months on treatment \n",
      "-> if further progression -> consider ph1  vs abcp\n",
      "not suitable for tropion\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "; been on osimertinib and tepotinib for 3 weeks \n",
      "\n",
      "mild pitting edema\n",
      "g1 mild intermittent diarrhea\n",
      "nil ulcer\n",
      "g1 fatigue - still running 10km\n",
      "\n",
      "o/e\n",
      "hs dual\n",
      "lungs clear\n",
      "abdomen soft\n",
      "\n",
      "Common Lab Results (CBC,FBC,Chem,LFT):  \n",
      "17/06/25\tHb: 14.7, WBC: 5.72, Hct: 42.9, Plt: 220. \n",
      "17/06/25\tNeut: 58.0% , Neut Abs: 3.32, MCV: 91.3% , Lymph: 28.7% , Mono: 9.4% , Eos: 3.7% , Baso: 0.2% . \n",
      "lfts pending  \n",
      "\n",
      "\n",
      "patient comms\n",
      "-> overall tolerating with insight2\n",
      "-> suggest earlier scan in 2 months on treatment \n",
      "-> if further progression -> consider trial  tropion vs abcp\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "\n",
      "{\n",
      "  \"diagnosis\": \"Rectal\",\n",
      "  \"stage\": \"Stage III\"\n",
      "} near-obstructing recto-sigmoid cancer (resected, T4aN2b (<DATE>) with solitary liver metastasis  \n",
      "CLR: <HCW>\n",
      "Liver: (<HCW> <PATIENT> was at <HOSPITAL>\n",
      "Haem: <PATIENT><HCW>\n",
      "\n",
      "s/p Laparoscopic Low Anterior Resection on <DATE> \n",
      "<IOF>: \n",
      "> Bulky circumferential near obstructing rectosigmoid cancer \n",
      "> No ascites ; > No other obvious peritoneal mets seen \n",
      ">Solitary liver met seen on CT scan, but not obvious laparoscopically \n",
      "Omental adhesions to anterior abd wall \n",
      " \n",
      "Histo: \n",
      "T4aN2b rectosigmoid CA (31/69 LNs) 5 tumor deposits\n",
      "Mod diff adenoCA\n",
      "PNI (+) LVI (+)\n",
      "Tumor budding low \n",
      "pMMR by IHC\n",
      " \n",
      "MRI Liver (<DATE>): Solitary liver metastasis S4 ; Several new subsegmental portal vein thrombi S8''\n",
      "\n",
      "on oral NoAC (seeing Haem); <DATE>\t11:45\t<HCW>\t<ID>\t54\tMalay\tFEMALE\tSUB\n",
      " \n",
      " \n",
      " \n",
      "Assessment (Brief Summary)\n",
      "Near-obstructing recto-sigmoid cancer (resected, T4aN2b (<DATE>) with solitary liver metastasis  \n",
      " \n",
      "Details\n",
      "Pre-op CEA : 51 (<DATE>) CT TAP (<DATE>): Sigmoid cancer , regional nodes ; Single 1.8 cm S4a met, incidental bilateral pubic bodies lucency left pubic body.  \n",
      " \n",
      "s/p Laparoscopic Low Anterior Resection on <DATE> \n",
      "Histo:  T4aN2b rectosigmoid CA (31/69 LNs) 5 tumor deposits\n",
      "Mod diff adenoCA PNI (+) LVI (+)  Tumor budding low  pMMR by IHC\n",
      " \n",
      "MRI Liver (<DATE>): Solitary liver metastasis S4 ; Several new subsegmental portal vein thrombi S8 \n",
      "  \n",
      "started on SC Clexane 60mg OM , saw Haem, converted to oral NoAC\n",
      " \n",
      "SSTP: APC p.(Arg805*)  p.(His1490fs) TP53: p.(Arg213*)\n",
      " \n",
      "Discussed at <HOSPITAL> : for systemic chemotherapy in view of MRI Liver (<DATE>): Solitary liver metastasis S4 ; Several new subsegmental portal vein thrombi S8 and high nodal burden\n",
      " \n",
      "Port a cath <DATE> .  \n",
      " \n",
      " \tTreatment break\tXELOX #7 30/<DATE>\n",
      "Pani/FOLFOX #1 <DATE> #2 <DATE>\n",
      "FOLFOX #3 <DATE>\n",
      " Pani/FOLFOX #4 <DATE> #5 16/12\t \tXELOX #4 26/7 #5 16/8 #6 6/9\tXELOX \n",
      "#1 25/3 #2 14/6 #3 5/7\t \n",
      "Xeloda\t \t \t \t \t3150\t \n",
      "Oxali\t \t210\n",
      "140\t \t \t210\t \n",
      "5FU\t \t400/3900\t \t \t \t \n",
      "Folinic\t \t400\t \t \t \t \n",
      "Pani\t \t370\t \t \t \t \n",
      " \t2/1: 4.0\t26/9 13.5\n",
      "17/10: 11.1\n",
      "15/11: 7.3\n",
      "2/12: 4.5\t \t \t22/4: 51\n",
      "13/6: 43\t \n",
      " \tCT 11/2/25\tCT 19/12/24\tMRI liver 12/9\tCT 12/9\tCT 17/7\tCT & MRI 22&24/4/24\n",
      "S4\tStable ill-defined faint hypodensity in hepatic segment IV, \t5mm\t1\t1\t1.3\t1.6\n",
      "S8 PV thrombi\tnot reported\tnot reported\tnew subcapsular 1.1 cm \tnot seen on CT\tdifficult to appreciate on MRI\tPV thrombosis on MRI\n",
      "public body\t \t \t \t \tstable indeterminate sclerosis\t \n",
      "L breast UOQ\t \t \t \t \tstable 0.6 cm non-spec nodule\t \n",
      "public body\t \t \t \tstable sclerosis\t \t \n",
      "L iliac bone\t \t \t \tstbble lucnecy\t \t \n",
      "lung\tResolved (given benefit of doubt)\tResolved previously documented multiple peribronchial \n",
      "consolidation.\t \tnew multiple (infection vs early mets)\tmultiple stable sub-cm nodules\t \n",
      "RUL\t \t \t \t0.7\t \t \n",
      "RUL\t \t \t \t0.6\t \t \n",
      "RML\t \t \t \t0.9\t \t \n",
      "RML\t \t \t \t0.8\t \t \n",
      "RLL\t \t \t \t0.7\t \t \n",
      "RLL\t \t \t \t0.7\t \t \n",
      "LUL\t \t \t \t0.7\t \t \n",
      "LUL\t \t \t \t0.6\t \t \n",
      "LUL\t \t \t \t0.8\t \t \n",
      "LLL\t \t \t \t0.9\t \t \n",
      "LLL\t \t \t \t0.5\t \t \n",
      " \n",
      "Oxaliplatin \n",
      " \n",
      "G2 ADR To oxaliplatin on 16/11/24:\n",
      "G2 ADR 18-Nov-2024 erythema and pruritic rash after 41 mins; did not rechallenge \n",
      "G2 ADR 02-Dec-2024, final dose 140 mg, completed infusion w/o further ADR,\n",
      " \n",
      "IV dexamethasone 20mg IV diphenhydramine 75mg  IV famotidine 20mg oxaliplatin keep at 3hrs\n",
      "16/12/24: could complete Oxaliplatin \n",
      " \n",
      " \n",
      "This visit\n",
      " \n",
      "Came alone ;   walked in \n",
      " \n",
      "symptoms: \n",
      "(asked re: fever/diarrhea/vomit/SOB/new neuropathy/rash HFS/stomatitis)\n",
      " \n",
      "Exam: \n",
      "no palpable axillary or supraclav nodes\n",
      "Lungs clear \n",
      "A: Soft NT BS (+) wounds all well healed \n",
      "no pedal edema \n",
      " \n",
      " \n",
      " \n",
      " \n",
      "Previous comms : \n",
      " \n",
      "Sep-24\t? Lung mets apparent and new liver lesion though other lesion responding \n",
      "Not keen to consider surgery as it is very high nodal burden\n",
      "Lung disease is indeterminate presently \n",
      "Suggest consider adding anti-EGFR\n",
      "Had PV thrombus: not keen for Bev just yet \n",
      "May-24:\t Very high nodal burden, (31 LN)+ ; Pre-op CEA 51 In theory, solitary liver mets , can consider \"curative\" intent surgery, however, with high nodal burden, very likely occult systemic metastases\n",
      "Medical consensus at MTB is for chemotherapy first: will prefer to complete XELOX #8 \n",
      "Role of targeted therapy uncertain in May-24\n",
      " \n",
      " \n",
      " \n",
      "New events (first line is a summary of this visit)\n",
      " \n",
      "SD after chemotherapy for 9 months and chemo break for 3+ months\n",
      "Should consider resection \n",
      " \n",
      "MRI Liver : \n",
      "Treated liver lesions: Seg VIII decreased to 0.7cm, Seg IVa/b barely visible on DWI. Incidental: hepatic/renal cysts, gallstones, adenomyomatosis. Otherwise normal.\n",
      " \n",
      "MRI Liver 2/6/25: \n",
      "S8: Stable hepatocyte defect(0.7cm)??since 9/24(?treated met).\n",
      "S4A/B: DWI focus(no hepatocyte defect)?replaced nodule from 4/25(?tr\n",
      "{'diagnosis': 'Small cell lung cancer', 'stage': 'Extensive stage'} DA - Synflex (erythroderma)\n",
      "\n",
      "1. Extensive small cell lung ca with low vol brain mets\n",
      "- Etoposide carboplatin atezolizumab x4 from <DATE>, maintained atezo alone from <DATE>\n",
      "\n",
      "\n",
      "PMH\n",
      "BP\n",
      "Lipids\n",
      "\n",
      "\n",
      "* G2 ADR ATEZOLIZUMAB *; \n",
      "Alert lucid\n",
      "Nutrition intact\n",
      "No psychological issues\n",
      "\n",
      "Feeling better overall\n",
      "Mild gastritis\n",
      "Bloods ok\n",
      "\n",
      "Afebrile\n",
      "No nodes\n",
      "Heart and lung clear\n",
      "Abdo soft non tender\n",
      "No LL oedema\n",
      "\n",
      "{'diagnosis': 'Metastatic Breast Cancer', 'stage': 'IV'} -\n",
      "Metachronous Cancers\n",
      "1. Metastatic Left Breast Cancer ER/PR+ HER2-\n",
      "- SOD: Left breast primary, nodal and lung \n",
      "2. Locally Recurrent Right Malignant Phyllodes \n",
      "\n",
      "- <DATE>: p/w bilateral breast lumps for <DATE>\n",
      "  > Left Breast: Invasive carcinoma NST ductal G1\n",
      "    > ER+ (100%) PR+ (100%) HER2- (0)\n",
      "  > Right Breast: fibroepithelial lesion  \n",
      "- <DATE>: Started on Lucrin/Letrozole/Palbociclib \n",
      "- <DATE>: Switch Palbociclib to Ribociclib \n",
      "- <DATE>: CT PR \n",
      "- <DATE>: was non compliant in interim, restarted treatment \n",
      "- <DATE>: Left Breast stable, Right breast larger\n",
      "- <DATE>: switch to Tamoxifen\n",
      "  > offered Paclitaxel - not keen\n",
      "- <DATE>: s/p Right Mastectomy \n",
      "  > Malignant Phyllodes with stromal overgrowth\n",
      "  > 16cm, closest margin 0.1mm \n",
      "- <DATE>: s/p RT to Right breast\n",
      "- <DATE>: CT - SD but larger left SCF and R Lung GG nodules\n",
      "- <DATE>: CT - SD, Left SCF stable, but satellite breast nodules marginally larger \n",
      "- <DATE>: Added on Lucrin \n",
      "- <DATE>: s/p palliative RT to left breast and SCF\n",
      "- <DATE>: CT - SD\n",
      "- <DATE>: CT - PR in left SCF (prev RT), mild PD in left cervical Level V LN (6mm to 10mm)\n",
      "- <DATE>: CT - recurrence of  nodule at R) mastec surgical bed\n",
      "- <DATE>: underwent US Core biopsy\n",
      "  > malignant spindle cell tumour \n",
      "- <DATE>: s/p Right Wide local excision <DATE>\n",
      "  > malignant spindle cell tumour consistent with recurrent phyllodes tumour (sarcomatoid component) - clear margins\n",
      "    > FNCLCC Grade III \n",
      "    > high grade sarcoma with patchy rhabomyoblastic features\n",
      "  > Incidental multifocal invasive carcinoma (ductal/NST) G1\n",
      "    > pT1a (4mm) \n",
      "    > involving superior margin \n",
      "    > ER+ (90%) PR+ (90%) HER2- (1+)\n",
      "- <DATE>: PET/CT - SD \n",
      "- <DATE>: undecided about \"adjuvant\" chemo for Phyllodes\n",
      "- <DATE>: restarted on Tamoxifen/Lucrin \n",
      "- <DATE>: PET/CT - SD \n",
      "- <DATE>2025: CT - local recurrence near left breast lesion\n",
      "\n",
      "BRS: Dr Jeffrey Hing \n",
      "DRO: Dr Richard Yeo\n",
      "DMO (Sarcoma): Dr Eileen Poon \n",
      "\n",
      "PMHx: Nil\n",
      "SHx: married with 2 children(19 and 24yo 2023), works as healthcare assistant\n",
      "FMHx: maternal aunt x 2 breast cancer in 50s; Oncological Summary: Recurrent Phylloides tumor (DFI 9 months) - challenging to operate, biology does not appear to be favourable \n",
      "Treatment regimen: #1 Doxil 8th April 2025, \n",
      "Primary Oncologist: Eileen Poon\n",
      "\n",
      "--------------------------------------------------------------------------------------------------------\n",
      "Current visit: review for #3 Doxil chemo \n",
      "\n",
      "Received #1 Doxil on 8th April 2025, \n",
      "saw CRC on 14th April 2025 for ?Chemo related nausea and GERD \n",
      "\n",
      "#2 Doxil 7th May 2025 \n",
      "--------------------------------------------------------------------------------------------------------\n",
      "\n",
      "Currently,\n",
      "feels well\n",
      "some hair loss but not much \n",
      "\n",
      "no nausea\n",
      "feels more comfortable overall\n",
      "no further ulceration \n",
      "\n",
      "\n",
      "\n",
      "o/e:\n",
      "ECOG0\n",
      "\n",
      "HS1S2\n",
      "Lungs clear \n",
      "Abdomen soft nontender\n",
      "Calves supple no oedema \n",
      "\n",
      "central lump (multi lobulated) ~7x5cm in size --> ~5x5cm (multilobulation not as signficant) \n",
      "overlying skin is somewhat thin.\n",
      "no broken skin \n",
      "lump seems to be flattening out as well \n",
      "\n",
      "Lymph Nodes\n",
      "none palpable\n",
      "==============================\n",
      "Investigations done: \n",
      "bloods noted \n",
      "\n",
      "  \n",
      "\n",
      "\n",
      "\n",
      "==============================\n",
      "Impression:\n",
      "Clinical PR\n",
      "{'diagnosis': 'cancer site', 'stage': 'cancer stage'} Stage 4 ACC pancreas s/p subtotal pancreatectomy/ splenectomy on <DATE>\n",
      "s/p mfolfirinox adjuvant \n",
      "ct <DATE> - ned\n",
      "ct <DATE> - ned\n",
      "ct <DATE> - ned; Emailed me because of low ANC for D15 Gem + Abraxane. \n",
      "Had D15 on <DATE> \n",
      "\n",
      "{'diagnosis': 'melanoma of soft parts', 'stage': 'Stage IV'} A/\n",
      "melanoma of soft parts/ clear cell sarcoma\n",
      "- SOD: Brain, Lung, Liver, LN, Bone, Subcutaneous nodules (Multiple - Scalp, Back, abdomen, axilla), muscles \n",
      "\n",
      "[RX]\n",
      "<DATE>: pembrolizumab; A/\n",
      "melanoma of soft parts/ clear cell sarcoma\n",
      "- SOD: bone, lung, liver, LN, subcut nodules\n",
      "\n",
      "[RX]\n",
      "<DATE>: pembrolizumab; Reason for visit: post #1 pembro\n",
      "English speaking, came with <PATIENT><HCW><PATIENT> <HCW><PATIENT> and mother\n",
      "\n",
      "<HCW>/<HCW> MDT <DATE>\n",
      "PET CT Scan reviewed:\n",
      "extensive disease involving bone, lung, liver, subcutaneous nodules, lymph nodes that are avid\n",
      "\n",
      "Histo reviewed:\n",
      "Overall consistent with melanoma although no skin tissue involved\n",
      "Can call melanoma of soft parts\n",
      "\n",
      "Recommend:\n",
      "Send for additional immunohisto stains\n",
      "Send for molecular testing/ SSTP\n",
      "for palliative systemic therapy \n",
      "\n",
      "S/\n",
      "1. fever, lethargic since discharge\n",
      "2. noted new lumps on back\n",
      "\n",
      "Appetite: poor\n",
      "PU/BO: normal\n",
      "\n",
      "O/\n",
      "Wt    49.8kg \n",
      "T 38.4 BP 113/69 HR 125 Sp02 98% (RA)\n",
      "\n",
      "came in via WC\n",
      "Alert, oriented, non-toxic\n",
      "Well nourished\n",
      "No pallor. No sclera icterus \n",
      "No oral ulcers or thrush \n",
      "\n",
      "L: equal AE B/L\n",
      "A: soft, NT, BS +\n",
      "No pedal edema.   \n",
      "\n",
      "No palpable cervical/ supraclavicular/ axillary/ inguinal lymph nodes\n",
      "\n",
      "INVX\n",
      "FBC, UECr, LFT - pending\n",
      "\n",
      "A/\n",
      "melanoma of soft parts/ clear cell sarcoma\n",
      "- ?hyper-progression post #1 pembro\n",
      "- TRO concomitant infection \n",
      "; Reason for visit: post #1 pembro\n",
      "English speaking, came with <HCW><PATIENT> and mother\n",
      "\n",
      "<HCW>/<HCW> MDT <DATE>\n",
      "PET CT Scan reviewed:\n",
      "extensive disease involving bone, lung, liver, subcutaneous nodules, lymph nodes that are avid\n",
      "\n",
      "Histo reviewed:\n",
      "Overall consistent with melanoma although no skin tissue involved\n",
      "Can call melanoma of soft parts\n",
      "\n",
      "Recommend:\n",
      "Send for additional immunohisto stains\n",
      "Send for molecular testing/ SSTP\n",
      "for palliative systemic therapy \n",
      "\n",
      "S/\n",
      "1. fever, lethargic since discharge\n",
      "2. noted new lumps on back\n",
      "\n",
      "Appetite: poor\n",
      "PU/BO: normal\n",
      "\n",
      "O/\n",
      "Wt    49.8kg \n",
      "T 38.4 BP 113/69 HR 125 Sp02 98% (RA)\n",
      "\n",
      "came in via WC\n",
      "Alert, oriented, non-toxic\n",
      "Well nourished\n",
      "No pallor. No sclera icterus \n",
      "No oral ulcers or thrush \n",
      "\n",
      "L: equal AE B/L\n",
      "A: soft, NT, BS +\n",
      "No pedal edema.   \n",
      "\n",
      "No palpable cervical/ supraclavicular/ axillary/ inguinal lymph nodes\n",
      "\n",
      "INVX\n",
      "FBC, UECr, LFT - pending\n",
      "\n",
      "A/\n",
      "melanoma of soft parts/ clear cell sarcoma\n",
      "- ?hyper-progression post #1 pembro\n",
      "- TRO concomitant infection \n",
      "\n"
     ]
    }
   ],
   "execution_count": 31
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "prepare trial data",
   "id": "24aa4554895fc3ae"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "if have old trials info, load and analysis",
   "id": "235759eb9ad4edac"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:26.027320Z",
     "start_time": "2025-07-15T04:20:26.025387Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# summarized_trials_df = pd.read_csv('./data/output/example/06 NCCS_CT dd 10May2025_deepseek.csv')\n",
    "# summarized_trials_df.columns"
   ],
   "id": "e5fb54a9e9cb7080",
   "outputs": [],
   "execution_count": 32
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:27.018440Z",
     "start_time": "2025-07-15T04:20:27.011947Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import json\n",
    "import re\n",
    "\n",
    "\n",
    "def find_all(string, sub):\n",
    "    start = 0\n",
    "    pos = []\n",
    "    while True:\n",
    "        start = string.find(sub, start)\n",
    "        if start == -1:\n",
    "            return pos\n",
    "        pos.append(start)\n",
    "        start += len(sub)\n",
    "\n",
    "\n",
    "class Trial:\n",
    "    def __init__(self, name, title, patient, phase):\n",
    "        self.name = name\n",
    "        self.title = title\n",
    "        self.required_patients = patient\n",
    "        self.phase = phase\n",
    "\n",
    "    def add_required_patient(self, required_patient):\n",
    "        self.required_patients.append(required_patient)\n",
    "\n",
    "\n",
    "# summarized_trials_json = []\n",
    "trials_list = []\n",
    "phase_one_trial_list, normal_trial_list = [], []\n",
    "for name, title, status, phase, tagged_site, tagged_stage in zip(trials_df['Trial Name'],\n",
    "                                                                 trials_df['Title of Study'],\n",
    "                                                                 trials_df['Study Status'],\n",
    "                                                                 trials_df['Phase'],\n",
    "                                                                 trials_df['Site'],\n",
    "                                                                 trials_df['Stage of cancer']):\n",
    "\n",
    "    if 'Open' not in status:\n",
    "        t = Trial(name=name, title=title, patient=[], phase=phase)\n",
    "        trials_list.append(t)\n",
    "        continue\n",
    "    # st = site_stage[0]\n",
    "    # for st in summarized_trials:\n",
    "    # i = st.find('</think>')\n",
    "    # st = st[i + len('</think>'):]\n",
    "    # print(st)\n",
    "    # ind_left = find_all(st, '{')\n",
    "    # ind_right = find_all(st, '}')\n",
    "    # print(ind_left, ind_right)\n",
    "    t = Trial(name=name, title=title, patient=[], phase=phase)\n",
    "    # print('required: ', len(t.required_patients))\n",
    "    t_site = [item.strip() for item in tagged_site.split(';') if item.strip()]\n",
    "    # print(t_site)\n",
    "    for site in t_site:\n",
    "        tagged_patient_data = {\n",
    "            'diagnosis': site,\n",
    "            'stage': tagged_stage,\n",
    "        }\n",
    "        tagged_patient = Patient(cancer_site=[tagged_patient_data['diagnosis']],\n",
    "                                 cancer_stage=[tagged_patient_data['stage']], patient_number = -1)\n",
    "        t.add_required_patient(tagged_patient)\n",
    "\n",
    "    if phase == '1' or phase == 1:\n",
    "        phase_one_trial_list.append(t)\n",
    "    else:\n",
    "        normal_trial_list.append(t)\n",
    "    trials_list.append(t)\n",
    "\n",
    "    # for p in t.required_patients:\n",
    "        # print(p.site, end='; ')\n",
    "\n",
    "    # print(st)\n",
    "    # summarized_trials_json.append(json.loads(st.replace(\"'\", '\"').replace(\"\\\\n\", \"\")))\n",
    "\n",
    "trials_site_stage_template = '''the trial is asking for patient who has {cancer_site}, which is {cancer_stage}'''"
   ],
   "id": "2837a7c93c9670b0",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['Ovarian/Fallopian Tube Cancer', 'Ovarian Cancer', 'Germ Cell Tumor', 'Sex Cord Stromal Tumor', 'Soft Tissue Cancer', 'Soft Tissue Sarcoma', 'Angiomatoid Fibrous Histiocytoma', 'Miscellaneous Neuroepithelial Tumor', 'Infantile Fibrosarcoma', 'Malignant Glomus Tumor', 'Gastrointestinal Stromal Tumor', 'Myofibromatosis', 'Thyroid Cancer', 'Pleural Cancer', 'Mesothelioma', 'Pancreatic Cancer', 'Biliary Tract Cancer', 'Hepatobiliary Cancer', 'Breast Cancer', 'Breast Sarcoma', 'Head and Neck Cancer', 'Melanoma', 'Parathyroid Cancer', 'Salivary Gland Cancer', 'Sialoblastoma', 'Eye Cancer', 'Lacrimal Gland Tumor', 'Retinoblastoma', 'Ampullary Carcinoma', 'Ampullary Cancer', 'Thymic Cancer', 'Thymic Tumor', 'Cervical Cancer', 'Peripheral Nervous System Cancer', 'Peripheral Nervous System', 'Nerve Sheath Tumor', 'Bowel Cancer', 'Gastrointestinal Neuroendocrine Tumor', 'Anal Cancer', 'Appendiceal Cancer', 'Small Bowel Cancer', 'Tubular Adenoma of the Colon', 'Colorectal Cancer', 'Bone Cancer', 'Skin Cancer', 'Skin Cancer, Non-Melanoma', 'Bladder/Urinary Tract Cancer', 'Bladder Cancer', 'CNS/Brain Cancer', 'CNS Cancer', 'Glioma', 'Choroid Plexus Tumor', 'Primary CNS Melanocytic Tumors', 'Melanocytoma', 'Pineal Tumor', 'Embryonal Tumor', 'Desmoplastic/Nodular Medulloblastoma', 'Medulloblastoma', 'Large Cell/Anaplastic Medulloblastoma', 'Medulloblastoma with Extensive Nodularity', 'Sellar Tumor', 'Miscellaneous Brain Tumor', 'Adrenal Gland Cancer', 'Adrenocortical Carcinoma', 'Pheochromocytoma', 'Adrenocortical Adenoma', 'Prostate Cancer', 'Lung Cancer', 'Non-Small Cell Lung Cancer', 'Small Cell Lung Cancer', 'Penile Cancer', 'Uterine Cancer', 'Uterine Sarcoma', 'Endometrial Cancer', 'Gestational Trophoblastic Disease', 'Adenocarcinoma In Situ', 'Testicular Cancer', 'Liver Cancer', 'Malignant Rhabdoid Tumor of the Liver', 'Undifferentiated Embryonal Sarcoma of the Liver', 'Peritoneal Cancer', 'Peritoneal Cancer, NOS', 'Histiocytosis', 'Blastic Plasmacytoid Dendritic Cell Neoplasm', 'Myelodysplastic/Myeloproliferative Neoplasms', 'Myeloproliferative Neoplasms', 'Myeloid Neoplasms with Germ Line Predisposition', 'Myelodysplastic Syndromes', 'Mastocytosis', 'Vulvar/Vaginal Cancer', 'Vaginal Cancer', 'Vulvar Carcinoma', 'Kidney Cancer', 'Renal Cell Carcinoma', 'Wilms Tumor', 'Renal Neuroendocrine Tumor', 'Rhabdoid Cancer', 'Clear Cell Sarcoma of Kidney', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer', 'Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']\n",
      "['Ovarian/Fallopian Tube Cancer']; ['Ovarian Cancer']; ['Germ Cell Tumor']; ['Sex Cord Stromal Tumor']; ['Soft Tissue Cancer']; ['Soft Tissue Sarcoma']; ['Angiomatoid Fibrous Histiocytoma']; ['Miscellaneous Neuroepithelial Tumor']; ['Infantile Fibrosarcoma']; ['Malignant Glomus Tumor']; ['Gastrointestinal Stromal Tumor']; ['Myofibromatosis']; ['Thyroid Cancer']; ['Pleural Cancer']; ['Mesothelioma']; ['Pancreatic Cancer']; ['Biliary Tract Cancer']; ['Hepatobiliary Cancer']; ['Breast Cancer']; ['Breast Sarcoma']; ['Head and Neck Cancer']; ['Melanoma']; ['Parathyroid Cancer']; ['Salivary Gland Cancer']; ['Sialoblastoma']; ['Eye Cancer']; ['Lacrimal Gland Tumor']; ['Retinoblastoma']; ['Ampullary Carcinoma']; ['Ampullary Cancer']; ['Thymic Cancer']; ['Thymic Tumor']; ['Cervical Cancer']; ['Peripheral Nervous System Cancer']; ['Peripheral Nervous System']; ['Nerve Sheath Tumor']; ['Bowel Cancer']; ['Gastrointestinal Neuroendocrine Tumor']; ['Anal Cancer']; ['Appendiceal Cancer']; ['Small Bowel Cancer']; ['Tubular Adenoma of the Colon']; ['Colorectal Cancer']; ['Bone Cancer']; ['Skin Cancer']; ['Skin Cancer, Non-Melanoma']; ['Bladder/Urinary Tract Cancer']; ['Bladder Cancer']; ['CNS/Brain Cancer']; ['CNS Cancer']; ['Glioma']; ['Choroid Plexus Tumor']; ['Primary CNS Melanocytic Tumors']; ['Melanocytoma']; ['Pineal Tumor']; ['Embryonal Tumor']; ['Desmoplastic/Nodular Medulloblastoma']; ['Medulloblastoma']; ['Large Cell/Anaplastic Medulloblastoma']; ['Medulloblastoma with Extensive Nodularity']; ['Sellar Tumor']; ['Miscellaneous Brain Tumor']; ['Adrenal Gland Cancer']; ['Adrenocortical Carcinoma']; ['Pheochromocytoma']; ['Adrenocortical Adenoma']; ['Prostate Cancer']; ['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Small Cell Lung Cancer']; ['Penile Cancer']; ['Uterine Cancer']; ['Uterine Sarcoma']; ['Endometrial Cancer']; ['Gestational Trophoblastic Disease']; ['Adenocarcinoma In Situ']; ['Testicular Cancer']; ['Liver Cancer']; ['Malignant Rhabdoid Tumor of the Liver']; ['Undifferentiated Embryonal Sarcoma of the Liver']; ['Peritoneal Cancer']; ['Peritoneal Cancer, NOS']; ['Histiocytosis']; ['Blastic Plasmacytoid Dendritic Cell Neoplasm']; ['Myelodysplastic/Myeloproliferative Neoplasms']; ['Myeloproliferative Neoplasms']; ['Myeloid Neoplasms with Germ Line Predisposition']; ['Myelodysplastic Syndromes']; ['Mastocytosis']; ['Vulvar/Vaginal Cancer']; ['Vaginal Cancer']; ['Vulvar Carcinoma']; ['Kidney Cancer']; ['Renal Cell Carcinoma']; ['Wilms Tumor']; ['Renal Neuroendocrine Tumor']; ['Rhabdoid Cancer']; ['Clear Cell Sarcoma of Kidney']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']; ['Melanoma', 'Lung Cancer', 'Non-Small Cell Lung Cancer', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer']\n",
      "['Melanoma']; ['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Pancreatic Cancer', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer']\n",
      "['Pancreatic Cancer']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Ovarian/Fallopian Tube Cancer', 'Ovarian Cancer', 'Germ Cell Tumor', 'Sex Cord Stromal Tumor', 'Soft Tissue Cancer', 'Soft Tissue Sarcoma', 'Angiomatoid Fibrous Histiocytoma', 'Miscellaneous Neuroepithelial Tumor', 'Infantile Fibrosarcoma', 'Malignant Glomus Tumor', 'Gastrointestinal Stromal Tumor', 'Myofibromatosis', 'Thyroid Cancer', 'Pleural Cancer', 'Mesothelioma', 'Pancreatic Cancer', 'Biliary Tract Cancer', 'Hepatobiliary Cancer', 'Breast Cancer', 'Breast Sarcoma', 'Head and Neck Cancer', 'Melanoma', 'Parathyroid Cancer', 'Salivary Gland Cancer', 'Sialoblastoma', 'Eye Cancer', 'Lacrimal Gland Tumor', 'Retinoblastoma', 'Ampullary Carcinoma', 'Ampullary Cancer', 'Thymic Cancer', 'Thymic Tumor', 'Cervical Cancer', 'Peripheral Nervous System Cancer', 'Peripheral Nervous System', 'Nerve Sheath Tumor', 'Bowel Cancer', 'Gastrointestinal Neuroendocrine Tumor', 'Anal Cancer', 'Appendiceal Cancer', 'Small Bowel Cancer', 'Tubular Adenoma of the Colon', 'Colorectal Cancer', 'Bone Cancer', 'Skin Cancer', 'Skin Cancer, Non-Melanoma', 'Bladder/Urinary Tract Cancer', 'Bladder Cancer', 'CNS/Brain Cancer', 'CNS Cancer', 'Glioma', 'Choroid Plexus Tumor', 'Primary CNS Melanocytic Tumors', 'Melanocytoma', 'Pineal Tumor', 'Embryonal Tumor', 'Desmoplastic/Nodular Medulloblastoma', 'Medulloblastoma', 'Large Cell/Anaplastic Medulloblastoma', 'Medulloblastoma with Extensive Nodularity', 'Sellar Tumor', 'Miscellaneous Brain Tumor', 'Adrenal Gland Cancer', 'Adrenocortical Carcinoma', 'Pheochromocytoma', 'Adrenocortical Adenoma', 'Prostate Cancer', 'Lung Cancer', 'Non-Small Cell Lung Cancer', 'Small Cell Lung Cancer', 'Penile Cancer', 'Uterine Cancer', 'Uterine Sarcoma', 'Endometrial Cancer', 'Gestational Trophoblastic Disease', 'Adenocarcinoma In Situ', 'Testicular Cancer', 'Liver Cancer', 'Malignant Rhabdoid Tumor of the Liver', 'Undifferentiated Embryonal Sarcoma of the Liver', 'Peritoneal Cancer', 'Peritoneal Cancer, NOS', 'Histiocytosis', 'Blastic Plasmacytoid Dendritic Cell Neoplasm', 'Myelodysplastic/Myeloproliferative Neoplasms', 'Myeloproliferative Neoplasms', 'Myeloid Neoplasms with Germ Line Predisposition', 'Myelodysplastic Syndromes', 'Mastocytosis', 'Vulvar/Vaginal Cancer', 'Vaginal Cancer', 'Vulvar Carcinoma', 'Kidney Cancer', 'Renal Cell Carcinoma', 'Wilms Tumor', 'Renal Neuroendocrine Tumor', 'Rhabdoid Cancer', 'Clear Cell Sarcoma of Kidney', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer', 'Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']\n",
      "['Ovarian/Fallopian Tube Cancer']; ['Ovarian Cancer']; ['Germ Cell Tumor']; ['Sex Cord Stromal Tumor']; ['Soft Tissue Cancer']; ['Soft Tissue Sarcoma']; ['Angiomatoid Fibrous Histiocytoma']; ['Miscellaneous Neuroepithelial Tumor']; ['Infantile Fibrosarcoma']; ['Malignant Glomus Tumor']; ['Gastrointestinal Stromal Tumor']; ['Myofibromatosis']; ['Thyroid Cancer']; ['Pleural Cancer']; ['Mesothelioma']; ['Pancreatic Cancer']; ['Biliary Tract Cancer']; ['Hepatobiliary Cancer']; ['Breast Cancer']; ['Breast Sarcoma']; ['Head and Neck Cancer']; ['Melanoma']; ['Parathyroid Cancer']; ['Salivary Gland Cancer']; ['Sialoblastoma']; ['Eye Cancer']; ['Lacrimal Gland Tumor']; ['Retinoblastoma']; ['Ampullary Carcinoma']; ['Ampullary Cancer']; ['Thymic Cancer']; ['Thymic Tumor']; ['Cervical Cancer']; ['Peripheral Nervous System Cancer']; ['Peripheral Nervous System']; ['Nerve Sheath Tumor']; ['Bowel Cancer']; ['Gastrointestinal Neuroendocrine Tumor']; ['Anal Cancer']; ['Appendiceal Cancer']; ['Small Bowel Cancer']; ['Tubular Adenoma of the Colon']; ['Colorectal Cancer']; ['Bone Cancer']; ['Skin Cancer']; ['Skin Cancer, Non-Melanoma']; ['Bladder/Urinary Tract Cancer']; ['Bladder Cancer']; ['CNS/Brain Cancer']; ['CNS Cancer']; ['Glioma']; ['Choroid Plexus Tumor']; ['Primary CNS Melanocytic Tumors']; ['Melanocytoma']; ['Pineal Tumor']; ['Embryonal Tumor']; ['Desmoplastic/Nodular Medulloblastoma']; ['Medulloblastoma']; ['Large Cell/Anaplastic Medulloblastoma']; ['Medulloblastoma with Extensive Nodularity']; ['Sellar Tumor']; ['Miscellaneous Brain Tumor']; ['Adrenal Gland Cancer']; ['Adrenocortical Carcinoma']; ['Pheochromocytoma']; ['Adrenocortical Adenoma']; ['Prostate Cancer']; ['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Small Cell Lung Cancer']; ['Penile Cancer']; ['Uterine Cancer']; ['Uterine Sarcoma']; ['Endometrial Cancer']; ['Gestational Trophoblastic Disease']; ['Adenocarcinoma In Situ']; ['Testicular Cancer']; ['Liver Cancer']; ['Malignant Rhabdoid Tumor of the Liver']; ['Undifferentiated Embryonal Sarcoma of the Liver']; ['Peritoneal Cancer']; ['Peritoneal Cancer, NOS']; ['Histiocytosis']; ['Blastic Plasmacytoid Dendritic Cell Neoplasm']; ['Myelodysplastic/Myeloproliferative Neoplasms']; ['Myeloproliferative Neoplasms']; ['Myeloid Neoplasms with Germ Line Predisposition']; ['Myelodysplastic Syndromes']; ['Mastocytosis']; ['Vulvar/Vaginal Cancer']; ['Vaginal Cancer']; ['Vulvar Carcinoma']; ['Kidney Cancer']; ['Renal Cell Carcinoma']; ['Wilms Tumor']; ['Renal Neuroendocrine Tumor']; ['Rhabdoid Cancer']; ['Clear Cell Sarcoma of Kidney']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']; ['Lung Cancer', 'Non-Small Cell Lung Cancer', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Ovarian/Fallopian Tube Cancer', 'Ovarian Cancer', 'Germ Cell Tumor', 'Sex Cord Stromal Tumor', 'Soft Tissue Cancer', 'Soft Tissue Sarcoma', 'Angiomatoid Fibrous Histiocytoma', 'Miscellaneous Neuroepithelial Tumor', 'Infantile Fibrosarcoma', 'Malignant Glomus Tumor', 'Gastrointestinal Stromal Tumor', 'Myofibromatosis', 'Thyroid Cancer', 'Pleural Cancer', 'Mesothelioma', 'Pancreatic Cancer', 'Biliary Tract Cancer', 'Hepatobiliary Cancer', 'Breast Cancer', 'Breast Sarcoma', 'Head and Neck Cancer', 'Melanoma', 'Parathyroid Cancer', 'Salivary Gland Cancer', 'Sialoblastoma', 'Eye Cancer', 'Lacrimal Gland Tumor', 'Retinoblastoma', 'Ampullary Carcinoma', 'Ampullary Cancer', 'Thymic Cancer', 'Thymic Tumor', 'Cervical Cancer', 'Peripheral Nervous System Cancer', 'Peripheral Nervous System', 'Nerve Sheath Tumor', 'Bowel Cancer', 'Gastrointestinal Neuroendocrine Tumor', 'Anal Cancer', 'Appendiceal Cancer', 'Small Bowel Cancer', 'Tubular Adenoma of the Colon', 'Colorectal Cancer', 'Bone Cancer', 'Skin Cancer', 'Skin Cancer, Non-Melanoma', 'Bladder/Urinary Tract Cancer', 'Bladder Cancer', 'CNS/Brain Cancer', 'CNS Cancer', 'Glioma', 'Choroid Plexus Tumor', 'Primary CNS Melanocytic Tumors', 'Melanocytoma', 'Pineal Tumor', 'Embryonal Tumor', 'Desmoplastic/Nodular Medulloblastoma', 'Medulloblastoma', 'Large Cell/Anaplastic Medulloblastoma', 'Medulloblastoma with Extensive Nodularity', 'Sellar Tumor', 'Miscellaneous Brain Tumor', 'Adrenal Gland Cancer', 'Adrenocortical Carcinoma', 'Pheochromocytoma', 'Adrenocortical Adenoma', 'Prostate Cancer', 'Penile Cancer', 'Uterine Cancer', 'Uterine Sarcoma', 'Endometrial Cancer', 'Gestational Trophoblastic Disease', 'Adenocarcinoma In Situ', 'Testicular Cancer', 'Liver Cancer', 'Malignant Rhabdoid Tumor of the Liver', 'Undifferentiated Embryonal Sarcoma of the Liver', 'Peritoneal Cancer', 'Peritoneal Cancer, NOS', 'Histiocytosis', 'Blastic Plasmacytoid Dendritic Cell Neoplasm', 'Myelodysplastic/Myeloproliferative Neoplasms', 'Myeloproliferative Neoplasms', 'Myeloid Neoplasms with Germ Line Predisposition', 'Myelodysplastic Syndromes', 'Mastocytosis', 'Vulvar/Vaginal Cancer', 'Vaginal Cancer', 'Vulvar Carcinoma', 'Kidney Cancer', 'Renal Cell Carcinoma', 'Wilms Tumor', 'Renal Neuroendocrine Tumor', 'Rhabdoid Cancer', 'Clear Cell Sarcoma of Kidney', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer', 'Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']\n",
      "['Ovarian/Fallopian Tube Cancer']; ['Ovarian Cancer']; ['Germ Cell Tumor']; ['Sex Cord Stromal Tumor']; ['Soft Tissue Cancer']; ['Soft Tissue Sarcoma']; ['Angiomatoid Fibrous Histiocytoma']; ['Miscellaneous Neuroepithelial Tumor']; ['Infantile Fibrosarcoma']; ['Malignant Glomus Tumor']; ['Gastrointestinal Stromal Tumor']; ['Myofibromatosis']; ['Thyroid Cancer']; ['Pleural Cancer']; ['Mesothelioma']; ['Pancreatic Cancer']; ['Biliary Tract Cancer']; ['Hepatobiliary Cancer']; ['Breast Cancer']; ['Breast Sarcoma']; ['Head and Neck Cancer']; ['Melanoma']; ['Parathyroid Cancer']; ['Salivary Gland Cancer']; ['Sialoblastoma']; ['Eye Cancer']; ['Lacrimal Gland Tumor']; ['Retinoblastoma']; ['Ampullary Carcinoma']; ['Ampullary Cancer']; ['Thymic Cancer']; ['Thymic Tumor']; ['Cervical Cancer']; ['Peripheral Nervous System Cancer']; ['Peripheral Nervous System']; ['Nerve Sheath Tumor']; ['Bowel Cancer']; ['Gastrointestinal Neuroendocrine Tumor']; ['Anal Cancer']; ['Appendiceal Cancer']; ['Small Bowel Cancer']; ['Tubular Adenoma of the Colon']; ['Colorectal Cancer']; ['Bone Cancer']; ['Skin Cancer']; ['Skin Cancer, Non-Melanoma']; ['Bladder/Urinary Tract Cancer']; ['Bladder Cancer']; ['CNS/Brain Cancer']; ['CNS Cancer']; ['Glioma']; ['Choroid Plexus Tumor']; ['Primary CNS Melanocytic Tumors']; ['Melanocytoma']; ['Pineal Tumor']; ['Embryonal Tumor']; ['Desmoplastic/Nodular Medulloblastoma']; ['Medulloblastoma']; ['Large Cell/Anaplastic Medulloblastoma']; ['Medulloblastoma with Extensive Nodularity']; ['Sellar Tumor']; ['Miscellaneous Brain Tumor']; ['Adrenal Gland Cancer']; ['Adrenocortical Carcinoma']; ['Pheochromocytoma']; ['Adrenocortical Adenoma']; ['Prostate Cancer']; ['Penile Cancer']; ['Uterine Cancer']; ['Uterine Sarcoma']; ['Endometrial Cancer']; ['Gestational Trophoblastic Disease']; ['Adenocarcinoma In Situ']; ['Testicular Cancer']; ['Liver Cancer']; ['Malignant Rhabdoid Tumor of the Liver']; ['Undifferentiated Embryonal Sarcoma of the Liver']; ['Peritoneal Cancer']; ['Peritoneal Cancer, NOS']; ['Histiocytosis']; ['Blastic Plasmacytoid Dendritic Cell Neoplasm']; ['Myelodysplastic/Myeloproliferative Neoplasms']; ['Myeloproliferative Neoplasms']; ['Myeloid Neoplasms with Germ Line Predisposition']; ['Myelodysplastic Syndromes']; ['Mastocytosis']; ['Vulvar/Vaginal Cancer']; ['Vaginal Cancer']; ['Vulvar Carcinoma']; ['Kidney Cancer']; ['Renal Cell Carcinoma']; ['Wilms Tumor']; ['Renal Neuroendocrine Tumor']; ['Rhabdoid Cancer']; ['Clear Cell Sarcoma of Kidney']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']; ['Pancreatic Cancer']\n",
      "['Pancreatic Cancer']; ['Breast Cancer']\n",
      "['Breast Cancer']; ['Ovarian/Fallopian Tube Cancer', 'Ovarian Cancer', 'Lung Cancer', 'Non-Small Cell Lung Cancer', 'Breast Cancer', 'Endometrial Cancer']\n",
      "['Ovarian/Fallopian Tube Cancer']; ['Ovarian Cancer']; ['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Breast Cancer']; ['Endometrial Cancer']; ['Ovarian/Fallopian Tube Cancer', 'Ovarian Cancer', 'Lung Cancer', 'Non-Small Cell Lung Cancer', 'Endometrial Cancer']\n",
      "['Ovarian/Fallopian Tube Cancer']; ['Ovarian Cancer']; ['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Endometrial Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer', 'Head and Neck Cancer', 'Cervical Cancer', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Head and Neck Cancer']; ['Cervical Cancer']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Bladder/Urinary Tract Cancer', 'Bladder Cancer']\n",
      "['Bladder/Urinary Tract Cancer']; ['Bladder Cancer']; ['Bladder/Urinary Tract Cancer', 'Bladder Cancer']\n",
      "['Bladder/Urinary Tract Cancer']; ['Bladder Cancer']; ['Breast Cancer']\n",
      "['Breast Cancer']; ['Breast Cancer']\n",
      "['Breast Cancer']; ['Breast Cancer']\n",
      "['Breast Cancer']; ['Breast Cancer']\n",
      "['Breast Cancer']; ['Breast Cancer']\n",
      "['Breast Cancer']; ['Breast Cancer']\n",
      "['Breast Cancer']; ['Esophageal/Stomach Cancer', 'Esophagogastric Cancer', 'Pancreatic Cancer', 'Biliary Tract Cancer', 'Hepatobiliary Cancer']\n",
      "['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Pancreatic Cancer']; ['Biliary Tract Cancer']; ['Hepatobiliary Cancer']; ['Liver Cancer', 'Hepatobiliary Cancer']\n",
      "['Liver Cancer']; ['Hepatobiliary Cancer']; ['Liver Cancer', 'Hepatobiliary Cancer']\n",
      "['Liver Cancer']; ['Hepatobiliary Cancer']; ['Liver Cancer', 'Hepatobiliary Cancer']\n",
      "['Liver Cancer']; ['Hepatobiliary Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer', 'Head and Neck Cancer', 'Esophagogastric Cancer', 'Skin Cancer, Non-Melanoma', 'Cervical Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Head and Neck Cancer']; ['Esophagogastric Cancer']; ['Skin Cancer, Non-Melanoma']; ['Cervical Cancer']; ['Small Cell Lung Cancer', 'Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Small Cell Lung Cancer']; ['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Small Cell Lung Cancer', 'Lung Cancer']\n",
      "['Small Cell Lung Cancer']; ['Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Non-Hodgkin Lymphoma', 'Mature B-Cell Neoplasms', 'Leukemia', 'Lymphatic Cancer', 'Lymphatic Cancer, NOS', 'Blood Cancer', 'Blood Cancer, NOS']\n",
      "['Non-Hodgkin Lymphoma']; ['Mature B-Cell Neoplasms']; ['Leukemia']; ['Lymphatic Cancer']; ['Lymphatic Cancer, NOS']; ['Blood Cancer']; ['Blood Cancer, NOS']; ['Lymphatic Cancer', 'Lymphatic Cancer, NOS', 'Mature T and NK Neoplasms', 'Blood Cancer', 'Blood Cancer, NOS']\n",
      "['Lymphatic Cancer']; ['Lymphatic Cancer, NOS']; ['Mature T and NK Neoplasms']; ['Blood Cancer']; ['Blood Cancer, NOS']; ['Non-Hodgkin Lymphoma', 'Mature B-Cell Neoplasms', 'Lymphatic Cancer', 'Lymphatic Cancer, NOS\\nBlood Cancer', 'Blood Cancer, NOS']\n",
      "['Non-Hodgkin Lymphoma']; ['Mature B-Cell Neoplasms']; ['Lymphatic Cancer']; ['Lymphatic Cancer, NOS\\nBlood Cancer']; ['Blood Cancer, NOS']; ['Non-Hodgkin Lymphoma', 'Mature B-Cell Neoplasms', 'Lymphatic Cancer', 'Lymphatic Cancer, NOS\\nBlood Cancer', 'Blood Cancer, NOS']\n",
      "['Non-Hodgkin Lymphoma']; ['Mature B-Cell Neoplasms']; ['Lymphatic Cancer']; ['Lymphatic Cancer, NOS\\nBlood Cancer']; ['Blood Cancer, NOS']; ['Non-Hodgkin Lymphoma', 'Mature B-Cell Neoplasms', 'Lymphatic Cancer', 'Lymphatic Cancer, NOS\\nBlood Cancer', 'Blood Cancer, NOS']\n",
      "['Non-Hodgkin Lymphoma']; ['Mature B-Cell Neoplasms']; ['Lymphatic Cancer']; ['Lymphatic Cancer, NOS\\nBlood Cancer']; ['Blood Cancer, NOS']; ['Head and Neck Cancer']\n",
      "['Head and Neck Cancer']; ['Pancreatic Cancer']\n",
      "['Pancreatic Cancer']; ['Prostate Cancer']\n",
      "['Prostate Cancer']; ['Prostate Cancer']\n",
      "['Prostate Cancer']; ['Prostate Cancer']\n",
      "['Prostate Cancer']; ['Prostate Cancer']\n",
      "['Prostate Cancer']; ['Prostate Cancer']\n",
      "['Prostate Cancer']; ['Renal Cell Carcinoma']\n",
      "['Renal Cell Carcinoma']; ['Lung Cancer', 'Non-Small Cell Lung Cancer']\n",
      "['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Ovarian/Fallopian Tube Cancer', 'Ovarian Cancer', 'Germ Cell Tumor', 'Sex Cord Stromal Tumor', 'Soft Tissue Cancer', 'Soft Tissue Sarcoma', 'Angiomatoid Fibrous Histiocytoma', 'Miscellaneous Neuroepithelial Tumor', 'Infantile Fibrosarcoma', 'Malignant Glomus Tumor', 'Gastrointestinal Stromal Tumor', 'Myofibromatosis', 'Thyroid Cancer', 'Pleural Cancer', 'Mesothelioma', 'Pancreatic Cancer', 'Biliary Tract Cancer', 'Hepatobiliary Cancer', 'Breast Cancer', 'Breast Sarcoma', 'Head and Neck Cancer', 'Melanoma', 'Parathyroid Cancer', 'Salivary Gland Cancer', 'Sialoblastoma', 'Eye Cancer', 'Lacrimal Gland Tumor', 'Retinoblastoma', 'Ampullary Carcinoma', 'Ampullary Cancer', 'Thymic Cancer', 'Thymic Tumor', 'Cervical Cancer', 'Peripheral Nervous System Cancer', 'Peripheral Nervous System', 'Nerve Sheath Tumor', 'Bowel Cancer', 'Gastrointestinal Neuroendocrine Tumor', 'Anal Cancer', 'Appendiceal Cancer', 'Small Bowel Cancer', 'Tubular Adenoma of the Colon', 'Colorectal Cancer', 'Bone Cancer', 'Skin Cancer', 'Skin Cancer, Non-Melanoma', 'Bladder/Urinary Tract Cancer', 'Bladder Cancer', 'CNS/Brain Cancer', 'CNS Cancer', 'Glioma', 'Choroid Plexus Tumor', 'Primary CNS Melanocytic Tumors', 'Melanocytoma', 'Pineal Tumor', 'Embryonal Tumor', 'Desmoplastic/Nodular Medulloblastoma', 'Medulloblastoma', 'Large Cell/Anaplastic Medulloblastoma', 'Medulloblastoma with Extensive Nodularity', 'Sellar Tumor', 'Miscellaneous Brain Tumor', 'Adrenal Gland Cancer', 'Adrenocortical Carcinoma', 'Pheochromocytoma', 'Adrenocortical Adenoma', 'Prostate Cancer', 'Lung Cancer', 'Non-Small Cell Lung Cancer', 'Small Cell Lung Cancer', 'Penile Cancer', 'Uterine Cancer', 'Uterine Sarcoma', 'Endometrial Cancer', 'Gestational Trophoblastic Disease', 'Adenocarcinoma In Situ', 'Testicular Cancer', 'Liver Cancer', 'Malignant Rhabdoid Tumor of the Liver', 'Undifferentiated Embryonal Sarcoma of the Liver', 'Peritoneal Cancer', 'Peritoneal Cancer, NOS', 'Histiocytosis', 'Blastic Plasmacytoid Dendritic Cell Neoplasm', 'Myelodysplastic/Myeloproliferative Neoplasms', 'Myeloproliferative Neoplasms', 'Myeloid Neoplasms with Germ Line Predisposition', 'Myelodysplastic Syndromes', 'Mastocytosis', 'Vulvar/Vaginal Cancer', 'Vaginal Cancer', 'Vulvar Carcinoma', 'Kidney Cancer', 'Renal Cell Carcinoma', 'Wilms Tumor', 'Renal Neuroendocrine Tumor', 'Rhabdoid Cancer', 'Clear Cell Sarcoma of Kidney', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer', 'Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']\n",
      "['Ovarian/Fallopian Tube Cancer']; ['Ovarian Cancer']; ['Germ Cell Tumor']; ['Sex Cord Stromal Tumor']; ['Soft Tissue Cancer']; ['Soft Tissue Sarcoma']; ['Angiomatoid Fibrous Histiocytoma']; ['Miscellaneous Neuroepithelial Tumor']; ['Infantile Fibrosarcoma']; ['Malignant Glomus Tumor']; ['Gastrointestinal Stromal Tumor']; ['Myofibromatosis']; ['Thyroid Cancer']; ['Pleural Cancer']; ['Mesothelioma']; ['Pancreatic Cancer']; ['Biliary Tract Cancer']; ['Hepatobiliary Cancer']; ['Breast Cancer']; ['Breast Sarcoma']; ['Head and Neck Cancer']; ['Melanoma']; ['Parathyroid Cancer']; ['Salivary Gland Cancer']; ['Sialoblastoma']; ['Eye Cancer']; ['Lacrimal Gland Tumor']; ['Retinoblastoma']; ['Ampullary Carcinoma']; ['Ampullary Cancer']; ['Thymic Cancer']; ['Thymic Tumor']; ['Cervical Cancer']; ['Peripheral Nervous System Cancer']; ['Peripheral Nervous System']; ['Nerve Sheath Tumor']; ['Bowel Cancer']; ['Gastrointestinal Neuroendocrine Tumor']; ['Anal Cancer']; ['Appendiceal Cancer']; ['Small Bowel Cancer']; ['Tubular Adenoma of the Colon']; ['Colorectal Cancer']; ['Bone Cancer']; ['Skin Cancer']; ['Skin Cancer, Non-Melanoma']; ['Bladder/Urinary Tract Cancer']; ['Bladder Cancer']; ['CNS/Brain Cancer']; ['CNS Cancer']; ['Glioma']; ['Choroid Plexus Tumor']; ['Primary CNS Melanocytic Tumors']; ['Melanocytoma']; ['Pineal Tumor']; ['Embryonal Tumor']; ['Desmoplastic/Nodular Medulloblastoma']; ['Medulloblastoma']; ['Large Cell/Anaplastic Medulloblastoma']; ['Medulloblastoma with Extensive Nodularity']; ['Sellar Tumor']; ['Miscellaneous Brain Tumor']; ['Adrenal Gland Cancer']; ['Adrenocortical Carcinoma']; ['Pheochromocytoma']; ['Adrenocortical Adenoma']; ['Prostate Cancer']; ['Lung Cancer']; ['Non-Small Cell Lung Cancer']; ['Small Cell Lung Cancer']; ['Penile Cancer']; ['Uterine Cancer']; ['Uterine Sarcoma']; ['Endometrial Cancer']; ['Gestational Trophoblastic Disease']; ['Adenocarcinoma In Situ']; ['Testicular Cancer']; ['Liver Cancer']; ['Malignant Rhabdoid Tumor of the Liver']; ['Undifferentiated Embryonal Sarcoma of the Liver']; ['Peritoneal Cancer']; ['Peritoneal Cancer, NOS']; ['Histiocytosis']; ['Blastic Plasmacytoid Dendritic Cell Neoplasm']; ['Myelodysplastic/Myeloproliferative Neoplasms']; ['Myeloproliferative Neoplasms']; ['Myeloid Neoplasms with Germ Line Predisposition']; ['Myelodysplastic Syndromes']; ['Mastocytosis']; ['Vulvar/Vaginal Cancer']; ['Vaginal Cancer']; ['Vulvar Carcinoma']; ['Kidney Cancer']; ['Renal Cell Carcinoma']; ['Wilms Tumor']; ['Renal Neuroendocrine Tumor']; ['Rhabdoid Cancer']; ['Clear Cell Sarcoma of Kidney']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']; ['Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach', 'Liver Cancer', 'Hepatobiliary Cancer', 'Esophageal/Stomach Cancer', 'Esophagogastric Cancer']\n",
      "['Gastrointestinal Neuroendocrine Tumors of the Esophagus/Stomach']; ['Liver Cancer']; ['Hepatobiliary Cancer']; ['Esophageal/Stomach Cancer']; ['Esophagogastric Cancer']; ['Pancreatic Cancer', 'Miscellaneous Neuroepithelial Tumor', 'Pheochromocytoma', 'Renal Cell Carcinoma', 'Gastrointestinal Stromal Tumor']\n",
      "['Pancreatic Cancer']; ['Miscellaneous Neuroepithelial Tumor']; ['Pheochromocytoma']; ['Renal Cell Carcinoma']; ['Gastrointestinal Stromal Tumor']; ['ovarian, primary peritoneal, or fallopian tube cancer, High-grade endometrioid ovarian cancer']\n",
      "['ovarian, primary peritoneal, or fallopian tube cancer, High-grade endometrioid ovarian cancer']; "
     ]
    }
   ],
   "execution_count": 33
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:27.251264Z",
     "start_time": "2025-07-15T04:20:27.248216Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# for t in phase_one_trial_list:\n",
    "#     print(len(t.required_patients))\n",
    "# print(len(phase_one_trial_list), len(normal_trial_list))"
   ],
   "id": "6f2868d16691c67b",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5\n",
      "3\n",
      "4\n",
      "1\n",
      "1\n",
      "6\n",
      "5\n",
      "6\n",
      "8 46\n"
     ]
    }
   ],
   "execution_count": 34
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "### Two way to approach prematch here\n",
    "- I am considering using code to process, based on the word in the tag then can build a dictionary\n",
    "- or we can just transfer the tags and the patient cancer site and stage into vectors to get similarity"
   ],
   "id": "49f7cb726217f5a3"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "embedding model",
   "id": "a8275c30718c10b5"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:47.042492Z",
     "start_time": "2025-07-15T04:20:27.907250Z"
    }
   },
   "cell_type": "code",
   "source": [
    "from sentence_transformers import SentenceTransformer\n",
    "import torch\n",
    "from torch.nn import functional as F\n",
    "\n",
    "embedding_model = SentenceTransformer('ksg-dfci/TrialSpace', trust_remote_code=True)\n",
    "\n",
    "\n",
    "def embedding_out_tensor(sentence):\n",
    "    with torch.no_grad():\n",
    "        return embedding_model.encode(sentence, convert_to_tensor=True)"
   ],
   "id": "ce398fb40a3ac131",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "modeling_qwen.py: 0.00B [00:00, ?B/s]"
      ],
      "application/vnd.jupyter.widget-view+json": {
       "version_major": 2,
       "version_minor": 0,
       "model_id": "7ba0ac2576af4aab80dc6d9d2cf0a1f1"
      }
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "A new version of the following files was downloaded from https://huggingface.co/dunzhang/stella_en_1.5b_v5:\n",
      "- modeling_qwen.py\n",
      ". Make sure to double-check they do not contain any added malicious code. To avoid downloading new versions of the code file, you can pin a revision.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "Loading checkpoint shards:   0%|          | 0/2 [00:00<?, ?it/s]"
      ],
      "application/vnd.jupyter.widget-view+json": {
       "version_major": 2,
       "version_minor": 0,
       "model_id": "b72a45534eb24efdaf477a1838052eb9"
      }
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "execution_count": 35
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "#### code based:\n",
    "1. match the patient to trial based on the tags\n",
    "2. vectorize them(title, study description and inclusion criteria) and rank the prematch list by similarity score"
   ],
   "id": "1818b16e84be3e98"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "##### do mapping",
   "id": "be4f3f3e1a679c4d"
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "load mapping file",
   "id": "f901a3911a5b01d7"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:47.061285Z",
     "start_time": "2025-07-15T04:20:47.049350Z"
    }
   },
   "cell_type": "code",
   "source": [
    "mapping_df = pd.read_csv('./data/output/Oncotree_list.csv')\n",
    "# mapping_df.columns"
   ],
   "id": "963862a62325d1dd",
   "outputs": [],
   "execution_count": 36
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": [
    "1. separate the cancer site result into words\n",
    "2. match the Code, if any matched, must be the one\n",
    "3. match the Name, find the one that highest number of words matches into and return the Main Type as a result"
   ],
   "id": "e1e021e8e828cdb4"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:47.663494Z",
     "start_time": "2025-07-15T04:20:47.100462Z"
    }
   },
   "cell_type": "code",
   "source": [
    "def separate_into_words(sentence):\n",
    "    start, end = 0, 0\n",
    "    words = []\n",
    "    for i, c in enumerate(sentence):\n",
    "        end = i\n",
    "        if i == len(sentence) - 1 and start != end:\n",
    "            words.append(sentence[start:])\n",
    "        if c.isalpha() or c.isdigit():\n",
    "            continue\n",
    "        else:\n",
    "            if start == end:\n",
    "                if i < len(sentence) - 1:\n",
    "                    start, end = i + 1, i + 1\n",
    "                else:\n",
    "                    break\n",
    "            else:\n",
    "                words.append(sentence[start:end])\n",
    "                if i < len(sentence) - 1:\n",
    "                    start, end = i + 1, i + 1\n",
    "                else:\n",
    "                    break\n",
    "    return words\n",
    "\n",
    "\n",
    "'''\n",
    "    I'm thinking if there are ways to do match just based on the cancer sites words, so separate the response into words, and find which cancer name contains most the words.\n",
    "    if nothing matched, thought can just return 'cancer' as result\n",
    "'''\n",
    "\n",
    "\n",
    "def mapping_to_maintype(cancer_site):\n",
    "    cancer_words = separate_into_words(cancer_site)\n",
    "    mapped_cancer_type = []\n",
    "    # print(mapped_cancer_type)\n",
    "    max_matched_word_count = 0\n",
    "    for code, name, maintype in zip(mapping_df['Code'], mapping_df['Name'], mapping_df['Maintype']):\n",
    "        word_count = 0\n",
    "        # print(cancer_words, 'match to', name, mapped_cancer_type)\n",
    "        '''matched code means 100% match'''\n",
    "        for word in cancer_words:\n",
    "            if word.upper() == code.upper():\n",
    "                mapped_cancer_type = [maintype]\n",
    "                max_matched_word_count = len(cancer_words)\n",
    "\n",
    "        '''count the match words number'''\n",
    "        for word in cancer_words:\n",
    "            if word.upper() in name.upper():\n",
    "                word_count += 1\n",
    "        if word_count == 0:\n",
    "            # print('continue')\n",
    "            continue\n",
    "        '''higher means better match'''\n",
    "        if word_count > max_matched_word_count:\n",
    "            mapped_cancer_type = [maintype]\n",
    "            max_matched_word_count = word_count\n",
    "        '''keep the equal match'''\n",
    "        if word_count == max_matched_word_count:\n",
    "            if maintype not in mapped_cancer_type:\n",
    "                # print(mapped_cancer_type)\n",
    "                mapped_cancer_type.append(maintype)\n",
    "\n",
    "    if len(mapped_cancer_type) == 0:\n",
    "        mapped_cancer_type = ['Cancer']\n",
    "    return mapped_cancer_type\n",
    "\n",
    "\n",
    "'''mapping the patient and the trials'''\n",
    "patient_origin_site, patient_mapped_site = [], []\n",
    "for i, patient in enumerate(patient_list):\n",
    "    mapped_site = []\n",
    "    for site in patient.site:\n",
    "        # print(i, site)\n",
    "        mapped_site += mapping_to_maintype(site)\n",
    "        # print(mapped_site)\n",
    "    patient_list[i].mapping_site(mapped_site)\n",
    "    patient_origin_site.append(patient.site)\n",
    "    patient_mapped_site.append(mapped_site)\n",
    "\n",
    "patient_df['origin site'] = patient_origin_site\n",
    "patient_df['mapped site'] = patient_mapped_site\n",
    "\n",
    "# if not os.path.exists('./data/output/prematch_exam/'):\n",
    "#     os.makedirs('./data/output/prematch_exam/')\n",
    "patient_df.to_csv(f'./data/output/prematch_exam/{patient_file}_mapped.csv', index=False)\n",
    "\n",
    "for i, trial in enumerate(phase_one_trial_list):\n",
    "    for p, patient in enumerate(phase_one_trial_list[i].required_patients):\n",
    "        mapped_site = []\n",
    "        for site in patient.site:\n",
    "            # print(i, site)\n",
    "            mapped_site += mapping_to_maintype(site)\n",
    "            # print(mapped_site)\n",
    "        phase_one_trial_list[i].required_patients[p].mapping_site(mapped_site)\n",
    "\n",
    "for i, trial in enumerate(normal_trial_list):\n",
    "    for p, patient in enumerate(normal_trial_list[i].required_patients):\n",
    "        mapped_site = []\n",
    "        for site in patient.site:\n",
    "            # print(i, site)\n",
    "            mapped_site += mapping_to_maintype(site)\n",
    "            # print(mapped_site)\n",
    "        normal_trial_list[i].required_patients[p].mapping_site(mapped_site)\n",
    "\n",
    "trials_origin_site, trials_mapped_site = [], []\n",
    "for i, trial in enumerate(trials_list):\n",
    "    trial_patient_origin_site, trial_patient_mapped_site = [], []\n",
    "    for p, patient in enumerate(trials_list[i].required_patients):\n",
    "        mapped_site = []\n",
    "        for site in patient.site:\n",
    "            mapped_site += mapping_to_maintype(site)\n",
    "        trials_list[i].required_patients[p].mapping_site(mapped_site)\n",
    "        trial_patient_origin_site += patient.site\n",
    "        trial_patient_mapped_site += mapped_site\n",
    "    trials_origin_site.append(trial_patient_origin_site)\n",
    "    trials_mapped_site.append(trial_patient_mapped_site)\n",
    "\n",
    "trials_df['origin site'] = trials_origin_site\n",
    "trials_df['mapped site'] = trials_mapped_site\n",
    "# if not os.path.exists('./data/output/example/'):\n",
    "#     os.makedirs('./data/output/example/')\n",
    "trials_df.to_csv(f'./data/output/example/{trial_file}_deepseek_mapped.csv', index=False)"
   ],
   "id": "814b629fc306d715",
   "outputs": [],
   "execution_count": 37
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:47.687805Z",
     "start_time": "2025-07-15T04:20:47.684422Z"
    }
   },
   "cell_type": "code",
   "source": "# mapping_to_maintype('solid tumor'), mapping_to_maintype('Solid tumor'), mapping_to_maintype('Solid Tumor')",
   "id": "54e453bcbf850408",
   "outputs": [],
   "execution_count": 38
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:47.732471Z",
     "start_time": "2025-07-15T04:20:47.729378Z"
    }
   },
   "cell_type": "code",
   "source": [
    "# mapped_site = []\n",
    "# for site in patient_list[0].site:\n",
    "#     # print(site)\n",
    "#     mapped_site += mapping_to_maintype(site)\n",
    "#     # print(mapped_site)\n",
    "# patient_list[0].mapping_site(mapped_site)\n",
    "# print(patient_list[0].mapped_site, len(patient_list[0].mapped_site))"
   ],
   "id": "1e5a48aca444cae3",
   "outputs": [],
   "execution_count": 39
  },
  {
   "metadata": {},
   "cell_type": "markdown",
   "source": "do match",
   "id": "c17f93a39ba3a1db"
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:20:47.779201Z",
     "start_time": "2025-07-15T04:20:47.776411Z"
    }
   },
   "cell_type": "code",
   "source": [
    "llm_query_role = 'you are an experienced oncology physician'\n",
    "patient_gene_mutation_llm_query_prompt = '''I have a patient which profile is below: {patient_profile}, tell the gene mutation the patient has from it. if it doesn't have, just return NaN. Do not add preceding text before the abstraction, and do not add notes or commentary afterwards. This will not be used for clinical care, so do not write any disclaimers or cautionary notes.'''\n",
    "# Ner_response_structure = {\n",
    "#     \"diagnosis\": 'cancer site',\n",
    "#     \"stage\": 'cancer stage'\n",
    "# }\n",
    "# summarized_patients = []\n",
    "# for patient in zip(patient_df['Clinical Note']):\n",
    "#     summarized_patients.append(Ask_LLM(model='deepseek-r1:14b',\n",
    "#                                        role=llm_query_role,\n",
    "#                                        query=patient_llm_query_prompt.format(patient_profile=patient,\n",
    "#                                                                              structure=Ner_response_structure)))"
   ],
   "id": "b0bf7c5bc5ceb40d",
   "outputs": [],
   "execution_count": 40
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:28:30.281070Z",
     "start_time": "2025-07-15T04:20:47.842018Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import os\n",
    "\n",
    "def get_top(tup, number):\n",
    "    key = []\n",
    "    tup = sorted(tup, key=lambda x: x[0], reverse=True)[:number]\n",
    "    for t in tup:\n",
    "        key.append(t[1])\n",
    "    return key\n",
    "\n",
    "\n",
    "def range_trials(tup):\n",
    "    key = []\n",
    "    tup = sorted(tup, key=lambda x: x[0], reverse=True)\n",
    "    for t in tup:\n",
    "        key.append(str(t[1]))\n",
    "    return key\n",
    "\n",
    "\n",
    "def prematch_trials(trial_list, patient):\n",
    "    pending_trials = []\n",
    "    # print(len(pending_trials))\n",
    "    for trial in tqdm(trial_list):\n",
    "        patient_mapped_site = patient.mapped_site\n",
    "        match_plag = False\n",
    "        for required_patient in trial.required_patients:\n",
    "            for pmappedsite in patient_mapped_site:\n",
    "                if pmappedsite in required_patient.mapped_site:\n",
    "                    # print(pmappedsite, required_patient.mapped_site)\n",
    "                    match_plag = True\n",
    "                    break\n",
    "        if match_plag:\n",
    "            # print('patient info: ', patient_mapped_site, patient.stage)\n",
    "            trials_mapped_site, trials_stage = [], []\n",
    "            for required_patient in trial.required_patients:\n",
    "                trials_mapped_site += required_patient.mapped_site\n",
    "                trials_stage += required_patient.stage\n",
    "            # print('trials info: ', trials_mapped_site, trials_stage)\n",
    "            pending_trials.append(trial)\n",
    "    return pending_trials\n",
    "\n",
    "\n",
    "from tqdm import tqdm\n",
    "\n",
    "prematched_trial_for_patient = dict()\n",
    "patient_id, patient_profiles, ctp = [], [], []\n",
    "for patient in patient_list:\n",
    "    patient_number = patient.patient_number\n",
    "    print(patient_number)\n",
    "    '''code match the trials'''\n",
    "    # separate the trial into phase_one and normal, do the match separately\n",
    "    pending_trials = []\n",
    "\n",
    "    pending_phase_one_trials = prematch_trials(trial_list=phase_one_trial_list, patient=patient)\n",
    "    pending_normal_trials = prematch_trials(trial_list=normal_trial_list, patient=patient)\n",
    "\n",
    "    # if the trials more than 10 or no gene mutation, just use the normal trials.\n",
    "    gene_mutation_response = Ask_LLM(model='deepseek-r1:14b',\n",
    "                                     role=llm_query_role,\n",
    "                                     query=patient_gene_mutation_llm_query_prompt.format(patient_profile=patient))\n",
    "    i = gene_mutation_response.find('</think>')\n",
    "    gene_mutation = gene_mutation_response[i + len('</think>'):]\n",
    "\n",
    "    # pending_trials = pending_normal_trials\n",
    "\n",
    "    if 'nan' in gene_mutation.lower():\n",
    "        pending_trials = pending_normal_trials + pending_phase_one_trials\n",
    "    else:\n",
    "        if len(pending_normal_trials) + len(pending_phase_one_trials) > 10:\n",
    "            pending_trials = pending_normal_trials\n",
    "        else:\n",
    "            pending_trials = pending_normal_trials + pending_phase_one_trials\n",
    "\n",
    "    # if len(pending_normal_trials) + len(pending_phase_one_trials) > 10:\n",
    "    #     pending_trials = pending_normal_trials\n",
    "    # else:\n",
    "    #     if 'NaN' in gene_mutation:\n",
    "    #         pending_trials = pending_normal_trials\n",
    "    #     else:\n",
    "    #         pending_trials = pending_normal_trials + pending_phase_one_trials\n",
    "\n",
    "    '''get score'''\n",
    "    score_list = []\n",
    "    patient_sentence = patient_site_stage_template.format(cancer_site=patient.site,\n",
    "                                                          cancer_stage=patient.stage)\n",
    "    print(len(pending_trials))\n",
    "    for trial in tqdm(pending_trials):\n",
    "        trial_required_sentence = []\n",
    "        # print(len(trial.required_patients))\n",
    "        for required_patient in trial.required_patients:\n",
    "            trial_required_sentence.append(trials_site_stage_template.format(cancer_site=required_patient.site,\n",
    "                                                                             cancer_stage=required_patient.stage))\n",
    "        score = max(F.cosine_similarity(embedding_out_tensor(patient_sentence),\n",
    "                                        embedding_out_tensor(trial_required_sentence)).cpu().numpy())\n",
    "        score_list.append((score, trial.name))\n",
    "\n",
    "    prematched_trial_name = range_trials(score_list)\n",
    "    # print(prematched_trial_name)\n",
    "\n",
    "    prematched_trial_name_str = ','.join(prematched_trial_name)\n",
    "\n",
    "    patient_id.append('Patient' + str(patient_number))\n",
    "    patient_profiles.append(patient.profile)\n",
    "    ctp.append(prematched_trial_name_str)\n",
    "\n",
    "    this_patient_dataframe = pd.DataFrame()\n",
    "    this_patient_dataframe['no.'] = [0]\n",
    "    this_patient_dataframe['Patient ID'] = ['Patient' + str(patient_number)]\n",
    "    this_patient_dataframe['Patient Profile'] = [patient.profile]\n",
    "    this_patient_dataframe['Trial Name'] = [prematched_trial_name_str]\n",
    "    per_patient_save_path = f'./data/output/prematch/{patient_file}/'\n",
    "    if not os.path.exists(per_patient_save_path):\n",
    "        os.makedirs(per_patient_save_path)\n",
    "    this_patient_dataframe.to_csv(per_patient_save_path + f'{patient_file} patient {patient_number} prematch result' + '.csv')\n",
    "\n",
    "prematched_trial_for_patient['Patient ID'] = patient_id\n",
    "prematched_trial_for_patient['Patient Profile'] = patient_profiles\n",
    "prematched_trial_for_patient['Trial Name'] = ctp\n",
    "prematched_trial_for_patient_df = pd.DataFrame(prematched_trial_for_patient)\n",
    "prematched_trial_for_patient_df.to_csv(f'./data/output/prematch/{patient_file}.csv',\n",
    "                                       index=False)"
   ],
   "id": "d513c7a70c680133",
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 82850.45it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 295917.15it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "0it [00:00, ?it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 91428.97it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 209487.50it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "25\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 25/25 [00:06<00:00,  3.58it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 116914.40it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 185339.08it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "47\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 47/47 [00:08<00:00,  5.66it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 154628.72it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 97002.51it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 6/6 [00:04<00:00,  1.22it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 99273.47it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 136932.56it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 7/7 [00:04<00:00,  1.50it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 135847.90it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 226719.14it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "22\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 22/22 [00:05<00:00,  4.31it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 81840.08it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 203735.99it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 11/11 [00:05<00:00,  2.18it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "7\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 110376.42it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 234432.54it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 6/6 [00:04<00:00,  1.29it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 122016.12it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 228059.08it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 11/11 [00:05<00:00,  2.15it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 79891.50it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 168947.45it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "37\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 37/37 [00:06<00:00,  5.52it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 145257.28it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 261079.82it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 6/6 [00:04<00:00,  1.29it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "11\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 86703.96it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 116790.55it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 9/9 [00:04<00:00,  1.83it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "12\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 84733.41it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 191787.26it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "24\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 24/24 [00:06<00:00,  3.85it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "13\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 111848.11it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 226719.14it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "26\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 26/26 [00:06<00:00,  4.30it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "14\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 117323.19it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 231896.62it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 4/4 [00:04<00:00,  1.13s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "15\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 106184.91it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 209487.50it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 4/4 [00:04<00:00,  1.15s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "16\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 111107.39it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 216055.97it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 9/9 [00:04<00:00,  1.84it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "17\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 100462.37it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 153980.83it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "47\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 47/47 [00:07<00:00,  6.27it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "18\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 123361.88it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 226187.55it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 9/9 [00:04<00:00,  1.83it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "19\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 89003.80it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 230511.33it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "24\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 24/24 [00:06<00:00,  3.95it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "20\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 101372.91it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 251221.33it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 9/9 [00:04<00:00,  1.82it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "21\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 113743.84it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 223566.61it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 4/4 [00:04<00:00,  1.16s/it]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "22\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 118987.35it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 229961.84it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "5\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 5/5 [00:04<00:00,  1.10it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "23\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 122461.43it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 203951.36it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "6\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 6/6 [00:04<00:00,  1.28it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "24\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 108240.10it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 195479.21it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "37\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 37/37 [00:07<00:00,  5.25it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "25\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 66576.25it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 129837.14it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "52\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 52/52 [00:07<00:00,  6.70it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "26\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 73262.95it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 153368.83it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "47\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 47/47 [00:07<00:00,  6.19it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "27\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 134217.73it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 228870.68it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 9/9 [00:04<00:00,  1.87it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "28\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 34663.67it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 74753.19it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "37\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 37/37 [00:06<00:00,  5.60it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "29\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 112222.18it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 207237.36it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:04<00:00,  1.63it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "30\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 97259.22it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 215092.51it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "37\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 37/37 [00:06<00:00,  5.47it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "31\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 82040.18it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 221513.18it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "31\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 31/31 [00:06<00:00,  4.94it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "32\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 13701.28it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 173193.88it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "47\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 47/47 [00:07<00:00,  6.18it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "33\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:00<00:00, 98400.09it/s]\n",
      "100%|██████████| 46/46 [00:00<00:00, 171653.01it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "8\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 8/8 [00:04<00:00,  1.64it/s]\n"
     ]
    }
   ],
   "execution_count": 41
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-07-15T04:28:30.328736Z",
     "start_time": "2025-07-15T04:28:30.326506Z"
    }
   },
   "cell_type": "code",
   "source": "",
   "id": "5f1232f8f6e32942",
   "outputs": [],
   "execution_count": null
  },
  {
   "metadata": {},
   "cell_type": "code",
   "outputs": [],
   "execution_count": null,
   "source": "",
   "id": "8176cd419870cc65"
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "openai",
   "language": "python",
   "name": "openai"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
